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ABSTRACT
Staphylococcus aureus is a highly problematic human pathogen due to its ability to
cause devastating infections, paired with a capacity to withstand the action of a large
fraction of available antibiotics. Both pathogenicity and antibiotic resistance are encoded
by numerous genomic elements, though the expression of these factors is energetically
costly and not always beneficial for cellular survival. Therefore, S. aureus has
developed sophisticated regulatory networks to integrate a multitude of signals,
enabling it to navigate the delicate balance between its pathogenic lifestyle and baseline
needs for cellular energy homeostasis. It is thus imperative to study S. aureus behavior
and its underlying regulatory circuits not as isolated entities, but rather holistically as
part of an optimized, highly interconnected system. To do so, we must seek to achieve
a comprehensive understanding of all encoded regulators, that is, not only historically
well defined elements like transcription factors, two-component systems and σ factors,
but also the lesser studied ’non-classical’ regulators like small regulatory RNAs and
regulatory subunits of RNA-dependent RNA polymerase (RNAP). To this end, we
describe here the identification of numerous, previously unidentified sRNAs and their
incorporation into a new standardized cataloging and annotation system. The
identification and annotation procedures are based on a number of RNAseq
experiments performed in three different S. aureus backgrounds (MRSA252, NCTC
8325, and USA300). We then apply RNAseq to evaluate the expression patterns of
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these elements when grown in human serum, thus probing for possible connections
between sRNAs and S. aureus pathogenicity. In addition, we characterize the role of
two small RNAP subunits, δ and ω, for S. aureus RNAP function. δ is of particular
interest, as it is unique to Gram-positive bacteria; deletion of the subunit results in a loss
of transcriptional stringency and decreased expression of numerous virulence
determinants. These alterations are accompanied by impaired survival of the δ mutant
in whole human blood, increased phagocytosis by human leukocytes, and decreased
survival in a murine model septicemia when compared to its parental strain. In contrast,
there is no indication of direct and gene-specific transcriptional functions for ω. Rather,
we describe a role for ω in the structural integrity of the RNAP complex, where its loss
leads to a structural disturbance in the RNAP complex that causes altered affinities for
(alternative) σ factors and the δ subunit. Overall, the findings presented here contribute
to a better understanding of the intricate regulatory systems that guide the lifestyle of an
organism that presents an immense burden to patients and our health care system
alike.
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CHAPTER 1: INTRODUCTION

A CASE FOR THE COMPLEXITY OF THE STAPHYLOCOCCUS AUREUS
LIFESTYLE AND THE NEED FOR CONSTANT ADAPTATION
“Life is not always a matter of holding good cards, but sometimes, playing a poor hand
well.”
- Jack London
Staphylococcus aureus is a Gram-positive, facultative anaerobe. Phylogenetically, this
coccal bacterium belongs to the phylum Firmicutes, whose members are characterized
by a low G-C content. This bacterium can be found as a commensal asymptomatically
colonizing the human body, but can alternatively present itself as a formidable
pathogen. It is thus characterized as an opportunistic pathogen. Since its first isolation
in 1880 [1], the bacterium has garnered widespread attention driven by several key
events, the most notable of which being the development of resistance to a number of
widely used antibiotics [2-5] and large-scale outbreaks in nosocomial settings, as well
as in healthy communities in Northern America, Europe, and the Asia-Pacific region. A
recent study reported ~500,000 S. aureus-related hospitalizations in the USA in 2005,
associated with annual costs of an estimated $830 million to $9.6 billion [6], highlighting
the immense socio-economic burden this organism presents.

1

From the hospital to the community: The adaptation of S. aureus to the healthy
population
Historically, S. aureus infections have occurred in high rates within the nosocomial
setting. These trends have escalated due to the appearance of numerous resistance
mechanisms against most available antibiotics [7, 8]. These “waves of resistance’ [8]
have been the result of the acquisition of genetic elements that render the bacterium,
which is ‘naturally susceptible to virtually every antibiotic that has ever been developed’
[8], resistant to precisely these antimicrobial agents. Soon after the introduction of the
very first antibiotic, penicillin, in 1941 the first resistant strains were reported in 1942 [2]
and soon spread through the hospital system. As of 1959, it was possible to combat
these strains for a limited time through the use of methicillin. Nevertheless, the
appearance of methicillin-resistant S. aureus (MRSA) [3], which acquired the mecA
locus in the early 1960’s, caused a second large wave of infections (reviewed by [9]).
These infections were largely nosocomial, so the causative strains were referred to as
hospital acquired-MRSA (HA-MRSA). Subsequently, a third large wave occurred in the
late 70’s and mid 80’s [8] and led to high usage of vancomycin, a last resort antibiotic
against MRSA infection. The bacterium quickly adapted, and intermediate (vancomycin
intermediate S. aureus, VISA) [4] and full vancomycin resistance (vancomycin
resistance S. aureus, VRSA) [5] appeared. This development seriously endangered the
treatment of complicated infections, but the concerning strains were still largely refined
to hospitals. However, novel strains appeared concurrently and were able to infect the
otherwise healthy population (community acquired MRSA, CA-MRSA) in Western
Australia [10] as well as in the US [11]. Research into the unique features and
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differences between HA-MRSA and CA-MRSA is an active field of research and has
been reviewed in detail on several occasions [12-15]. In order to delineate between S.
aureus subgroups in context of the health care setting, the Center for Disease Control
and Prevention (CDC) has defined a case as CA-MRSA-related when MRSA isolates
from outpatients were obtained within 48 h after admission to the hospital and
underlying risk factors like a history of hospitalizations, surgery, dialysis, or residence in
a long-term care facility within one year prior to hospitalization are absent. Disqualifying
criteria for CA-MRSA also include the presence of an indwelling catheter or
percutaneous device and previous isolation of MRSA from the patient [16].

From an epidemiological standpoint, CA-MRSA strains in the US belong to the USA300
and USA400 pulsed-field gel electrophoresis (PFGE) pulsotypes, while HA-MRSA are
commonly USA100 and USA200 [17]. As mentioned before, outbreaks with CA-MRSA
strains usually affect parts of the population that did not have any previous
hospitalization or underlying risk factors. Nevertheless, certain groups with elevated
risks for infection are present in the population, and David and Daum [12] have
produced a comprehensive overview of outbreaks in a variety of community settings.
Briefly, parts of the population that are proposed to be at particular risk for CA-MRSA
infections are, amongst others, children of different ages, athletes of various sports
(usually those involving skin to skin contact), underserved urban communities,
indigenous populations, inmates in correctional facilities, military members, and
individuals that are in close contact with animals (e.g. livestock handlers, pet owners,
veterinarians) [12]. The newly acquired ability to infect young and otherwise healthy
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individuals has attracted a lot of attention from the scientific community, and we have
consequently developed a clearer understanding of the genomic changes that allow
transition from the hospital to the community. Several hallmarks of CA-MRSA strains,
when compared to their nosocomial counterparts, were identified [14]:

i) A major finding was that there are obvious differences in the genomic content
concerning the presence of distinct mobile genetic elements in HA- and CA-MRSA
strains. As mentioned above, MRSA strains carry the mecA gene, which encodes for
penicillin binding protein 2a, conferring resistance to methicillin [18]. Together with two
regulators of mecA, mecI and mecR, this locus is encoded on the staphylococcal
cassette chromosome mec (SCCmec) [19]. At least 11 different SCCmec types with
varying structural organization and content have been found ([20]; an updated list is
available under http://www.sccmec.org/). While HA-MRSA strains carry the larger
SCCmec types I-III, the smaller types IV or V are found in CA-MRSA. Though the size
of the latter two is connected to a lower fitness cost [21] and a higher mobility of the
elements themselves [22], types I-III carry additional antibiotic resistance genes [23],
explaining the multi-drug resistance (MDR) phenotypes of HA-MRSA. In contrast, CAMRSA strains are, with exceptions [24], sensitive to non-β lactam antibiotics. Combined,
these findings concerning the distribution of SCCmec elements aided our understanding
of the differences between HA- and CA-MRSA strains, ultimately leading Lee and
colleagues [21] to propose that the presence of type IV and V elements in CA-MRSA is
driven by ‘the selection for factors that contribute to ecological fitness [and] may
outweigh the need for multiple resistance determinants’.
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ii) As CA-MRSA strains are able to infect otherwise healthy individuals, it was long
suspected that community and hospital strains differ in the expression of virulence
determinants (S. aureus encodes for a large number of proteins that allow for
colonization and survival in or on the host, termed virulence factors, and collectively
referred to as the ‘virulome’ [25]). Such a notion has now been confirmed for several
proteins that directly contribute to S. aureus pathogenicity. These factors include the
Panton-Valentine Leukocidin (PVL), several Phenol Soluble Modulins (PSMs), and αtoxin, all of which are cytolytic (though acting against different cell types). The twocomponent leukocidin PVL was first described and connected to infection in 1894 [26]
and 1932 [27], respectively. The factor was the first to be thoroughly researched for a
connection to the appearance of CA-MRSA strains, as it was observed early that the
encoding genes (lukS-PV and lukF-PV) are found in nearly all CA-MRSA isolates [2831] and are often absent in HA-MRSA strains [28]. Although this β-pore-forming toxin is
well known to lyse human neutrophils [32] and is therefore considered a bona fide
virulence factor, there is debate as to how much the factor actually contributes to the
CA-MRSA specific pathophysiology (discussed by [12, 14, 33]). This doubt is derived
mainly from the finding, amongst others, that PVL action is model-dependent [32] (e.g.
mouse [34] vs. rabbit [35]) and therefore studies have produced partially contradicting
results.

Two additional (groups of) toxins that have been connected to the appearance of CAMRSA strains are PSMs [36] and the α-toxin [37], both of which are effective cytolysins
(reviewed by [38] and [39, 40], respectively). The seven PSMs (PSMα1-PSMα4,
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PSMβ1, PSMβ2 and δ-toxin) encoded by S. aureus are small amphipathic α-helical
peptides that have been linked to S. aureus pathogenicity [36, 41], largely due to their
ability to lyse neutrophils [36], erythrocytes [42] and osteoblasts [43]. Alpha-toxin, also
known as α-hemolysin, due to its ability to lyse erythrocytes (amongst a variety of other
cell types [40]), has also been shown to contribute to the ability of S. aureus to cause
disease [41, 44]. In contrast to PVL, there is no obvious difference in the presence of αtoxin and PSM genes between HA- and CA-MRSA isolates. Nevertheless, differences in
their corresponding expression patterns (and subsequently protein abundance) when
comparing HA- and CA-MRSA have been described [36, 45]. Since both PSM [46] and
α-toxin [47] loci are controlled by the major regulatory system Agr (discussed in more
detail below), the discovery of increased Agr activity in CA-MRSA [48] ultimately
explained the higher abundance of such toxins in these strains.

iii) Another factor that was connected to the success of S. aureus as a pathogen within
the healthy community was the acquisition of an additional mobile genetic element,
ACME (arginine catabolic mobile element). This element, acquired originally from
Staphylococcus epidermidis [49], is omnipresent in the USA300 pulsotype and has
been linked to its ability to cause disease in a rabbit model [49]. At least two avenues for
how the ACME-encoded genes aid colonization and infection by S. aureus have been
reported. First, the gene cluster encodes for an arginine deiminase system (Arc), which
enables S. aureus to persist in acidic environments [50], such as that found on human
skin [51]. A second gene, speG, encodes for a spermine/spermidine-acetyltransferase,
which confers resistance to polyamines (e.g. spermine and spermidine) [52].
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Polyamines are naturally produced by the human body as important factors in wound
healing [50, 53]. Interestingly, it was previously thought that all forms of life were able to
synthesize and therefore resist possible inhibitory effects of polyamines. Contrary to this
assumption, it was recently shown that S. aureus inherently is incapable of producing
polyamines and is highly sensitive to their presence [52]. By the acquisition of ACME,
and in particular speG, CA-MRSA strains are able to overcome these effects. Thus, the
presence of ACME allows S. aureus to effectively colonize and infect the skin, which
explains the high incident rate of skin infections with CA-MRSA strains (as discussed in
the following section). These findings extend our epidemiological understanding of S.
aureus in other contexts, too: since ACME was described to be solely present in the
USA300 lineage [54], it has been suggested that the element aided in the replacement
of other CA-MRSA lineages, e.g. USA400 [50].

Overall, the differences between HA- and CA-MRSA are multifactorial, but can be
summarized as a fine balance between virulence and fitness. While certain virulence
genes are upregulated (PSMs and α-toxin) or omnipresent (PVL) in CA-MRSA strains,
these lineages sacrificed larger SCCmec elements that carry higher number of
resistance genes for smaller and more mobile elements with a smaller fitness burden on
the cell. Simultaneously, the acquisition of novel elements, such as ACME, presents a
fitness advantage on the skin, therefore making parts of the human body more
accessible to CA-MRSA strains. These alterations have been the result of both
horizontal gene transfer (e.g. in case of PVL or ACME) as well as modifications of
existing genomic content (e.g. increased activity of Agr and a concomitant increase in
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expression of virulence determinants). Ultimately, the findings summarized in this
section highlight the extraordinary ability of this pathogen to adjust to novel conditions
and challenges, e.g. the increased usage of antibiotics, and explain our difficulties in
overcoming the negative impact of HA- as well as CA-MRSA strains; despite all of the
advancements made in our health care system.

Not a one-trick pony: The broad spectrum of diseases caused by S. aureus
The increasing attention cast towards S. aureus can be explained by its versatility as a
pathogen, allowing the bacterium to infect almost every site within the human body
(comprehensively reviewed by [55]). Amongst the different disease manifestations,
perhaps the most concerning is the occurrence of invasive infections, and the
development of acute Staphylococcus aureus bacteremia (SAB) [56-60]. In this regard,
several studies found S. aureus to be the leading cause of bacteremia in Europe [61]
and the Americas [62, 63]. Although advances in health care and in particular the
introduction of antibiotics (i.e. penicillin [64]), have rapidly decreased mortality rates
from untreated S. aureus infections (75%-82%) [65, 66], mortality within 30 days of the
onset of infection at the end of the 20th and beginning of the 21st century is still ~20%
[67-69]. These numbers represent the immense progress modern medicine has made
to date, but also highlight existing limitations for treatment of SAB and the threat that an
impending postantibiotic era due to increasing (multi-) drug resistance amongst
bacterial pathogens presents [70]. In addition to general and systemic implications of
SAB, infection of the endocardium (invasive endocarditis, IE) is especially problematic
and commonly seen during invasive infection with S. aureus. At this point, S. aureus is
8

still a leading cause of IE and was found to be the most prevalent pathogen when
investigating ~1800 cases of IE in 16 countries [71]. Even more concerning, the number
of patients in the US affected by IE as well as overall mortality rates have been
increasing during the first decade of the 21st century [72]. Beyond these directly lifethreatening invasive infections, S. aureus is the leading cause of osteoarticular
infections, including osteomyelitis, septic arthritis, and prosthetic joint infection [55]. In
particular, the latter presents a large burden in a steadily aging population, where
arthroplasty is and will continue to be a common procedure [73]; with ~2% of patients
affected by S. aureus [74, 75].

Although invasive infections present a major concern, not all diseases caused by S.
aureus require deep penetration of the bacterium into the human body: the clinical
picture of S. aureus also commonly comprises skin and soft tissue infections (SSTIs),
including cutaneous abscesses as well as purulent and non-purulent cellulitis, impetigo,
and necrotizing fasciitis [12]. Although these infections have been prevalent and
historically connected to S. aureus, the number of such diseases has drastically
increased since the appearance of CA-MRSA strains, and is particularly driven by the
USA300 lineage [76-78]. Severity of these infections can vary widely, but increasing
numbers of hospitalizations have been observed [78], adding to the challenges that S.
aureus presents for society and the healthcare system. Lastly, along with the disease
manifestations above, S. aureus is a common cause for a variety of pleuropulmonary-,
gastrointestinal-, and urinary tract infections, as well as for bacterial meningitis, which
won’t be discussed in detail here, but have been reviewed elsewhere [55].
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These high numbers of infections within the hospital and in the community ultimately
raise the question of the natural reservoir and/or path of infection. In a nosocomial
environment, transmissions have been well tracked and it is widely acknowledged that
improved hygienic standards can effectively prevent S. aureus outbreaks and crosscontamination between patients [79-83]. In contrast, the mode of transmission within the
community is more complex, though we now have a better understanding of the survival
of the bacterium on different fomites [84], as well as its transmission dynamics
(reviewed by [12]). Such findings ultimately let the CDC to release a list of risk factors
for MRSA transmission (‘5 C’s’): i) Crowding ii) frequent skin-to-skin Contact iii)
Compromised skin iv) Contaminated items and surfaces and v) lack of Cleanliness
(http://www.cdc.gov/niosh/topics/mrsa/). Furthermore, nose picking was related to
higher chances of S. aureus nasal colonization and therefore should be avoided where
possible [85].

Despite these hygiene and safety measures, we now appreciate that large numbers of
individuals are asymptomatically colonized with S. aureus at a variety of sites of the
human body [86]. Most notably, S. aureus has a natural reservoir in vestibulum nasi
within the squamous epithelium [86]. Additionally, extra-nasal colonization sites include
skin, throat, perineum, vagina, and gastrointestinal tract [86-89].

Adjustment to highly variable environments: From nasal colonization to invasive
infection
As discussed in the previous sections, S. aureus strains have evolved to interact with
10

healthy and predisposed individuals alike, causing a variety of clinical manifestations.
Nevertheless, S. aureus can also reside on the human host without causing any
symptoms. This asymptomatic colonization with a highly virulent pathogen raises the
question: how does the bacterium employ its genetic content to foster a balance that
allows for niche survival without triggering a strong immune response, such that it can
survive in close proximity to its host? Therefore, this section will consider the adaptation
of S. aureus to various host environments, with a focus on the nose as the primary
reservoir for S. aureus colonization.

Colonization with S. aureus
Numerous studies have investigated the extent of colonization with S. aureus within the
healthy population, i.e. asymptomatic colonization. This is of particular interest, as nasal
colonization is associated with risk of infection by the pathogen [86, 90, 91]. Historically,
three colonization patterns have been identified to describe S. aureus carrier
subpopulations. These include i) persistent carriers who always carry the bacterium in
their nose (~20% of the population), ii) intermittent carriers who carry the bacterium for
short times (~30%), and iii) non-carriers who are never colonized (~50%) (reviewed by
[86]). These categories, however, have been brought into question recently, and it has
been recommended to distinguish only between carriers and ‘others’ [92], as
intermittent and non-carriers show similarly contrasting features from persistent carriers
when comparing i) immune response to colonization [92], ii) bacterial loads during
colonization [92], iii) survival rates of the bacterium in the nose [92], and iv) risk of
infection [93]. This latter point is additionally supported by evidence that the
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endogenous strain is usually that found during invasive infection [91]. Nevertheless,
persistent colonization has been associated with lower mortality rates in the event of an
invasive infection [94].

Microbial interaction during nose colonization
Once S. aureus is transferred and begins to colonize the nose, the bacterium
encounters a number of unfavorable factors, from nutrient limitation, to mechanical
forces, to the action of the immune system. Moreover, due to its constant stream of
airflow, the nose is an organ that is heavily colonized with a number of other
microorganisms [95], and we are only starting to understand the complex interplay of S.
aureus with other members of the nasal microbiome [96]. Antagonistic interactions have
been reported for many of these co-colonizers, including Lactobacillus [90, 97],
Corynebacterium sp. [98, 99], Streptococcus pneumoniae [100, 101], Streptococcus
mitis [90] and S. epidermidis [99, 102, 103]. Particular focus has been given to
competition with Staphylococcus ludgenensis, as this bacterium produces a
thiazolidine-containing cyclic peptide antibiotic, Lugdunin, which inhibits S. aureus
growth and could be used as a novel therapeutic [104]. Although information concerning
the interaction of S. aureus with the nasal microbiota is steadily growing, it is noteworthy
that some studies reported partially conflicting results [105] (here in the case of S.
epidermidis and Corynebacterium sp.), which may be attributable to strain- and speciesspecific differences and highlight the need to further investigate polybacterial
interactions in this niche.
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Adaptation to the nasal environment
Adhesion to (biotic or abiotic) surfaces is the first and most important step for
colonization, and ultimate success, of a pathogen (with the exception of toxin-mediated
diseases). Although the colonization and formation of biofilms on abiotic medical
devices, e.g. catheters or artificial heart valves, is an immense problem in the hospital
setting [55], this section will primarily focus on the attachment to biotic surfaces.
Attachment is typically differentiated into i) primary attachment through binding to a
(host) surface, and ii) the formation of a biofilm, which necessitates proliferation and
establishment of contact between dividing bacteria (intercellular adherence) [106].
During initial attachment to surfaces, bacterial proteins interact with host extracellular
matrix components via both proteinaceous and non-proteinaceous factors. Components
that are attached to the cell wall, usually by action of the protein sortase [107], are
termed microbial surface components recognizing adhesive matrix molecules
(MSCRAMMs) [108]. In addition, secreted proteins that are not anchored to the cell wall
but still affect adhesion (and in some cases immune response) are referred to as
secretable expanded repertoire adhesive molecules (SERAMs) [109]. Lastly, nonspecific interactions have also been suggested to play a role, e.g. in the form of
hydrophobic interactions [110]. Numerous host factors are bound by MSCRAMMs and
SERAMs, including fibronectin, fibrinogen, fibrin, collagen, elastin, vitronectin,
thrombospondin, bone sialoprotein, elastin, collagen, prothrombin, and von Willebrand
factor (reviewed by [111]).
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Although there are numerous MSCRAMMs and SERAMs, only a few have been shown
to significantly affect colonization of the nose [112, 113]. Two MSCRAMMs, clumping
factor B (ClfB) [114-117] and iron-regulated surface determinant A (IsdA) [118-120], as
well as wall teichoic acids (WTA) [121, 122], have been identified as the main
contributors to nasal attachment. Additionally, the MSCRAMMs S. aureus surface
protein G (SasG) [123] and serine-aspartic acid repeat proteins C and D (SdrC/D) [124]
allow binding to human desquamated nasal epithelial cells, while fibronectin binding
proteins (FnBPs) can mediate internalization into a number of (non-phagocytic) cell
types [125]. Some other factors (summarized by [126]) have also been linked to nose
colonization, although to a lesser extent than those listed above.

Several of these adhesion factors are seemingly redundant as they are able to bind to
the same cell types. Burian et al. [127] shed light on this apparent redundancy with their
investigation into temporal expression patterns over 10 days of nose colonization using
a cotton rat model. The study revealed that WTA biosynthesis genes are highly
expressed during early stages of attachment, while later phase attachment is driven
primarily by high expression of clfB and isdA. This finding is consistent with a study
investigating the effects of loss of adhesion factors on the adhesion process [128], in
which, as expected, a WTA-deficient strain had a severely impaired ability to colonize
rat noses. Inversely, a sortase mutant deficient in MSCRAMM display on the cell
surface (ClfB and IsdA, amongst others) was able to undergo early colonization, but
was prematurely cleared some time between 6 and 14 days post infection, indicating a
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role in colonization persistence, which is also in line with other group’s findings [116,
117].

In addition to investigating the expression patterns of adhesion factors, numerous
studies (including those referred to above) have sought to understand how cellular
physiology is shaped by exposure to the environmental conditions found in the nose,
using in vitro (employing artificial nasal medium) [129] and in vivo transcriptomics [127,
130-132], as well as proteomic [133] approaches. All of these studies have consistently
shown that the environment in the nose not only strongly favors attachment but also
induces the expression of immune evasion proteins [130, 131] and simultaneous
decreases virulence factor and toxin production [129, 130], pointing towards a
commensal state for the bacterium. Correspondingly, known regulators of virulence,
including agr and sae, sigB, sarR, graR, have each been reported by one or more
studies to be lowly expressed [127, 129-131]. Interestingly, gene expression patterns
can differ from host to host, indicating that a host-specific response is present, further
complicating the host-pathogen interaction [130, 131]. This notion is made evident by a
recent study using a mouse model, which showed that the transcriptional profiles of
invading S. aureus are strongly dependent on (the level of) the immune response of the
host [132]. Such a notion was furthermore supported by the finding that persistent
carriers decontaminated for S. aureus tend be re-colonized with their previously
endogenous strain when exposed to a mixture of strains, ultimately pointing towards the
existence of optimal host-pathogen pairings [92].
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All of these adaptation processes are guided by complex regulatory networks that
determine the balance between commensalism and invasive disease. In this regard,
Edwards et al. [112] postulate that an absence of evolutionary pressure for virulence
expression in the nose is consistent with low expression of the agr system, and the
-

presence of agr genotypes in nasal and blood isolates [134-136]. Nevertheless,
virulence factor expression is determinative for S. aureus infection, and cues must
therefore be present that switch the balance towards virulence, and thus favor invasive
behavior, rather than adhesion and asymptomatic colonization.

After entering the body
Although the human skin is a formidable physical barrier with various additional defense
mechanisms [137, 138], S. aureus is still able to penetrate and cause invasive infection.
For a long time, it was believed that a breach in the skin is required for infection, e.g.
due to contact in sports (such as football or wrestling) [139, 140], intravenous drug use
[141], or shaving and subsequent skin-to-skin contact during sex [142]. Nevertheless,
recent studies investigating the invasion of healthy skin showed that S. aureus is able to
provoke programmed cell death (pyroptosis) and thereby penetrate through the
keratinocyte barrier without necessitating previous structural damage [143, 144].
Once inside the body, information about site-specific in vivo interactions with the host is
less complete, due to the complexity of the system, and the inaccessibility of sites
compared to the nose. We (chapter 4 of this dissertation) and others have attempted to
perform transcriptomics either under conditions that are thought to mimic the conditions
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found within the host [145] or from specimens collected directly from infection sites
[146]. Nevertheless, this picture is far from complete, as a multitude of factors influence
the behavior of the pathogen when entering the human body. This section thus provides
only a brief overview of this complex field of investigation.

A comprehensive review of the adjustment of S. aureus to various sites and conditions
was recently published by Balasubramanian and colleagues [147]. The authors describe
in great detail the response of S. aureus to different environments and conditions within
the host as well as the bacterial regulatory response, with a focus on the expression of
virulence determinants. In general, four main categories of stimuli are delineated, all of
which can differ significantly between different organs and organ systems: i) oxygen
content, ii) nutrient (e.g. carbohydrates or amino acids) availability, iii) iron availability,
and iv) organ-specific immune responses:

i) The human body varies widely in local oxygen levels, ranging from high oxygen levels
in the blood to nearly anaerobic conditions in the intestines. Since bacteria as well as
recruited immune cells consume oxygen, levels have been shown to further decrease at
sites of infection ([148, 149] and reviewed by [150]). In the context of hypoxia (a state of
oxygen deprivation), osteomyelitis has been studied intensively. Osseous tissue is
considered hypoxic [151], particularly during infection [152]. This environment triggers a
complex response in S. aureus involving multiple regulatory systems (e.g. SrrAB),
leading to an increased cytotoxicity towards both murine and human cell types [152].
NreBC [153, 154] and AirSR/YhcSR [155, 156] regulatory networks, too, have been
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connected to adaptation to hypoxic conditions, underscoring the complex response of
the bacterium to oxygen levels as an environmental stimulus.

ii) Similar to oxygen sensitivity, cells are able to react to fluctuating nutrient availability,
including carbon sources and amino acids, which can vary greatly between distinct sites
in the human body. Furthermore, the amount of available compounds depends on the
individual and any comorbid conditions, e.g. increased glucose in patients suffering from
diabetes mellitus triggers an alternative reaction by the pathogen. In line with these
findings, high glucose levels following surgery were connected to increased occurrence
of infection (not limited to S. aureus) in diabetic patients [157]. These patients have a
increased risk for pneumonia caused by S. aureus and are often affected by infections
of foot ulcers [158], leading to further complications and increased mortality [159].
Similarly, poorer outcomes after infection have been reported during animal studies
using a diabetic mouse model compared to healthy counterparts [160].

The effects of high glucose levels on S. aureus were investigated to elucidate how
comorbid conditions affect the pathogen. A connection between glucose availability and
disease manifestation was established when mutants deficient in glucose uptake were
shown to display attenuated virulence in a murine SSTI model [161]. Likewise, high
glucose levels are connected to elevated expression of virulence factors dependent on
the regulator CcpA [162]. CcpA is known to be involved in carbon catabolite repression,
a common theme in Gram-positive bacteria [163, 164]. Other regulators that connect
the physiological state of the cell with the expression of virulence determinants are the
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regulators RpiRc [165, 166] and CodY [167, 168]. While RpiRc repression of virulence
is induced during metabolic shifts, CodY repression of virulence genes is induced during
shortage of branched chain amino acids. These examples serve to highlight the
response of S. aureus to changing environments, linking metabolism and virulence by
connecting nutritional status to the invasive and pathogenic behavior of S. aureus.

iii) Another response by the human host to infection is driven by the iron requirement
(as well as other transition metals) for all forms of life. Due to its vital importance, host
and invading pathogen constantly compete for this valuable resource. This interplay has
been extensively researched and reviewed on several occasions [169-171]. Briefly, the
host is able to efficiently bind and store iron, creating an extremely iron-deprived
environment with extracellular concentrations of free iron at attomolar (10-18 M) levels
[172]. These levels are actively decreased further in response to infection, leaving
bacteria extremely iron-starved, effectively supporting the activity of the immune system
in a process described as ‘nutritional immunity’ [173]. In response to these low iron
levels, S. aureus has developed sophisticated mechanisms to free iron from the host,
including scavenging iron from host glycoproteins (siderophore-mediated), or
internalization of host heme and recovery of bound iron. The important survival function
of these mechanisms is demonstrated by studies showing that depletion of involved
proteins leaves the bacterium significantly impaired in its ability to cause disease in a
mouse model [174-176]. As would be expected for an important and limited resource,
several regulatory circuits within the bacterium are in place to ensure sufficient iron
pools. These are directed by the main regulator Fur, which represses iron-
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transport/import in the presence of iron [177] to prevent toxic effects caused by excess
iron accumulation. Thus, this regulator, just like CodY, RpiRc and CcpA, connects
nutritional status to virulence by repressing virulence determinants in response to iron
starvation [178].

iv) Although our understanding of the human immune system has dramatically
improved over the last few decades, only limited information is available about organspecific (innate) immune responses to S. aureus. Nonetheless, this is currently a highly
active area of investigation whose work will be indispensable to our understanding of S.
aureus infection (discussed in detail elsewhere [179, 180]). For now, a model has been
posited to guide efforts in this direction with emphasis on the influence of the unique
interaction that each organ maintains with the environment (i.e. varying exposure to
microorganisms). In this model, each organ has a colonization threshold depending on
its proximal environment and function (among other factors) ranging from ‘sterile’ to
heavily colonized organs [180]. Therefore, S. aureus likely has to exploit various
mechanisms to avoid eradication by the immune system with location-dependent
specificity, and a consideration for macro- and micronutrient levels.

Regulatory circuits guiding S. aureus
S. aureus encodes an exceptionally large arsenal of virulence determinants that aid in
its ability to infect various sites in the human body [181-183]. As the expression of these
virulence determinants requires precise spatio-temporal control at each colonization
site, complex regulatory networks must be in place to secure a precise orchestration of
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these factors [184]. These ‘classical’ regulatory proteins include 115 transcriptional
regulators [185] and 16 two-component systems (TCSs) [185, 186]. Furthermore, S.
aureus encodes four σ factors, including σA [187], the house keeping factor; σB [188],
the primary alternative σ factor; and two additional alternative factors, σH [189] and σS
[190] with more elusive roles.

Due to their importance for S. aureus pathogenicity, regulatory proteins have been
identified as possible targets for the development of antimicrobials against S. aureus
[191-194]. Accordingly, these regulatory networks have long been the focus of S.
aureus research. Initial investigation into these systems was vastly advanced with the
discovery of the Agr (accessory gene regulator) system, still widely regarded as the
most important regulatory system of the bacterium ([195-197] and reviewed by [198]).
The agr locus (agrBDCA) was found to encode a quorum sensing system [199] that
allows the activation of virulence once the population reaches a critical mass [200]. In
this system, agrD encodes for a propeptide that is processed and secreted by the
membrane protein AgrB in concert with the peptidase SpsB [201]. Processing of the
propeptide results in the mature autoinducing peptide (AIP), which, once a threshold
extracellular concentration is reached, is bound by the receptor AgrC. This sensory
protein coordinates with the response regulator AgrA in a TCS. Upon AIP-dependent
activation of the system, AgrA induces expression of the agrBDCA promoter (P2),
initiating a positive feedback loop. In addition, AgrA induces expression from the
promoter P3 (downstream and divergent to P2) as well as other target promoters (e.g.
controlling PSM genes) [46]. It is thought that AgrA’s primary contribution to S. aureus
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pathogenicity is mediated via the effector transcript RNAIII, which is under control of
promoter P3 [47, 202]. RNAIII itself is a ‘pleiotropic effector’ [203] that not only encodes
for δ-hemolysin [204] but also acts as a regulatory RNA either directly, or indirectly
through its action on the regulator Rot. For its direct regulatory roles, RNAIII binds its
target mRNAs - virulence factors like protein A [205], coagulase [206], SA1000 and
SA2353 [207] - to prevent translation and induce degradation of the transcripts
(reviewed by [208]). Perhaps the most thoroughly studied RNAIII interaction is with the
rot transcript, which was first identified by McNamara and colleagues [209] during a
transposon screen for compensatory mutations in an agr-null strain. The mechanistic
significance of this interaction is that RNAIII-mediated translational repression of the rot
transcript, via binding and degradation, prevents Rot-dependent repression of virulence
factors (Rot: repressor of toxins) [207, 210]. This clarified why i) an agr null strain is
severely impaired in virulence factor expression [47] and ii) an agr rot double mutant
displays increased production of these factors when compared to an agr single mutant
[209, 211]. However, it is also noteworthy that Rot can also act as a positive regulator.
Its overall regulon includes 146 genes, of which 60 are negatively and 86 positively
regulated [212]. Therefore, the name Rot, though historically justified, is partially
misleading in the context of its overall function.

In addition to this well-characterized system, there are myriad other systems involved in
the regulation of S. aureus virulence. The Rot protein, for example, belongs to the family
of SarA proteins, which encompasses at least eleven members in S. aureus and was
defined based on homology of the proteins to the S. aureus staphylococcal accessory
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regulator A (SarA) regulator [213, 214]. The SarA protein was first described by Cheung
and colleagues [215] in connection to agr [216]. Since these early investigations, this
regulator has been the topic of extensive research (reviewed by [203]) describing both,
the direct and indirect, effects of the protein. SarA has been shown to i) induce
expression of genes controlled by promoters P2 and P3, thereby feeding into the action
of the Agr system [217-219]; ii) facilitate the binding of AgrA to P2 and P3 [220]; and iii)
directly bind to sites upstream of its target genes to induce their expression [219, 221,
222]. Each of these actions directly affects the expression of virulence determinants,
establishing SarA as one of the master regulators of S. aureus pathogenicity [213]. The
control of sarA itself is multifactorial (reviewed by [203]), but peak expression has been
reported during later growth phases [223] and thus approximately coincides with Agrdependent activation of virulence determinants. Additional post-translational regulatory
mechanisms have also been proposed [224, 225], adding further nuance to this already
complex system.

Another protein with homology to SarA is MgrA (formerly referred to as Rat, [226]),
which has a tripartite effect on virulence factor expression, by either i) direct interaction
with Agr, ii) interaction with the transcription factor SarS or iii) direct induction of its
target transcripts [227]. In these ways, the regulator positively and negatively controls a
large regulon, which, amongst others, includes numerous virulence factors and surface
proteins [228]. Other systems in turn control MgrA, e.g. the TCS ArlRS [229] as well as
the small regulatory RNA RsaA [230]. RsaA is of particular interest, as (translational)
regulation by RNA-RNA interaction has been found to be a ubiquitous mechanism of
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gene regulation (reviewed by [208, 231]), as discussed in chapter 4 of this dissertation.
RsaA thus interacts with the mgrA transcript and represses translation of the transcript
[230]. Notably, RsaA itself is controlled by the alternative σ factor σB [230, 232], which
has been previously shown to modulate virulence of S. aureus [233-237]. This creates a
rather interesting situation where an alternative σ factor (σB) controls a regulatory RNA
(RsaA), which in turn controls a transcription factor (MgrA), that interacts with the major
regulatory system (AgrBDCA), that activates another regulatory transcript (RNAIII),
which suppresses the (negative) regulator (Rot), allowing the expression of proteins that
promote invasive behavior and pathogenicity of S. aureus. Furthermore, even this
presentation belies the true complexity of these systems: at each junction, secondary
(direct or indirect) effects on other genes or regulators are also present, producing an
even more involved regulatory network. Several other transcription factors (e.g. other
members of the Sar family [203]), two-component systems (e.g. SaeRS [238-240]) and
regulatory RNAs (e.g. SSR42 [241], SprD [242] and SprC [243]) have been found to
influence pathogenic behavior, but will be not discussed in further detail here.

The intricacy, redundancy, and interconnectivity of these regulatory networks are no
mere coincidence but nothing less than an absolute requisite for survival. The delicate
modulation of energy-consuming virulence factor production under different micro- and
macronutrient conditions is exemplary of the economic allocation of energy resources in
this bacterium. Therefore, all indications support the case that no encoded regulatory
factor presents an unnecessary burden, but that every convergence and divergence,
every layer of regulation, and every additional regulator integrated in the network that
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guides S. aureus lifestyle serves an integral purpose for fine-tuning the conditions that
allow the bacterium to successfully colonize or invade its host.

S. aureus plays its hand
The environments where S. aureus must survive differ significantly on every possible
level, from an undisturbed colony in the human nose to the peril of engulfment by a
macrophage. Moreover, the organism must account for host-dependent, large-scale
variations (e.g. the immune response of carriers vs. non-carriers) as well as specific
interactions with other microorganisms in the polymicrobial communities where it
resides. In simpler terms, the living conditions of S. aureus are exceedingly complex;
the bacterium’s ability to quickly adjust to new conditions is thus the cornerstone of its
success as a pathogen. These changes are governed by elaborate regulatory networks
that dictate whether to hide or attack, to lie dormant or proliferate, to save or expend
energy. This complexity may well be the explanation for the failure of research across
several decades to find ‘the holy grail’ of S. aureus research, the single master regulator
that controls virulence; it is likely there is no such regulator, as the intricacy of
environmental cues and stimuli cannot be accommodated by one major switch, but
rather a finely adjusted system of interconnected relays. The shortcomings of this
pursuit are perhaps best exemplified in the fact that the most significant regulator of
virulence, the Agr quorum sensing system in concert with RNAIII, is inactive in
numerous clinical isolates, not only during invasive infection, but also prior to colonizing
the nose [134-136]. Therefore, it is imperative to consider the regulatory networks in
their entirety - every switch and gear that they encompass - for minor changes in these
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systems can propagate to major alterations in the final outcome (i.e. severe bacterial
infection). To do so, we must take into account not only ‘classical’ transcription factors
(TFs), two-component systems (TCSs) and σ factors, but other proteins and molecules
that have historically been underappreciated in terms of their regulatory capabilities.
These would include, for example, both regulatory small RNAs (sRNAs) and active
components of the transcription machinery, and will be referred to as ‘non-classical’
regulators. Both groups of alternative regulators will be discussed in this dissertation.
Specifically, the research described here aims to i) understand how under-investigated
components of the transcription machinery can have both global as well as genespecific effects on the transcription process (chapter 2 and 3), and ii) identify and
catalogue undiscovered regulatory elements (sRNAs) in S. aureus (chapter 4). This
latter approach is of particular interest, as horizontal gene transfer and strain-specific
differences have been shown to play an integral role in the evolution of this bacterium.

It is imperative to understand the precise role of these regulatory systems in the
adjustment of S. aureus to ever-changing environments, be it in a battle with the
immune system or other bacteria in its natural niche, in a quest for nutrients during
infection, or during exposure to antibiotics in the hospital. When performed in
meaningful backgrounds (e.g. the USA300), research directed to fill in the blanks of our
existing regulatory maps will produce invaluable information about the adaptive
mechanisms of S. aureus, an organism that must be constantly ‘running to stand still’
[112] in order to secure its success as a pathogen.
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SMALL THINGS CONSIDERED: THE SMALL ACCESSORY SUBUNITS OF RNA
POLYMERASE IN GRAM-POSITIVE BACTERIA

Note to reader
This chapter was previously published as a manuscript [244], and has been included
with permission from the publisher (Appendix I).
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CHAPTER 2: THE δ SUBUNIT OF RNA POLYMERASE GUIDES PROMOTER
SELECTIVITY AND VIRULENCE IN STAPHYLOCOCCUS AUREUS

NOTE TO READER
This chapter was previously published as a manuscript [245], and has been included
with permission from the publisher (Appendix II).
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CHAPTER 3: THE ω SUBUNIT GOVERNS RNA POLYMERASE STABILITY AND
TRANSCRIPTIONAL SPECIFICITY IN STAPHYLOCOCCUS AUREUS

NOTE TO READER
This chapter was previously published as a manuscript [246], and has been included
with permission from the publisher (Appendix III).
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CHAPTER 4: GENOME-WIDE ANNOTATION, IDENTIFICATION, AND GLOBAL
TRANSCRIPTOMIC ANALYSIS OF REGULATORY OR SMALL RNA GENE
EXPRESSION IN STAPHYLOCOCCUS AUREUS

NOTE TO READER
This chapter was previously published as a manuscript [247], and has been included
with permission from the publisher (Appendix IV).

30

CHAPTER 5: CONCLUDING REMARKS AND FUTURE DIRECTIONS

CHECKS…
The variation and hostility of the environments where S. aureus resides have demanded
an unparalleled versatility to secure bacterial survival. This adaptation involves the
ability to quickly adjust physiological processes via differential expression of regulatory
components governing these pathways. As discussed in this dissertation, a multitude of
individual regulatory elements (including the ones identified in chapters 2-4) guide
alterations in gene expression patterns. Nevertheless, our knowledge of regulators
individually must be complemented by an understanding of these factors in their native
context within global regulatory networks. Only this will allow us to ultimately develop an
understanding of how S. aureus (and bacteria in general) makes complex decisions in
an ever-changing environment [248].

Evidence suggests that at least some aspects of S. aureus gene expression follow
temporal patterns, perhaps driven by proliferation and subsequent increase in bacterial
culture density over time. The importance of these factors is reinforced by the central
role of the Agr quorum sensing system in the lifestyle of S. aureus (as discussed in
chapter 1). With regards to temporally resolved expression patterns, it has been
repeatedly demonstrated that different adhesins are expressed during the consecutive
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stages of nasal colonization [116, 117, 128]. Similarly, temporal patterns have long
been known to be present during the ‘normal’ bacterial growth curve under laboratory
conditions, wherein gene expression is regulated depending on culture density,
amongst other factors (as discussed by us recently [249]). Nevertheless, growth in a
laboratory setting presents a rather crude representation of the situation in vivo, since
(external) stimuli like nutrient alterations/limitations, sudden exposure to antibacterial
host molecules, and/or onset of an immune response, are entirely absent (although
nutrient and/or oxygen deprivation are present at later phases of growth). Furthermore,
bacteria in the nose fail to reach densities found in laboratory culture (though permanent
carriers have been connected to higher bacterial loads [92]), therefore limiting the
potential influence of quorum sensing signals under these conditions. In line with these
findings, Burian and colleagues [127, 130] showed that the agr locus (as well as saeRS)
is transcriptionally inactive during nasal colonization, while the essential walKR TCS is
highly transcribed, supporting the conclusion that the latter controls nasal adhesion.
Nevertheless, the precise stimulus for activation of the WalKR system is not known, and
it is therefore unresolved which signals guide temporal expression patterns during nasal
colonization. Such a shortcoming in understanding the adaptation to an important and,
at the same time, easily accessible, niche highlights the need to further investigate the
decision making process in S. aureus.

Regardless of these obvious limitations, the scientific community has made significant
advancements in unraveling the function as well as the signals governing numerous
regulators in S. aureus. Despite this progress, most studies that aim to understand a
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particular regulatory factor are restricted to only characterizing specific in- and outputs,
e.g. CodY (indirectly) senses the absence of branched chain amino acids and in turn
reduces expression of genes involved in central metabolism as well as virulence factor
production [167, 168, 250]. However, as indicated previously, no circumstance exists in
which only one input determines the cell’s fate. Rather, multiple signals are sensed at
any given time and the receiving factors/pathways intersect and interact synergistically
or antagonistically in turn. Therefore, bacterial gene regulation cannot be framed as a
linear series of events but rather as a three-dimensional network with a multitude of
nodes and switches that integrate these inputs to fine-tune major processes of the cell,
e.g. the Agr system’s role as a ‘nexus’ [25] for virulence.

Seshasayee and colleagues eloquently discuss these regulatory networks on the basis
of results from the model organism Escherichia coli [248], though their conclusions are
nonetheless valid for other bacteria, including S. aureus. In order to model how various
signals influence cellular behavior, three primary classes of transcription factors are
outlined: i) Exogenous regulators are often TCSs, which consist of two distinct
functional units: a membrane-bound sensor (histidine kinase) that responds to an
external stimulus by transmitting a signal to an intracellular TF, which then affects the
transcription of the system’s target genes [251]. External stimuli can also be sensed
when extracellular molecules are imported and bound by regulatory enzymes within the
cell. A primary example of this type of TF is the Fur regulator, which reacts to cellular
levels of the essential transition metal iron in S. aureus and other (pathogenic) bacteria
[252]. Another system able to sense external signals is the TCS SaeRS (described
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above) that adjusts virulence factor expression in response to salt stress, low pH,
subinhibitory clindamycin concentrations and exposure to proteins/peptides produced
by human neutrophils [253-255]. In contrast to exogenous TFs that connect cellular
physiology to the environment, ii) Endogenous TFs only bind molecules within the cell.
These are commonly key molecules of major metabolic pathways that indicate the
general energy and physiological state of the cell. iii) The last category, hybrid
regulators, can sense signals (e.g. amino acids) that can be of exo- or endogenous in
origin. This bifunctionality of such regulators prevents a definitive assignment to one of
the two previous groups.

Information about the abundance of each class of regulators can give general
information about the extent of interaction of a bacterium with its environment. In E. coli,
it was shown that ~24% of the 120 regulators with known targets are endogenous,
48.5% exogenous and 27.5% hybrid, meaning that ~76 % have the ability to respond to
external stimuli [256]. Although only speculative at this point, a similar relationship could
also be described for S. aureus, supported by the comparable numbers of TCSs and
TFs between S. aureus and E. coli (TCSs: 16 vs. 28, TFs: 115 vs. 120) [185, 186, 248,
257]. These findings corroborate the extensive interplay observed between S. aureus
and its immediate surroundings. Here, the bacterium must be able to integrate external
and internal signals that provide information about the activity (e.g. antibacterial) of the
host and the cell’s own physiological status, respectively. These inputs have to be
simultaneously processed so that the subsequent cellular responses can be
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orchestrated in a coordinated and logical fashion, securing survival of the single cell as
well as the population.

Although significant advances have been made in our understanding of regulatory
networks in general (with E. coli as the primary model) and TFs in S. aureus specifically,
our knowledge of the minutiae involved in global regulation is still rudimentary. This is
due to a variety of shortcomings, though a defining bottleneck is the identification and
characterization of large numbers of yet undescribed or uncharacterized regulators. As
discussed, regulatory active components of RNAP as well as regulatory RNAs are
prime examples of this shortcoming, which we attempted to resolve in this dissertation.

…AND BALANCES
In our effort to understand how and when a bacterium infects its host, we are inevitably
confronted with the questions ‘What defines virulence?’ and ‘Which bacterial properties
unlock its pathogenicity?’. Historically, we have characterized a bacterium’s pathogenic
capability as the sum of its encoded proteins that injure the host or avoid its immune
responses. Only recently has the scientific community started to appreciate that
virulence is not solely defined by encoded virulence determinants, but that virulence is
largely dependent on the susceptibility of the host and the nature of general hostpathogen interactions [258]. Opportunistic pathogens like Acinetobacter baumannii or S.
epidermidis exemplify the advantage of this perspective. While A. baumannii is
responsible for devastating infections [259, 260], it is only sparsely equipped with
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pathogenic factors, and it has even been proposed that the bacterium does not encode
a single bona fide virulence factor [261]. Similarly, S. epidermidis has been referred to
as an ‘accidental’ pathogen [262], as it is ubiquitously found as a commensal on the
human skin and lacks the vast majority of virulence factors found in related pathogens
(e.g. S. aureus) [263, 264]. Nevertheless, this commensalism can quickly escalate to
life-threatening invasive infections (e.g. blood stream infections in ICUs), particularly in
connection to indwelling implants [265, 266]. These examples highlight how largely
benign bacteria can, under certain conditions, cause disease and emphasize that a
bacteria-centric view, focusing only on encoded virulence markers, is indeed too
simplistic. Instead, the complex interplay at the host-pathogen interface must be
considered to understand a bacterium’s pathogenic potential.

For S. aureus, several lines of research have shown that the interaction of host and
bacterium is particularly host-specific. A prime example is the process of nasal
colonization, where a large number of studies identified, amongst other aspects, genetic
predisposition and gender to be risk factors for S. aureus colonization (comprehensively
reviewed in [267]). We now appreciate that the intricate relationship of S. aureus with its
human host is a result of co-evolution [268-270]. Both the host immune system and
bacterial virulence have evolved to survive at their interface in what has been described
as an ‘arms race’ by Dawkins and Krebs in 1979 [271]. Although a plethora of
battlegrounds for pathogen and host have been described, perhaps the best
characterized is the fight for iron (chapter 1). Here, the host has adapted to sequester
most available iron and even reduce iron levels upon recognition of an infection [172,
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173]. In response, S. aureus has developed sophisticated means to recover these
hidden treasures by ‘cheating, thievery, and piracy’ [170, 272]. Another important
example is the fine balance between commensalism and infection at the skin barrier,
where the (innate) immune system and bacterial factors (e.g. ACME-encoded SpeG
[52]) are engaged in a constant, counteractive effort [273]. Although this balance has
developed over millions of years, the equilibrium is frequently disturbed. An example of
this relationship is the start of the antibiotic era when the host prevailed and, for a very
brief window in the 60’s/70’s, we had the hubris to believe that we would be able to
eradicate bacterial infections altogether [274]. In response to the ‘many millions of
metric tons of antibiotic compounds… [that] have been released into the biosphere’
[275] since the beginning of the antibiotic era, bacteria have rapidly developed
resistance mechanisms to circumvent their negative actions [275]. Through these
antibiotic resistance patterns, in combination with the spread of newly emerging CAMRSA strains in the healthy population, the bacterium has once again gained significant
momentum. As these examples show, the host-pathogen balance is fragile, and small
changes, e.g. host-specific differences or evolutionary adaptation of the pathogen, can
have a strong influence on the overall outcome of any given interaction.

The delicacy of this interplay is now appreciated, and antimicrobial strategies, rather
than attempting to eradicate the pathogen, aim to disarm the organism or boost host
defense to increase the immune system’s chances of gaining the upper hand [276].
Historically, bacteriostatic antibiotics have followed this model, in which bacteria are
hindered in their plan of action and the eradication itself is driven by the immune system
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(reviewed by [277]). In this vein, interference with the host-pathogen balance can be far
subtler than our current approaches and still move the needle in favor of the host, in
turn promoting clearance of the infection. To date, significant process has been made in
this area, and numerous immunomodulatory candidate molecules have been identified
[278-285].

During the ‘arms race’ between bacteria and host, S. aureus strongly relies on virulence
factors that it utilizes in hiding from the immune system (e.g. various surface factors of
S. aureus [286]) and/or interference with the bodies defense mechanisms (e.g. cytolytic
toxins [287]). However, virulence factors expression is thought to be energetically costly
[288]; similar to antibiotic resistance expression (e.g. from larger SCCmec elements in
HA-MRSA strains [21]), this expression program is considered a fitness burden that
forces the bacterium to balance toxicity and energy homeostasis [289]. Ultimately, the
cell spends only i) as much as it can afford and ii) as much as is necessary [132]. In
terms of pathogenic organisms, this temporal thriftiness is closely related to the idea
that a given (virulence) gene can be beneficial under certain conditions, e.g. during
invasive disease, while being disadvantageous during others, e.g. colonization of the
host (a concept referred to as ‘antagonistic pleiotropy’ [290]). Bliven and Maurelli [269]
have thus speculated that pathogens circumvent this dilemma by ‘evolv[ing]
mechanisms to neutralize the deleterious effects arising from antagonistic pleiotropy,
while at the same time conserving the beneficial ones’. One way, for example, to
prevent the deleterious effects while maintaining the advantages is to use regulatory
systems that only use genes under certain conditions.
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In order to understand the interplay between host and pathogen and, more importantly,
to intervene with infection in a targeted manner, we must investigate those factors that
guide bacterial (virulence factor) gene expression. Bacteria not only gain new weapons
during their ‘arms race’ with the body, but also learn how to use them in the most
efficient way without disturbing the (energy) homeostasis of the cell. In the context of S.
aureus, it is necessary to elucidate how and why virulence is induced and how certain
genes (not only regulators, but effectors as well) influence the host-pathogen balance.
Once we have a better understanding of the regulatory processes and the signals that
influence the interaction between host and bacterium, we can utilize this information to
revise and extend treatment therapies.

THE IMPORTANCE OF NON-CLASSICAL REGULATORS
As discussed, it is of utmost importance to characterize regulatory circuits in their
entirety in order to understand and, in turn, predict bacterial pathophysiology. Although
significant progress has been made in the field of S. aureus gene regulation, our picture
is far from complete. These shortcomings are particularly salient in our current
understanding of ‘non-classical’ gene regulators.

For ‘classical’ proteinaceous regulatory molecules, including TFs, TCSs and σ factors,
an abundance of information is available, facilitating the identification [185] and
prediction of their function based on protein domain conservation [291] and homology to
proteins in other bacteria, e.g. ones deposited to the Protein Data Bank [292]. Similarly,
putative targets of TFs, TCSs or σ factors can be identified based on the known
39

consensus sequences for their binding sites on promoter regions (e.g. Fur box [293] or
the consensus sequence for the alternative σ factor σB [294]). For other regulatory
molecules, like small regulatory RNAs or proteins that exert their regulatory behavior via
alternative mechanisms (e.g. small accessory RNAP subunits), such endeavors are
significantly more challenging. Ultimately, the current limitations in the integration of
‘non-classical’ regulators into existing networks can be attributed to: i) not yet having
identified all such elements, ii) a lack of information about the signals that trigger a
specific response in these regulators, and iii) an unavailability of experimental data
identifying possible transcriptional targets of these regulators. In the following, we will
further discuss each of these challenges and the contribution of this dissertation in
overcoming them:

i) RNAP is one of the best-studied enzyme complexes due to its central role in
organismal function. Consequently, it has long been known that RNAP contains several
small subunits in addition to its four main subunits α2ββ’, and closely associated σ
factors [295-298] (though the presence of these subunits can differ between Grampositives and Gram-negatives [244]). Within the complex, several proteins have already
been assigned regulatory roles. It is generally appreciated that the α subunits are able
to make contact to DNA-sequences upstream of a promoter or bind additional
regulatory factors, while σ factors guide transcription machinery by recognizing specific
promoter sequences. In contrast, other subunits, i.e. δ, have been less appreciated for
their regulatory properties: while δ was initially studied in the context of phage-infection
[296], it was not until several decades later that the protein was established as a
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permanent RNAP component [299], which plays a role in the maintenance of stringency
in the transcriptional process (demonstrated in a number of studies and summarized by
us [244]). Although this general regulatory role was known, no gene-specific effects had
been assigned until recently, leading to its exclusion from ‘classical’ regulatory
networks. Through the research described in this dissertation, we have extended the
existing knowledge base and suggested potential selective effects for δ. Our data show
that abrogation of the subunit’s activity results in broadly altered virulence factor
expression. As we detected no large-scale alterations in expression of known S. aureus
virulence regulators, it is likely that δ interacts directly with its targets. Though precise
mechanisms for this phenomenon will need to be elucidated, these findings, together
with various observations from others ([300-303] and discussed by us [244]), imply a
potentially important role for this subunit within the regulatory circuits of S. aureus and
other bacteria. This is particular intriguing as δ resides ‘at the core’ of the transcriptional
process, pointing towards a very basic role in regulating intrinsically important
processes, e.g. as described for σ factors.

With respect to sRNAs, these molecules have been known to function as global
regulators of bacterial physiology [304], and have already been demonstrated to play
central roles in controlling virulence [305-308], stress response [309] and metabolism
[310]. They exert their roles by acting as important sensors, connectors or effectors
(transcriptional, post-transcriptional and at the protein level) in the regulatory network of
the cell, and it is thus crucial to include these elements in our future regulatory
roadmaps [311]. Unfortunately, the available information about encoded sRNAs was
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rudimentary for a long time, mainly due to technical limitations (to be discussed further).
Nevertheless, driven by the establishment of next generation sequencing (NGS) as a
standard lab technology, this picture is changing quickly [312, 313]. As a result of this
extensive use of NGS, the number of sequenced genomes in publicly available
databases steadily increases: at the time of this dissertation, >13k complete bacterial
genome sequences were available in the NCBI Microbial Genomes database
(https://www.ncbi.nlm.nih.gov/genome/). In order to transfer these raw sequences into a
usable format, adequate tools for reliable data processing and genome annotation must
be developed alongside these advances. Although automated annotation has
significantly improved [314], the sheer amount of available data still 'makes
bioinformatics the bottleneck' [315]. While prediction software can not only identify the
presence of protein-coding sequences but also certain conserved noncoding RNA
(ncRNA) species (i.e. tRNA and rRNA), the identification of genes (e.g. sRNAs) that are
not widely conserved, missing ribosomal binding sites, and/or with unclear open reading
frames commonly presents itself as a hurdle. Despite these challenges, automated
sRNA prediction is now a valuable tool to supplement proteinaceous as well as tRNA
and rRNA annotations [316-318]. As with all computational approaches, these
predictions must be complemented by experimental data to prevent erroneous
identification and allow for the confident integration of sRNAs into existing genome files
(and subsequently into regulatory networks). Likewise, a unified nomenclature system
for identified transcripts should be implemented, as discrepancies can lead to the
redundant identification of sRNAs.
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In the study described in chapter 4, we addressed each of these problems. For the first
time, we introduced an annotation system for S. aureus that supports the classification
and organization of all previously identified sRNAs. This was used as a platform for the
identification of 39 as yet undescribed transcripts, increasing the combined number of
currently known sRNAs in the USA300 background to 303 transcripts (~10% of all
encoded genes). This large number highlights the importance of this relatively
unexplored group of regulatory factors in S. aureus: while the bacterium encodes for
135 known proteinaceous regulatory factors (TFs, TCSs and σ factors combined), there
are at least twice as many sRNAs transcribed. Our optimized RNAseq [319] and sRNA
identification/annotation procedure can now be used as a blueprint for future studies in
other organisms. Consequently, we performed similar studies for three additional
organisms, S. epidermidis, S. carnosus [320] and A. baumannii [321]. The latter
bacterium was investigated due to its ability to cause devastating infections, including
ventilator-associated pneumonia, blood stream infections or SSTIs [322]. In our study of
this organism, we identified 78 uncharacterized sRNA transcripts [321], including a
group of conserved and highly expressed phage-derived sRNAs, as well as
conservation patterns amongst these sRNAs that suggest a modular arrangement
similar to protein domain architecture.

In order to further demonstrate the utility of our sRNA identification and annotation
approach, we employed our genome annotation files, now including currently known
sRNAs, to study the evolutionary implications of these transcripts [320]. Here, we crosscompared the sRNA content between a pathogenic bacterium (e.g. S. aureus),
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opportunistic pathogen (e.g. S. epidermidis) and non-pathogenic organism (e.g. S.
carnosus) [320]. In so doing, we were able to gain insight into orthologous elements that
pointed to both a set of core sRNAs, which are found in a wide number of strains, as
well as elements only present in virulent lineages, i.e. those that possibly contribute to
pathogenicity.

Though the identification and classification of these sRNAs is an important first step
toward a more complete understanding of bacterial gene regulation, the role of these
data is first and foremost the production of a solid foundation upon which further
experimental efforts can investigate the precise roles of these transcripts in the cell.
Indeed, these experiments have only further expanded the horizon of this field of
research, providing us with a greater appreciation for the magnitude of the task ahead.

ii) After initial identification and cataloguing, the next logical next step is exploration of
the precise conditions and signals that trigger a response by these elements.
Unfortunately, these factors are not yet known for many (if not most) sRNAs; largely as
a result of their absence in genome annotation files, and their consequent omission
from many high throughput transcriptomic analyses. Our unfamiliarity with such signals
is not only a problem for ‘non-classical’ regulators but also for known proteinaceous
elements, as discussed earlier in this dissertation. Only when we understand which
inputs govern and alter specific cellular processes can we create maps of networks and
predict the outcomes of host-pathogen interplay, which in turn will lead to more
successful attempts to interfere with the pathogen’s plan of action. As our ultimate goal
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is to identify the contribution of these S. aureus transcripts to its regulatory network (and
ultimately to its ability to cause disease), we need to decipher which of the transcripts
are active (or inactive) under conditions that mirror those found in the host. Herein we
extend current knowledge by performing RNAseq in human serum (chapter 4), as well
as during adaptation to stationary phase growth [249]. Serum was chosen for
examination because blood stream infections present an increasing problem [56-60],
and serum contains (natural) antibodies [323], antimicrobial peptides [324, 325], and
low iron levels [326], presenting an appropriate model for conditions and challenges that
the bacterium might encounter during host invasion. After initial examination, we
recorded decreased expression of RNAIII in line with previous studies [327, 328],
therefore validating our approach. In addition to RNAIII, 83 other sRNAs (~27% of the
total sRNA content) displayed differential expression in serum vs. TSB, with the two
most strongly affected transcripts showing a ~600-fold and ~1200-fold increase and
decrease in abundance, respectively. The decrease of agr/RNAIII expression itself
could be a result of AIP sequestration by the serum component apolipoprotein B [325],
or via a more active mechanism, as high virulence factor expression could be a
disadvantage during growth in serum [288]. Independent of the ultimate cause of altered
RNAIII expression, it is interesting to speculate as to whether the other differentially
expressed sRNAs are controlled in an agr-dependent manner, influenced by other
serum factors or react to the cell’s overall physiological state. Regardless of the nature
of the stimulus, these transcripts are certainly highly responsive to the environments
they encounter in the human body. Further work should aim to deconvolute which
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stimuli in human serum (i.e. as a system radically different from TSB) trigger the
activation of these transcripts and which other regulators mediate this response.

For any given sRNAs, the change observed in its expression pattern under certain
environmental conditions/stimuli is a good indicator for its role within the cell’s regulatory
networks. The role of proteinaceous factors, too, can often be evaluated for activity and
specificity of their response in this way (e.g. Agr system, σB). However, expressionactivity relationships are not always so straightforward; TCSs, for example, are often
constitutively expressed (although additional autoinduction can be present) [329].
Contrary to sRNAs and in line with TCS expression, we were able to show a relative,
stable and robust expression of small RNA polymerase subunits δ and ω throughout the
growth of S. aureus (chapter 2 and 3, as well as [249]). This finding is surprising given
the gene-specific regulatory roles of the δ subunit, and the likely non-constitutive
expression of most of its target genes (e.g. virulence determinants). We thus expect
alternative mechanisms to mediate activation/deactivation similarly to TCSs. Our
studies into the ω subunit of RNA polymerase (chapter 3) offered the first glimpse of
such an alternative control system for the δ subunit. The function of ω was found to be
mainly of a structural nature and deletion of the subunit induced structural stress within
the RNAP complex accompanied by release of δ. Since δ can only perform its function
when bound to the core RNAP subunits, this release would be an effective way to
regulate activity of δ itself. Although this hypothesis is rather novel and will require
further evaluation, this would indicate an additional layer of transcriptional regulation,
comparable to a previously described change in the affinity of alternative σ factors to ω-
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less RNAP in E. coli [330] and cyanobacteria [331]. In this type of regulatory setup, no
specific biochemical signals would be required; rather, it would allow the cell to respond
to structural damage of the RNAP complex, e.g. due to heat stress of other physical
signals (in the context of chapter 3, due to depletion of ω). This mode of activation
would conceptually resemble that of RNA thermometers, in which temperature-sensitive
RNA structures, e.g. in the 5’ untranslated region, control mRNA translation [332]. For
both RNAP subunits as well as RNA thermometers, the ‘signal’ would therefore cause
structural changes, which in turn alter regulator activity and transcriptional outcomes.

In summary, our studies have identified conditions of high/low activity of alternative
regulators of interest, and therefore present an important first step towards the
integration of sRNAs and small RNAP subunits into ‘classical’ regulatory networks.

iii) The last of the initial steps towards the incorporation of newly identified regulatory
elements into established networks is the characterization of their physiological effects.

In the context of small RNA polymerase subunits, in particular δ, our transcriptomics
approaches showed not only a general loss of stringency in the transcriptional process,
but also a decreased expression of various virulence determinants, which was
additionally confirmed by extensive phenotyping. This strong shift in expression of one
particular set of genes in the absence of any notable changes in expression of typical
regulators of S. aureus virulence implies that δ may in fact act as a gene-specific
regulator itself. If so, the subunit must be able to distinguish between genes while bound
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to RNAP via either specific DNA-sequences and/or DNA-modifications. Each of these
has been previously shown to be recognized by proteins carrying a specific (HARE)
helix-turn-helix (hth) domain [300] that we found to be highly conserved amongst δ
proteins across various Firmicutes [244]. During our investigation of possible δ-specific
promoter features, we were able to identify differences in abundance of the presence of
a consensus [HAATTWD] motif in promoter regions of putative δ-regulated genes
(unpublished observation). This sequence was found in the upstream regions of 76.5%
of genes that showed decreased expression in the δ-less strain, while only 24.5% of the
upregulated genes in this strain carried the motif in their extended promoter region.
These data are further supported by Prajapati et al, [303], who described that
replacement of certain AA repeats (as modeled in the consensus) by CC in AT-rich
regions diminished the positive transcriptional effects of δ on a model promoter.
Although somewhat preliminary at this point, these data combined suggest that the
selectivity of δ for its target genes is driven by the recognition of specific AT-rich
promoter features by a conserved hth domain of the subunit.

In contrast to target identification for RNAP subunits, where the search is limited to
particular DNA-sequences or modification, the pinpointing of sRNA targets is decidedly
more challenging. Accordingly, of the 303 sRNAs in S. aureus USA300, less than 10%
have been functionally characterized (often lacking the exact mechanism of action).
Although reverse genetic screens have been useful in the past in the identification of the
precise function of genes in S. aureus [333], this strategy proves to be recalcitrant for
sRNA study. The non-coding RNA SSR42, a strong effector of virulence in S. aureus
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[241], exemplifies these difficulties. This sRNA has been shown to be required for
cytolytic activity, immune evasion and pathogenesis during infection of a murine SSTI
model. Though the cell’s transcriptome is dramatically altered in a ΔSSR42 strain, no
specific cellular targets could be identified [241]. This case is particularly notable, as
loss of the sRNA results in clear phenotype, affecting one of the best-studied aspects
(virulence factor production) of S. aureus. This author, too, has spent significant energy
on identifying a target for SSR42 interaction (data not shown) to no avail. These
examples are not meant to belittle such efforts, but rather indicate how easy it can be to
miss even the biggest target when the system is as challenging as for sRNAs.

Overall, our studies serve as a model for the three steps required toward integration of
‘non-classical’ regulators into the ‘classical’ regulatory landscape of S. aureus: i) We
were able to describe the potentially gene-specific activity of a resident component (δ)
of RNAP. In addition, we identified 39 unknown sRNAs in the S. aureus USA300
background and made information about previously known sRNAs more accessible for
further investigations by creating the first publicly available genome files to contain
sRNA annotations. ii) These files were used to catalogue differential sRNA expression
under pathophysiologically relevant conditions (human serum), thereby establishing
relevance of these transcripts to the infection process. Furthermore, we reported the
release of δ from the structurally disturbed transcription machinery, explaining how this
regulatory active component of the RNAP complex could be controlled itself. iii) With
regard to target identification, evaluation of the diminished virulence factor production in
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δ-depleted strains led to the identification of putative targets and DNA features that may
mediate target recognition by this subunit.

In the future, each of these elements will need to be fully integrated into our existing
regulatory maps of the cell. Before then, there is significant amount of work ahead of us.
However, with the first steps behind us, further studies can evaluate the cross-talk of
these ‘non-classical’ regulators with known (and yet to be identified) elements and subnetworks. Such an endeavor will be a herculean task for the coming decades, but is
nonetheless paramount in the construction of a holistic view of the cell’s complex
machinery that will pave the way for more effective development of antimicrobial
treatments.

FUTURE DIRECTIONS
The experiments in this dissertation have advanced our knowledge about regulation in
S. aureus, and we hope that our contributions will bolster future efforts to combat this
pathogen that has for too long plagued patients across the globe. Nevertheless, our
studies have to be seen as just a starting point, and follow-up experiments are required
to fully elucidate the role of the investigated regulatory elements in S. aureus disease
causation. Experiments that could supplement this knowledge base are described in the
following two sections, with regard to either i) small RNAP subunits or ii) sRNA-related
projects.
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i) In the studies described in this dissertation, we were able to identify a role of δ in
gene-specific regulation of S. aureus and its effect on the production of numerous
virulence determinants. As this activity implies regulatory control by δ itself, we propose
that the physical state of the RNAP complex and δ release upon structural disturbance
may govern the activity of this subunit. Further characterization of promoter features
that result in δ subunit dependency will be required to adequately describe its effect on
target virulence factors. In order to characterize these features, DNA-sequences or
modifications of directly δ-dependent promoters need to be identified. In such
circumstances, where limited information is available about specific targets, chromatin
immunoprecipitation sequencing (ChIPseq) is often the method of choice. The method
was first introduced in 2007 [334] and is widely used today [335-337] in both prokaryotic
and eukaryotic studies. Briefly, ChIPseq is based on the use of tagged DNA-binding
proteins, which, after cross-linking, are enriched upon precipitation along with their
bound DNA-fragments. Sequencing of these fragments then provides information on the
target sequences of the regulator in question. Such an approach has previously been
successfully employed to study genomic RNAP distribution in E. coli [338]. In the
context of δ, a similar study could be conducted in the presence and absence of the
subunit, with precipitated promoters then correlated with existing RNAseq data to
generate a list of elements that are specific δ targets.

Ultimately, target identification for regulatory elements must be accompanied by
information concerning the conditions that prompt this regulation. Our experiments
suggested that, under certain conditions, i.e. due to loss of ω, δ can be released from
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the RNAP, abolishing its influence on transcription. Nevertheless, it is unclear as to
whether this “stress-model” is an artifact of the depletion of ω or if the release of ω (and
subsequently δ) actually occurs in vivo. This uncertainty highlights the future need to
study RNAP complex composition under different stressors to establish an improved
structure-function relationship. In the end, only this information can contextualize our
data to relevancy in the sophisticated regulatory machinery of S. aureus.

ii) As discussed earlier, expression and activity of sRNAs, as with bacterial regulators in
general, has to be investigated under meaningful conditions, preferably during infection.
Three studies which are prime examples of such in vivo systems include RNAseq
experiments with RNA isolated from immunodeficient versus healthy mice during
systemic infection [132], from a murine model of osteomyelitis [339] as well as from
human nasal S. aureus carriers [131]. Studies like these have the potential to greatly
advance the field and the publicly available datasets should be thoroughly investigated
for sRNA activity. Although all three studies are pushing the boundaries of our field, they
are limited to either easily accessible niches (e.g. nose) or cohorts of high S. aureus
abundance during infection (e.g. kidney). In comparison, one important niche stands out
as unexplored territory: though heavily guarded by the immune system, blood is the
medium that allows dissemination to distal sites. Therefore, gaining further insight into
the host-pathogen interaction at this particular juncture could prove beneficial to future
efforts to intervene with SAB and infection in general. Unfortunately, technical limitations
severely complicate this progress. While kidneys commonly bear the highest bacterial
loads in murine systemic infection models of S. aureus, bacterial loads in the blood are
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significantly lower, making RNA preparation from these samples challenging.
Nevertheless, these limitations may soon be overcome by recent advances in
sequencing technologies, of which a prime example is single cell RNAseq [340]. In this
technique, problems of low input are circumvented and additionally heterogeneity within
the sample appreciated. However, in order to reflect a bacterial community in its
entirety, information from several such experiemnts needs to be combined.

Despite a steadily increasing pool of information about S. aureus encoded sRNAs and
their expression patterns, identification of direct targets is indispensable and one of the
rate limiting steps in understanding the precise functions of these transcripts. Pulldown
procedures to pinpoint the interacting partners of sRNAs have been proposed and
tested, but reliable methods are still sparse. We are currently in the process of
examining an approach where an oligo d(A)25 tail is added to a plasmid-encoded version
of an sRNA in question along with its native promoter. As such long, homogenous
strings of a particular nucleotide are irregular in bacteria, the tagged sRNA is easily
distinguished from the remainder of the cell’s RNA content. Using a eukaryotic mRNA
cleanup kit (based on oligo d(A)25 coupled to magnetic beats), this RNA, as well as the
corresponding interacting elements (RNAs or proteins), can be identified via
transcriptomic or proteomic approaches.
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ABSTRACT
The DNA-dependent RNA polymerase core enzyme in Gram-positive bacteria consists of seven subunits. Whilst four of
them (α 2 ββ  ) are essential, three smaller subunits, δ, ε and ω (∼9–21.5 kDa), are considered accessory. Both δ and ω have been
viewed as integral components of RNAP for several decades; however, ε has only recently been described. Functionally these
three small subunits carry out a variety of tasks, imparting important, supportive effects on the transcriptional process of
Gram-positive bacteria. While ω is thought to have a wide range of roles, reaching from maintaining structural integrity of
RNAP to σ factor recruitment, the only suggested function for ε thus far is in protecting cells from phage infection. The
third subunit, δ, has been shown to have distinct influences in maintaining transcriptional specificity, and thus has a key
role in cellular fitness. Collectively, all three accessory subunits, although dispensable under laboratory conditions, are
often thought to be crucial for proper RNAP function. Herein we provide an overview of the available literature on each
subunit, summarizing landmark findings that have deepened our understanding of these proteins and their function, and
outline future challenges in understanding the role of these small subunits in the transcriptional process.
Keywords: RNA polymerase; delta subunit; RpoE; omega subunit; RpoZ; epsilon subunit; RpoY; transcriptional regulation

INTRODUCTION
The ability of bacterial cells to precisely adjust and adapt to
their environment is crucial for survival. Accordingly, the expression of genes, and their products that facilitate adaptation to changing conditions, is a highly controlled and organized process. Transcription in all forms of life is performed by
DNA-dependent RNA polymerase (RNAP), with enzymes from
the different branches of life showing a high degree of similarity (Ebright 2000; Sekine, Tagami and Yokoyama 2012). With respect to eubacteria, core RNAP consists of two α subunits, one β
and one β  subunit, all of which are essential for a viable cell.
Besides these well-studied and essential components, several

additional, smaller subunits, δ, ε and ω, have been described and
intensively researched over a number of decades (Burgess 1969;
Pero, Nelson and Fox 1975; Keller et al., 2014). Additional to this,
bacteria possess σ factors (housekeeping or alternative) that assist RNAP with promoter recognition, and the initiation of transcription (Helmann and Chamberlin 1988; Feklistov et al., 2014).
While α 2 ββ  RNAP and the σ factor together are able to perform
all of the required steps for transcription, the additional, smaller
subunits support the complex by various means, reaching from
coordinating RNAP folding and assembly to increased transcriptional specificity, influencing RNAP recycling and possibly protecting the cell against phage infection.
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THE δ SUBUNIT OF RNAP
Structure, abundance and interaction of the δ subunit
with RNAP
The interaction of δ with RNAP
The presence of δ as an integral part of RNAP was first described
in 1975 when Pero, Nelson and Fox (1975) identified and named
a 21.5 kDa protein that co-purified with the RNAP complex from
phage-infected Bacillus subtilis. Here the group reported for the
first time the effects of δ on transcriptional specificity, using
in vitro transcription assays that demonstrated it was required
to maintain the strand-specific transcription of phage genes
characteristically observed during in vivo infection. These experiments provided not only a structural but also a functional
link between RNAP and δ. Subsequently, several groups simultaneously described the co-purification of δ with RNAP in B.
subtilis (Halling, Burtis and Doi 1977; Plevan et al., 1977; Tjian
et al., 1977). In a more recent approach, Doherty et al. (2010)
used fluorescent-labeled δ in B. subtilis to observe its interaction with RNAP in vivo, showing the subcellular co-localization
of this subunit with other RNAP proteins (β  and ω). Lately, our
group demonstrated the interaction of δ with the β and β  subunits of RNAP under native conditions in Staphylococcus aureus
(Weiss et al., 2014). This interaction is most likely facilitated by
the N-terminus of the protein, since a C-terminally truncated
version of the enzyme still co-purifies with core RNAP (Lopez de
Saro, Woody and Helmann 1995). Stoichiometrically, it appears
that the subunit binds in an approximate 1:1 ratio with other
subunits of core-RNAP (the α subunit excepted) (Halling, Burtis
and Doi 1977). Interestingly, early studies were unable to purify
RNAP containing a σ factor as well as δ at the same time. This
led to the idea of temporally separated binding of these two subunits, and questions about when and how δ interacts with core
RNAP. In order to understand the association of δ with core RNAP
in a time-dependent manner, and in correlation to DNA-binding
and transcriptional initiation, sedimentation experiments were
used, demonstrating that excess amounts of the subunit lead to
release of the σ factor from B. subtilis RNAP (Williamson and Doi
1978). This seemed plausible since δ had been shown in early
studies to decrease activity of core RNAP at certain promoters,
while σ is well known to have stimulatory effects, suggesting
a competitive relationship between these two subunits. These

findings, to a certain extent, were overruled when experiments
showed the need for both subunits in the context of promoter
selection (Achberger and Whiteley 1981), leading to key studies
revealing that δ and σ factors are in fact able to bind to RNAP
at the same time (Hyde, Hilton and Whiteley 1986). This ultimately excluded the hypothesis of a completely competitive δ vs
σ relationship. Instead, the decreased binding ability of σ after δ
subunit association with RNAP indicates ‘negative cooperativity’
in which both proteins are able to bind to the RNAP simultaneously, but where binding of δ possibly weakens the binding of σ
and leads to increased release of the factor. Such a scenario suggests a model in which both subunits are required for directed
binding to promoter regions, and initiation of transcription.
δ expression and protein levels within the cell
Various studies have explored the conditions that affect δ abundance within bacterial cells, using a variety of different strains
and backgrounds. In general, there is agreement that rpoE (the
δ encoding gene) is highly expressed during exponential phase
(mid and late) and, to varying degrees, during stationary phase,
in standard laboratory conditions. In S. aureus, peak expression
appears to be during exponential phase under standard conditions and when grown in amino acid- or glucose-limiting media (Watson, Antonio and Foster 1998; Weiss et al., 2014). In B.
subtilis, rpoE is most highly expressed during the transition between exponential and stationary phase, as well as in extracts
from spores (Lopez de Saro, Yoshikawa and Helmann 1999). For
Streptococcus agalactiae, findings from reporter constructs mirror
that seen in S. aureus and B. subtilis, with rpoE being expressed
during all growth phases, peaking during lag and (late) log, before dropping slightly when reaching stationary phase (Seepersaud et al., 2006). In S. mutans, it was shown that rpoE is expressed
maximally during late exponential phase, and subsequently declines during stationary phase (Xue et al., 2010). One study suggested that δ accounts for 0.3% (± 0.1%) by weight of the total
soluble protein of B. subtilis cells (104 molecules cell−1 ), representing a 5:1 molar excess compared to RNAP during exponential and stationary growth phase (Lopez de Saro, Yoshikawa and
Helmann 1999). In contradiction, Doherty et al. (2010) found a total abundance of 2.1 × 104 (± 580) molecules per cell for the β 
subunit and 2.3 × 104 (± 900) molecules for δ in exponentially
growing cells, resulting in an approximate 1:1 ratio of the subunit to RNAP. Although these studies show variation in comparison to each other, it is clear that δ is present in relatively equal
amounts to other components of core RNAP, therefore suggesting a permanent interaction of this subunit with the transcription machinery. In terms of factors that influence its expression,
it has been reported for B. subtilis (Lopez de Saro, Yoshikawa and
Helmann 1999), S. agalactiae (Seepersaud et al., 2006) and S. aureus (Weiss et al., 2014) that rpoE transcription is driven from a σ A dependent promoter. Beyond this, rpoE does not appear to be autoregulated in B. subtilis, but is at least partially repressed by acid
and H2 O2 stress (Lopez de Saro, Yoshikawa and Helmann 1999).
Collectively, the strong presence of δ during most/all growth
phases, in multiple bacterial species, highlights its potential importance for Gram-positive cells.
Structure, domains and active sites of the δ subunit of RNAP
When studying the primary amino acid (aa) sequence of δ proteins from numerous organisms (Fig. 1), it is apparent that they
all possess two distinct regions, as first described by Lopez de
Saro, Woody and Helmann (1995): an ordered and structured
N-terminus, and a flexible and unstructured C-terminus. The
C-terminus is characterized by highly acidic and repetitive aa
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As ω is found in Gram-positive as well as Gram-negative bacteria (Minakhin et al., 2001), it has been more heavily investigated
than the other subunits (for a thorough review, see Mathew and
Chatterji 2006). With regard to the δ subunit, it is seemingly confined to the Firmicutes; although proteins with some sequence
homology can be found in certain Tenericutes as well (our unpublished observation). Collectively, despite many years of research on this protein in low G + C Gram-positive bacteria, the
literature documenting it has never been collated in a single
place. As such, it forms a major component of the work detailed
herein. Nevertheless, we also seek to also update the literature
surrounding ω, as well as introduce newly published data on ε.
We believe that of these subunits, δ is particularly interesting,
since we still lack a complete understanding of how this enigmatic protein mediates its function, despite a history of more
than 40 years of research. Accordingly, we present the progress
of δ research over four decades, summarizing key milestones
in our understanding of this subunit, and highlight future challenges in dissecting its role in transcription, as well as cellular
fitness and survival.
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residues; together, the N- and C-termini have a significantly
acidic pI of 3.6. A wealth of additional structural information
for δ was generated by Motackova et al. (2010) using NMR technology and the B. subtilis protein, specifically focusing on the
N-terminal 100 aa. Four α-helices were identified; each being 5 to
12 aa in length (residue Q8–K12, L16–H27, F33–L44, G52– N63). In
addition, a β-sheet, consisting of three β-strands (residues V31–
P32, F68–A70, T75–L78), was reported. A concern with these approaches was the inclusion of a His-tag to facilitate purification,
possibly interfering with NMR analysis. To assess this, the same
group later conducted structural analyses on the full-length protein lacking such a tag, again using NMR (Papouskova et al., 2013).
This approach proved to be especially challenging because of
the acidic C-terminus; however, these studies confirmed previous work with the His-tagged N-terminal variant. Relaxation experiments in these works showed that the C-terminal tail transiently contacts the ordered N-terminal domain, leading the authors to suggest that folding of the N-terminus may be influenced by interactions with its C-terminal partner. In addition,

interdomain interactions (between the C- and N-terminus, and
the C-terminus with itself), as well as the formation of possible
β-sheet structures, were predicted for the flexible C-terminal region.
An attempt to identify functional domains found only weak
homology to DNA/RNA-binding proteins for the N-terminus of δ,
and therefore initially no nucleic acid binding properties of the
subunit were assumed (Motackova et al., 2010). A more recent
study then compared sequence and structural features of a variety of elements to the human ASXL protein, identifying similarities of the ASXL N-terminus and δ (Aravind and Iyer 2012). The
N-terminus of this protein is characterized by a winged helixturn-helix (wHTH) domain that was named after its presence
in the group of HB1, ASXL and restriction endonuclease proteins (HARE-HTH). Other than the δ subunit, HARE-HTH domains
in prokaryotes are mainly found in restriction endonucleases
that are associated with DNA-modifying methylases. Based on
this study, a role in the recognition of modified DNA sequences
for δ has been suggested, although it is not yet experimentally
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Figure 1. Structural features of the δsubunit of RNAP. (A) Alignments of 130 representative δ proteins from different Gram-positive species (using CLC Main Workbench
software). Shown are (from top to bottom) broken black lines next to numbers from 1 to 130 (corresponding to bacterial species and IMG Gene ID numbers (Markowitz
et al., 2014), see Table S1, Supporting Information) represent the alignment of δ proteins. Sequence conservation is highlighted by two graphs: the upper one marks
residues that are at least 95% (black) and 99% (red) conserved. The one below highlights the amount of conservation (0–100%) for each amino acid. The gapped fraction
visualizes the amount of divergence in each region of the protein. At the bottom, an enlargement of the N-terminus is shown and highlights the conservation in
regions that harbor specific protein domains (α-helices or β-sheets). (B) Amino acid sequence of the B. subtilis δ subunit. Black letters mark the N-terminus and red
letters the C-terminus of the protein. (C) Secondary structure prediction of the ordered N-terminus and the disordered C-terminus of the δ protein, showing a bias
towards α and β structures, respectively. This figure is reproduced from Papouskova et al. (2013). (D) Structure of B. subtilis δ from the protein database (PDB ID: 2M4K).
The blue region corresponds to the HARE-HTH domain (residue 14–81); residues in red (≥99%) and orange (≥95%) highlight amino acids that are conserved from the
alignment.
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The δ subunit and its impact on transcriptional
selectivity
Early work highlighting the influence of δ on transcription
The majority of early information regarding δ function was generated by studies exploring transcriptional patterns of phage
genes in B. subtilis. Upon infection, phages go through a predictable pattern of early, middle (4–5 min) and late (8–10 min)
gene expression (Gage and Geiduschek 1971). Phage genes transcribed in this temporal pattern are located on different strands
(heavy or light) of the phage genome. Whilst these specific
temporal and strand-specific transcriptional patterns are governed by phage-encoded proteins (Gage and Geiduschek 1971;
Fox 1976; Giacomoni 1981), it has been shown that δ, as an innate
part of RNAP, is also involved in maintaining their specificity
and order of transcription (Pero, Nelson and Fox 1975; Achberger,
Hilton and Whiteley 1982a; Dobinson and Spiegelman 1987).
These experiments initially demonstrated that δ has a supportive role for transcriptional selectivity, acting alongside and in
concert with other transcription factors (e.g. phage-encoded σ
factors and regulatory proteins). This was projected to not only
be true for phage-related genes but for the transcriptional process in general.
The δ subunit enhances RNAP fidelity and selectivity
Other early studies on the function of δ centered not only around
phage genes but also on its effects on transcription from synthetic templates (poly(dA-dT)) (Tjian et al., 1977). It was reported that whilst δ had only a limited effect on the expression of phage genes, it strongly decreased RNAP activity towards
synthetic templates, suggesting a general function in selectivity. This led to studies focused on a wider spectrum of transcriptional targets, employing a variety of templates, including

different phages, B. subtilis chromosomal DNA, plasmids and
synthetic targets (Dickel, Burtis and Doi 1980). These in vitro transcription experiments revealed varying effects after the addition
of purified δ to reaction mixtures. Specifically, in the case of one
phage tested (e), δ had no negative effects on RNAP activity,
whilst for B. subtilis chromosomal DNA, the synthesis of RNA
was decreased by up to 87% for some regions in the presence of
this subunit. Moreover, transcription from DNA fragments that
did not contain specific and known promoter sequences was almost entirely repressed by the presence of δ. This suggests that
the δ subunit affects different promoters in different ways, thus
supporting promoter specificity of the transcriptional machinery, whilst at the same time suppressing transcription from loci
that do not contain δ-specific promoter elements. Similar effects
for δ on the transcription of non-coding-regions were also described by Achberger and Whiteley (1981). Their studies, using in
vitro transcription employing endonucleolytic fragmented DNA
from B. subtilis bacteriophage SP82, revealed that in the absence
of δ, the RNAP holoenzyme binds non-specifically to fragments
that do not have promoters, resulting in transcription from these
sites. The addition of δ to in vitro transcription reactions restored
binding of the complex exclusively to promoter regions and produced transcription patterns (mid vs late phage genes) that are
characteristic of those seen in vivo. Along the same lines, UV
cross-linking experiments reveal that the addition of δ to coreRNAP or the RNAP holoenzyme leads to decreased binding at
non-promoter sequences (Hilton and Whiteley 1985).
In a study by Dobinson and Spiegelman (1987), features that
guide the variable effects of different promoters were explored
by assessing the expression of two early 29 promoters in runoff experiments (initiation complex assays). In these works, it
was shown that the influence of δ on transcription appears
to be dependent on the strength of the promoter in question.
Specifically, varying effects on transcriptional repression were
observed, with the stronger of the two promoters showing no
decrease in expression upon δ addition, whilst the weaker promoter resulted in a 50% decrease in transcription after supplementation with the subunit. These results gave early insight into
the selective effects of δ, and suggested that promoter strength
may be a driving force of its activity. This model has been supported by the findings of Juang and Helmann (1994b) in their
work with the B. subtilis ilv-leu operon. In this study, it was shown
that δ negatively influences open complex formation and has
stronger effects towards the transcription of weaker promoters,
and less of an influence on medium strength promoters. Consequently, it was suggested that δ decreases promoter melting,
which leads to decreased transcription from non-promoter sequences, as well as at weaker promoters. In contrast, promoters
that are considered closer to optimal are relatively independent
of the effects of δ. Thus, a model describing three general types
of promoters and their susceptibility to δ was proposed as follows (Juang and Helmann 1994b): (i) at weak promoters, δ prevents RNAP binding and therefore transcription; (ii) at medium
strength promoters, δ allows the binding of RNAP, but decreases
open complex formation; and (iii) at strong promoters, δ seemingly has little effect on gene expression.
δ interferes with open complex formation
Initial Studies by Spiegelman, Hiatt and Whiteley (1978) and
Achberger, Hilton and Whiteley (1982a) indicated that δ functions in the window between promoter recognition and initiation, rather than being directly involved in initiation itself.
Subsequently, experiments by Chen and Helmann (1997) furthered this notion, showing that δ is important for open complex
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proven. Nevertheless, the presence of a HARE-HTH motif in δ
presents the interesting possibility that not only does it interact
with RNAP but that it also contacts DNA itself, allowing it to discriminate between sequences that differ, for example, in their
degrees of DNA modification. As such, it is tempting to speculate that, similar to alternative σ -factors, δ potentially mediates
directed transcriptional effects by recognizing specific promoter
features, rather than solely having global effects on a large number of genes through modulation of RNAP activity.
To understand the importance and conservation of key δ regions, our group recently published alignments using various
different species that carry a δ subunit protein (Weiss et al.,
2014) (Fig. 1). We demonstrate that HARE-HTH domains show a
higher degree of conservation than other portions of the protein,
emphasizing its likely importance for function. In contrast, the
C-terminus of δ shows a large degree of variation. Further to
this, there is a clear degree of divergence in the context of protein length for δ from various species (Table S1, Supporting Information), largely resulting from variations in the C-terminal
domain. This suggests that the C-terminus either plays species
specific roles or is at least partially dispensable for full function
of the subunit. In line with this latter idea, we have shown that
a δ variant of S. aureus containing a truncated C-terminus (missing ∼25% of the protein) is still able to successfully interact with
components of the transcription machinery, and complement,
at least in part, the phenotypes of an rpoE-null strain (Weiss et al.,
2014). This is in line with earlier findings in B. subtilis, also describing that interaction of δ with RNAP is mediated by the Nterminus of the subunit (Lopez de Saro, Woody and Helmann
1995).
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formation. This is in support of Juang and Helmann, who used,
amongst other approaches, footprinting analysis to describe
the inhibitory effects of δ on open complex formation (Juang
and Helmann 1994a, 1994b, 1995). Furthermore, they demonstrated that loss of δ specifically interfered with promoter melting, rather than impacting the stability of the open promoter
complex, which is somewhat in contrast to Rabatinova et al.
(2013), who suggested that the longevity of open complexes is diminished by δ. Importantly, each of these studies again support
the notion that δ influences transcription prior to initiation.

The role of the initiating nucleotide on δ-dependent regulation
Although the contention that δ-dependent transcriptional effects are influenced by individual promoter strength is well established, it fails to completely explain all changes in gene expression mediated by this subunit. Therefore, a more recent
study in B. subtilis has centered on delineating the exact role
of δ in promoter melting and open complex formation, with a
specific focus on the transcription initiating NTP (iNTP) (Rabatinova et al., 2013). This idea was shaped by previous works, showing that promoter activity is not only determined by pure binding efficiency of RNAP to promoter sequences but also by the
ability to initiate transcription. While high levels of iNTPs ensure efficient transcription, lower amounts cause collapse of the
open promoter complex, and prevent transcriptional initiation.
In Escherichia coli, transcriptional initiation from rRNA promoters, which have inherently unstable open promoter complexes,
is dependent on the availability of transcript specific iNTPs (ATP
or GTP) (Gaal et al., 1997; Murray, Schneider and Gourse 2003).
A similar scenario was also shown for B. subtilis, where nutritional starvation and onset of the stringent response results
in decreased levels of GTP and therefore negatively influences

transcription of iNTP-sensitive rRNA promoters (Ochi, Kandala
and Freese 1982; Krasny and Gourse 2004). Subsequently, it was
shown that such regulation is not only true of rRNA promoters but other genes as well, thus presenting a general regulatory concept (Krasny et al., 2008). Accordingly, Rabatinova et al.
(2013) explored the influence of iNTP on δ-mediated function in
B. subtilis, revealing that the δ subunit influences transcription by
enhancing the effects of iNTP on open complex formation. Promoters that possess relatively unstable open complexes require
higher amounts of iNTP to initiate transcription. δ destabilizes
open complex formation, thus increasing the amount of iNTP required for successful transcription initiation; supporting the notion of iNTP-dependent transcriptional regulation. This appears
to be particularly true for promoters that are iNTP sensitive (e.g.
rRNA promoters), whilst other promoters, which display stable
open complexes, are less likely to be affected by the influence of
the δ subunit.

The impact of abrogated δ activity on fitness and
virulence
Phenotypic effects of δ deletion
Although the specific effects of δ on transcription have been well
documented, uncovering the phenotypic effects of rpoE deletion
was, at least initially, more challenging. A B. subtilis mutant lacking the δ subunit of RNAP was shown to be viable, able to form
spores and did not display obvious growth defects under standard laboratory conditions (Lampe et al., 1988). Although unexpected at first, these results are not surprising for an accessory
subunit. They do, however, raise the question about under which
conditions the transcriptional effects of δ result in altered behavior of the cell, and, thus, under which stimuli the δ subunit is
beneficial for cellular survival. An early indication about possible
δ function came from a study in S. aureus investigating starvation
survival. Watson, Antonio and Foster (1998) identified rpoE during a transposon screen targeted towards genes that are important for survival and recovery from prolonged stationary phase
starvation. A transposon insertion within the early portion of
rpoE caused impaired survival under amino acid-limiting conditions and acid stress. Similar rpoE-dependent stress phenotypes
were later shown in S. mutans, where a δ subunit mutant is impaired in acid and H2 O2 stress survival (Xue et al., 2010). Additionally, the mutant was described as having a clumping phenotype, and to reach lower final densities in liquid cultures when
compared to the wild type. Another common phenotype described for various bacterial species, including B. subtilis (Lopez
de Saro, Yoshikawa and Helmann 1999), S. aureus (Weiss et al.,
2014) and S. agalactiae (Jones, Needham and Rubens 2003), is
the extended lag phase of rpoE-depleted strains when subcultured into fresh media from stationary phase growth. Thus, it
would appear that δ is required for adaption to, and survival
during, stress and changing environmental conditions, as well
as growth phase transition. It has also been documented that
B. subtilis rpoE mutants are characterized by elongated cell morphology, the propensity to clump during log phase and the appearance of rough-edged colonies when grown on solid media
(Lopez de Saro, Yoshikawa and Helmann 1999). Interestingly,
and despite earlier studies that described normal sporulation
of B. subtilis rpoE strains (Lampe et al., 1988; Lopez de Saro,
Yoshikawa and Helmann 1999), it has also been shown that a
transposon insertion in this gene suppresses the effects caused
by mutations (pdhB or pdhC) that block sporulation (Gao and
Aronson 2004). The exact mechanism by which this occurs is unclear; however, these findings emphasize the widespread effects
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RNAP recycling
Whilst the majority of δ-related studies describe its negative effects on transcription of specific promoters, several groups have
demonstrated that δ also has the capacity to increase overall
transcriptional activity (Spiegelman, Hiatt and Whiteley 1978;
Achberger and Whiteley 1981; Juang and Helmann 1994b). These
positive effects are suggested to be a result of a decrease in nonspecific transcription, as well as increased core-RNAP recycling
in the presence of δ. The specific mechanism by which this latter process occurs is not fully understood; however, a more efficient release of RNAP after termination of transcription has been
suggested (Juang and Helmann 1994b). This effect is thought to
parallel the manner by which δ prevents RNAP from binding to
non-promoter sequences, thereby leading to decreased product
inhibition, and increasing the speed at which the transcription
complex is available to initiate new rounds of gene expression.
Structurally, it has been hypothesized that this process is facilitated by the C-terminus of δ (Lopez de Saro, Woody and Helmann 1995), where the negatively charged part of the protein
competes with DNA/RNA for RNAP binding, thereby causing increased release of the transcriptional machinery. In more recent
experiments investigating the function of HelD, another RNAPassociated protein, it was confirmed that δ is able to increase
transcriptional cycling by faster release of RNAP after termination; and is also able to release stalled RNAP from DNA, increasing transcriptional activity (Wiedermannova et al., 2014). Both effects have also been found to be true for HelD, and interestingly,
both proteins together show a strong synergistic effect. Whilst
the precise reason for this synergy is incompletely understood,
the results highlight the complex and multifactorial regulation
of RNAP activity.
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of δ on transcription, and its importance in maintaining cellular homeostasis. Considering the widespread defects displayed
by rpoE mutants in a wealth of species, it is perhaps expected
that rpoE mutants of B. subtilis are readily outcompeted by the
wild-type strain when cultured together over prolonged periods
(Rabatinova et al., 2013).

Global transcriptional and translational effects of δ
Exploring the influence of δ on global gene expression has been
aided by cutting edge high-throughput methodologies, including transcriptomics and proteomics. These techniques have provided insight into the role of δ in maintaining transcriptional
specificity, and how this links to the various phenotypes observed. To explore why an rpoE mutant of S. mutans displays
alterations in virulence-related behaviors, as well as impaired
ability to survive during stress (Xue et al., 2010, 2011), gene expression (Xue et al., 2010) and protein abundance (Xue et al.,
2012) were assessed for the wild type and mutant under several conditions. Transcriptomic analyses conducted via microarray revealed that, independent of the growth condition, more
than 50% of the upregulated transcripts in an rpoE mutant were
non-coding regions (Xue et al., 2010). In comparison, only 20–30%
of non-coding transcripts displayed increased expression in the
mutant strain. These findings corroborate previous in vitro studies that demonstrate non-specific transcription of non-promoter
regions when δ is removed from core RNAP (see above).
In addition to its effects on non-coding regions, coding sequences were also shown to be influenced by δ in S. mutans,
in a manner partially independent of growth phase or condition (Xue et al., 2010). Specifically, 24 genes were identified as
being downregulated in the rpoE mutant under all conditions.
These genes were involved in malolactic fermentation, histidine metabolism, biofilm formation, adherence, virulence, and
resistance to antibiotics and other inhibitory compounds. In addition, during growth under standard laboratory conditions, a
large number of transcripts were differentially expressed when
comparing the mutant and parental strain, including those involved in the transport of a wealth of different compounds,
metabolism and energy production/conversion. Following H2 O2
or acid stress, a number of protective genes were not induced in
the mutant strain, indicating that an incomplete stress response
exists upon rpoE loss; however, the general stress response still
appeared to be intact in the mutant strain. The authors ultimately concluded from these works that diminished survival of
the mutant strain when exposed to stress results from a general deregulation of the S. mutans transcriptome, leading to an
impaired, slower and less directed attempt to adapt to changing
environments and stress conditions.
In follow-up studies, the same group compared previous
transcriptomic data with new proteomic data of the rpoE mutant and wild type, using identical growth conditions (Xue
et al., 2012). It was noted that two proteins, phosphoglucomutase (PGM) and phosphopentomutase (DeoB), were decreased in
abundance either during all (PGM) or most (DeoB) growth phases
and conditions. Both were identified as displaying this same pattern in microarray analysis as well, suggesting distinct and very
gene-specific regulatory effects of δ. In the context of growth
phase, chaperones, stress-related factors and enzymes known
to be involved in protein turnover were altered in the mutant
during exponential phase; whilst multiple sugar transporters
and metabolism (MSM) systems demonstrated fluctuations during stationary phase. It was suggested that these changes in
protein abundance could be an indicator of internal cell stress,
rather than direct rpoE-guided effects. When comparing protein
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The role of δ in pathogenic organisms
Several groups have examined the effects of rpoE deletion on
more complex processes, such as during the interaction of
pathogenic bacteria with their hosts. Since disease causation
is a process that involves the precise timing of expression for
a variety of different genes, including those required for interaction with the immune system, virulence factor expression,
biofilm formation and nutrient acquisition, it is perhaps no surprise that δ has been shown to play and important role in virulence. In S. agalactiae, a study employing signature-tagged transposon mutagenesis in a neonatal rat sepsis model identified an
rpoE mutant as displaying the most impaired virulence from
the entire library (Jones, Knoll and Rubens 2000). In a subsequent study by the same group, it was suggested that the virulence defect was linked to increased killing by phagocytes, explaining the lower survival rates observed for rpoE mutants in
whole human blood; despite not showing altered survival in human plasma and chemically defined media (Jones, Needham
and Rubens 2003). An important consideration with these findings is that the rpoE transposon mutant is not a complete knockout, but is in fact only a low rpoE expressing strain due to the
location of the insertion. As such, the strain possesses around
a 10-fold decrease in rpoE transcript compared to the wild type,
which is seemingly insufficient to maintain full δ-function, leading to the decrease in virulence described. Therefore, it appears
that in S. agalactiae, and perhaps other pathogens (see below),
there is a minimal concentration of δ required in the cell to ensure transcriptional specificity and facilitate virulence.
The pathogenic role of δ has also been explored in another
streptococcus, namely S. mutans. Interestingly, and in contrast to
the negative effects of rpoE loss on virulence that were obtained
for S. agalactiae, it was described that deletion of rpoE leads to increased expression of virulence-related traits (Xue et al., 2011).
Specifically, increased co- and self-aggregation, and an altered
extracellular matrix, have been reported for rpoE mutants, which
may be caused by differentially expressed surface proteins and
polysaccharides. Furthermore, S. mutans rpoE strains also display elevated attachment to human extracellular matrix components, such as collagen and fibronectin. Despite these seemingly enhanced aggregative properties, rpoE deletion causes an
inability to attach to human epithelial cells (HEp-2) compared
to the wild-type strain; likely due to increased clumping of the
mutant. Beyond these findings, loss of rpoE in S. mutans results in
the derepression of enzymes that facilitate the metabolism of a
number of sugars, allowing the mutant to utilize a larger array of
carbon sources than the parental strain. Additionally, a panel of
antibiotics and compounds that are toxic to the wild type were
ineffective against the mutant in phenotypic microarray studies. This highlights the remarkably broad impact that δ has on
bacterial physiology and metabolism, each of which influence
cellular fitness, and thus pathogenesis.
In a more recent study by our group, we explored the effects
of δ in the major human pathogen, S. aureus (Weiss et al., 2014).
Deletion of rpoE resulted in decreased expression and abundance of a variety of virulence factors, leading to decreased fitness of the strain and impaired virulence. This latter point is
manifested by a diminished ability to survive in whole human

blood, and resist phagocytosis by human leukocytes. These in
vitro/ex vivo phenotypes were shown to correlate with in vivo
findings, where the mutant strain was found to be significantly
impaired in its ability to cause disease in a murine model of sepsis and dissemination.
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stationary phase growth (as seen for S. aureus and S. mutans),
loss of rpoE leads to a complex deregulation of transcription,
causing differential expression patterns, and the upregulation
of typically lowly expressed genes and non-coding elements.
(iii) Finally, it has been shown that cells lacking rpoE still adapt
to changing environmental conditions, but in a less rapid and
less robust manner than the wild type. This would seem to
account for the decreased survival of rpoE mutants under stress
conditions, and also explain the extended lag phase observed
when mutants are subcultured into fresh media. Accordingly,
the effects of rpoE disruption on survival and adaptation
can be viewed as a fitness defect, resulting from diminished
transcription of specific pathways and traits due to relaxed
transcriptional specificity. With this being said, the specific
and direct regulation of certain genes (e.g. PGM and DeoB in
S. mutans) and traits (virulence determinants in S. aureus) still
occurs. Collectively, each of these facts and findings highlight
the multifactorial influence of δ, ranging from gene-specific to
global effects, leading to a lack of fitness, and alterations in key
cellular processes.

Summary of the δ subunit
Collectively, all of the information contained herein leads to
a model for δ function (Fig. 2): A major feature of the δ subunit is that it decreases the stability of RNAP-DNA interaction
at non-coding regions and weak promoters that possess inherently unstable open promoter complexes. Consequently, δ biases the transcriptional machinery towards those open-reading
frames that have strong promoters/stable open promoter complexes, thus favoring expression from such sites. In addition
to this, features beyond promoter strength (e.g. iNTP requirements) likely result in promoter-specific effects of δ in addition
to its more general role. Furthermore, δ increases RNAP recycling and causes overall enhanced transcriptional activity. In

Figure 2. A model describing the effect of δ on different phases of transcription. The available literature suggests that δ has varying effects on each stage of the
transcriptional process. The subunit prevents non-specific binding and transcription of RNAP from intergenic and non-promoter-containing regions. This influence on
open complex formation and the initiation of transcription vary from promoter to promoter, thereby increasing transcriptional specificity of RNAP. Whilst elongation
and termination are seemingly unaffected, δ does limit the binding of RNAP to DNA at terminators, allowing faster recycling of the enzyme, and increasing overall
transcription. Shown are the stages of transcription and the corresponding gene regions in black letters and δ-dependent effects in red. Note that the ε and ω subunits
are omitted from this figure for reasons of simplicity.
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composition of the rpoE mutant and parental strain after exposure to external stressors, it was noted that both strains were
able to induce protection-specific pathways, which was again
largely consistent with transcriptomic data. However, despite
general adaptation patterns being similar between mutant and
wild type, it was observed that the upregulation of proteins required to adapt to environmental change was weakened upon
the loss of δ, again indicating a slower or dampened response to
stress.
Using RNAseq technologies, our own group revealed similar effects of rpoE deletion in S. aureus as compared to S. mutans (Weiss et al., 2014). Specifically, our rpoE mutant displayed
differential expression of 191 genes compared to the wild type
during exponential growth, including a significant decrease in
many known or implicated virulence factors, such as toxins,
hemolysins and secreted proteases. While global regulators
were largely unaffected, the clustered alteration of virulence
gene expression again suggests gene specific effects, such as
those seen for PGM and DeoB in S. mutans (Xue et al., 2012). Beyond reduced virulence gene expression, we notably observed
that under standard conditions weakly expressed genes were
generally derepressed upon loss of rpoE. Interestingly, we also
saw a large increase in non-core genome elements, including
prophage-encoded genes. This parallels the effects seen for noncoding sequences in S. mutans, and further highlights that loss
of the δ subunit results in decreased transcriptional selectivity,
and an overall deregulation of the transcriptional process.
When one considers all of the available transcriptomic/proteomic studies with rpoE mutants, three general
conclusions can be made. (i) Certain genes and gene groups
are changed in expression/protein abundance independent of
growth phase or stress condition. This suggests a gene-specific
mechanism of regulation that involves δ, opening the possibility
that there may be promoter features other than strength (for
example iNTP-sensitivity) at work. (ii) During exponential and
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general, δ weakens the binding of RNAP to DNA and negatively
influence open complex formation and stability; which appears
to be mediated by structural features of the δ protein. Specifically, its N-terminus mediates interaction with core RNAP, whilst
the negatively charged and intrinsically disordered C-terminus
is thought to interfere with the RNAP-DNA interaction. Ultimately, δ acts as a guide for RNAP, increasing its transcriptional
specificity. Loss of this factor causes deregulation, and results in
a decreased ability to adjust to changing environments, general
fitness defects and the reduced virulence of pathogenic species.
All of these consequences highlight the central importance of δ
as a regulatory factor directing gene expression in Gram-positive
bacteria.

ADDITIONAL, SMALL ACCESSORY RNAP
SUBUNITS IN GRAM-POSITIVE BACTERIA

The ω subunit
The ω subunit of RNAP is an intensively studied protein that
has been widely described in the literature. With this being said,
the majority of studies have been performed using the Gramnegative model organism E. coli, and appear to be only partially
translatable to Gram-positive species, as discussed below. An extensive and comprehensive review on the history of ω research,
including Gram-positive as well as Gram-negative bacteria, has
been published by Mathew and Chatterji (2006) where the authors summarize structural and functional roles of the subunit.
In the context of this review, we will offer an overview of data
that is available and valid for Gram-positive organisms, as well
as highlight functional differences compared to Gram-negative
bacteria.
The ω protein is widely conserved across all forms of life
With an increasing number of bacterial, archaeal and eukaryotic genomes available, it has become clear that the ω subunit
is conserved in all branches of life. In eukaryotes, a sequence,
structural and functional homolog of ω (RPB6) exists that is associated with RNAPI, II and III, whilst archaeal genomes harbor
a sequence homolog termed RpoK (Minakhin et al., 2001). RPB6
has been shown to be essential for RNAP assembly in eukaryotes (Nouraini, Archambault and Friesen 1996); however, in bacteria, deletion of the ω subunit in a variety of different species
does not result in cell lethality (Gentry and Burgess 1989; Kojima et al., 2002; Mathew, Ramakanth and Chatterji 2005; Doherty et al., 2010; Jie, JiLiang and DongJie 2010; Santos-Beneit
et al., 2011; Gunnelius et al., 2014). This is particularly intriguing,
since the subunit is conserved in all of the sequenced genomes
of free-living bacteria (Minakhin et al., 2001), suggesting an important evolutionary role for it in cellular survival
The binding of ω to RNAP
The ω protein, which ranges in size from ∼9 to 11.5 kDa depending on the bacterial species in question, was first shown to be a
dedicated subunit of E. coli RNAP, rather than just a tightly bound
factor, when cross-linking experiments demonstrated its specific binding to the β  subunit (Gentry and Burgess 1993). Sub-

The role of ω for structural integrity of RNAP
Extensive research has been performed on the involvement of ω
in folding of the β  subunit, and RNAP assembly. Its importance
for the assembly process was first considered when RNAP purified from Rhodobacter capsulatus and E. coli was shown to require
ω, or GroEL and ω, respectively, to remain active in vitro (Mukherjee and Chatterji 1997; Richard et al., 2003). This requirement for
the GroEL chaperone was considered puzzling, but this factor
had been shown to co-purify with RNAP, and was thus thought
to be important for the folding of the transcriptional complex
(Mukherjee and Chatterji 1997; Mukherjee et al., 1999). Interestingly, deletion of ω in E. coli results in a massive increase of GroEL
recruitment to RNAP, suggesting that GroEL might be employed
to overcome misfolding due to ω loss (Mukherjee et al., 1999).
This was confirmed when in vivo GroEL substrates in E. coli were
determined (Houry et al., 1999), showing that other than β  , all
of the essential RNAP subunits, as well as ω, require GroEL for
proper folding. Surprisingly, these results were found to be only
partially true in B. subtilis, where GroEL does not appear to be
associated with RNAP subunits (Endo and Kurusu 2007). With
this being said, the Gram-positive study identified considerably
fewer GroEL substrates than the study performed in E. coli (28
vs ∼300). Therefore, either there are indeed fewer substrates for
this chaperone in B. subtilis or experimentation in the Grampositive organism had lower sensitivity in comparison with the
E. coli study.
Interestingly, an earlier study in E. coli described in vitro crosslinking of ω and β  (Gentry and Burgess 1993), whilst at the same
time showing that β  was not a substrate of GroEL and that the
ω subunit increases (together with GroEL) the in vitro activity of
RNAP. As such, it was suggested that ω had a specific function
in supporting the folding of β  . This hypothesis was reinforced
by a structural study that investigated the precise interplay of ω
and β  , demonstrating interaction of conserved regions for these
two proteins (Minakhin et al., 2001). Consequently, it was proposed that ω acts as a molecular latch, guiding the interaction of
β  with the α 2 β complex. Studies by Ghosh, Ishihama and Chatterji (2001) supported this notion by demonstrating that the interaction of ω with β  was able to prevent aggregation of the latter protein during in vitro renaturation. Furthermore, this same
group was able to show that native folding of β  requires ω, and
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In addition to the δ subunit, Gram-positive bacteria possess two
other accessory RNAP subunits, omega, ω (RpoZ) and epsilon, ε
(RpoY). Whilst ε is unique to Gram-positives, ω is found in RNAP
complexes from archea to eukaryotes. Both of these subunits
and their roles within the RNAP complex is discussed in the following sections.

sequently, it was found to be an integral part of the transcription machinery in vivo when the association of ω directly with
RNAP was shown (Dove and Hochschild 1998). In these studies,
ω was translationally fused to a DNA-binding protein (the cI repressor from bacteriophage λ) and was found to activate transcription of promoters adjacent to the corresponding λ operator, demonstrating interaction of the chimeric λcI-ω fusion protein with RNAP. Both of these studies have since been supported
by more recent work solving the structure of ω-containing RNAP
from Thermus aquaticus and E. coli (Zhang et al., 1999; Murakami
2013). Although no such crystallization studies for RNAP have
been performed in Gram-positive bacteria, several experiments
in B. subtilis demonstrate co-purification of ω with RNAP, highlighting its association with other subunits of the transcriptional
machinery (Spiegelman, Hiatt and Whiteley 1978; Achberger,
Tahara and Whiteley 1982b). These results were confirmed and
extended in a recent approach in which Delumeau et al. (2011)
were not only able to co-purify ω with the essential RNAP subunits (α, β, β  ) but also determined a 2:1:1:1 ratio for α 2 ββ  ω
during exponential and stationary growth. These results clearly
show that, as for Gram-negative bacteria, the ω subunit is an integral part of the Gram-positive transcriptional machinery.
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interactions with β  . This is especially interesting, given that
no complete Gram-positive RNAP structure is available so far,
and therefore no definite assumptions about ω − β  interaction
can be made. These differences in conformation and interaction
between the subunits could account for the various functional
properties of ω in different bacterial species, which are discussed
in the following section.

that folding of the β  subunit in the absence of ω results in an intermediate state between a denatured and native conformation
(Ghosh, Ramakrishnan and Chatterji 2003). These results were
supported by work in Bacillus cereus, where expression of ω increased by as much as 10-fold after heat stress (42◦ C), suggesting
a chaperone-like role, where larger amounts of the subunit can
counteract RNAP denaturation (Periago et al., 2002). Other than
a function in β  -folding, it was also shown that the removal of
ω leads to increased proteolytic cleavage of β  during RNAP isolation in Mycobacterium smegmatis, suggesting an additional protective role of the ω subunit (Mathew, Ramakanth and Chatterji
2005). Based on these studies, the involvement of ω in RNAP assembly was described, whereby an α-dimer and the β subunit
assemble before docking to ω-bound β  occurs (as visualized in
Mathew and Chatterji 2006 and shown in Fig. 3). Both the sequential assembly of the subunits themselves, as well as the importance of ω for the assembly process, was recently confirmed
by studies that investigated active RNAP reconstitution at air–
water interfaces (Ganguly and Chatterji 2011).
Further to this, the comparison of different RNAP crystal
structures revealed that ω seems to have varying interactions
with β  and within the RNAP complex in diverse organisms (Murakami 2013). For example, in T. aquaticus and E. coli, ω displays
only partially overlapping conformations, and thus has varying

ω is involved in σ factor recruitment
RNAP purified from E. coli rpoZ mutants displays an altered composition, with the amount of σ 70 associated diminished, and a
concomitant increase in bound σ 38 (Geertz et al., 2011). These
changes in RNAP composition result in altered gene expression
and DNA relaxation. Interestingly, the wild-type phenotype (increased supercoiling) is restored by overexpressing σ 70 in ω-null
strains. Similar results were obtained in the cyanobacterium
Synechocystis sp. PCC 6803 (Gunnelius et al., 2014a), wherein an
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Figure 3. Model for RNA polymerase assembly in Gram-positive bacteria. After
association of two α subunits, the dimer binds to the β subunit. The β  protein
is held by the ω subunit (Minakhin et al., 2001) in order to prevent misfolding
(Ghosh, Ramakrishnan and Chatterji 2003) and aggregation (Ghosh, Ishihama
and Chatterji 2001), before the β  -ω complex docks with α 2 β (Mathew and Chatterji 2006; Ganguly and Chatterji 2011). Thus far, it is unknown when the ε and
δ subunits bind to the complex; however, it is believed that ε interacts at the region of the β  jaw and secondary channel (Keller et al., 2014), whilst δ is thought
to interact with the β and β  subunits (Weiss et al., 2014). Finally, and in order to
enable RNAP to perform promoter-specific transcription, the σ factor docks with
core RNAP resulting in holoenzyme formation.

ω and the stringent response: structural and functional variability
in different bacterial species
In E. coli, the ω-encoding rpoZ gene is located in the same
operon as spoT (Gentry and Burgess 1989; Sarubbi et al., 1989).
SpoT is a bifunctional enzyme that facilitates the degradation
and synthesis of guanosine tetraphosphate and pentaphosphate (ppGpp and pppGpp), thus regulating the levels of these
alarmones, and onset of the stringent response (reviewed in
Cashel et al., 1996; Chatterji and Ojha 2001). In such a scenario,
ppGpp/pppGpp are produced as a result of nutritional stress
and cause global changes in transcription. Extensive work has
centered on the mechanism of ppGpp/pppGpp recognition by ω,
largely in E. coli (reviewed in Mathew and Chatterji 2006). Such
studies recently led to identification of the ‘magic spot’, the
binding site of ppGpp on RNAP (Kahrstrom 2013). Together three
publications by different groups described that the binding of
ppGpp to RNAP occurs at the interface of the β  and ω subunits
(Mechold et al., 2013; Ross et al., 2013; Zuo, Wang and Steitz 2013),
and that deletion of key residues negatively influences growth
under nutrient-limiting conditions via loss of ppGpp binding to
RNAP (Ross et al., 2013). Interestingly, homology analysis shows
that key β  and ω residues important for ppGpp binding are not
conserved within the Firmicutes (or the Thermus and Aquificales
genera), therefore suggesting alternative mechanisms of ppGpp
recognition by RNAP exist (Ross et al., 2013). This is in line
with findings from B. subtilis, highlighting that although ppGpp
is used as a signaling molecule to react to changing nutrient
availability, ppGpp does not change transcriptional specificity
by directly binding to ω and RNAP; thus, ω deletion does
not interfere with stringent response induction (Krasny and
Gourse 2004; Doherty et al., 2010; Kriel et al., 2012). Instead, this
alarmone causes changes in intracellular GTP concentrations
by modulating the activity of GTP synthesis proteins, which
subsequently leads to altered activity of GTP (iNTP) sensitive
promoters, such as ribosomal RNA genes (Krasny and Gourse
2004; Kriel et al., 2012). Together these findings show that,
although ω and the utilization of ppGpp to signal and react to
nutrient limitation are conserved, the mechanism for alarmone
recognition is variable. This emphasizes the need to examine
and understand the function of ω in species beyond the standard
model organism, E. coli. Interestingly, these possible functional
differences between genera are also mirrored in the cellular
abundance of the subunit itself. Doherty et al. (2010) were able
to show that in E. coli almost every RNAP polymerase includes a
ω subunit (85%), whilst in B. subtilis the amount is significantly
lower, with only 48% of RNAP complexes containing the subunit.
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rpoZ knockout had impaired recruitment of the primary σ factor, resulting in decreased expression of genes under the control of this element. Inversely, a large number of typically lowly
expressed genes were upregulated, suggesting activity of one or
more alternative σ factors. These data indicate a role for ω in
transcriptional specificity, and are supported by later publications describing an altered response to heat stress upon deletion of rpoZ, leading to impaired survival at higher temperatures
(Gunnelius et al., 2014b). Importantly, such findings correlate
with early studies showing that purification of ω-deficient RNAP
in E. coli is depleted for σ 70 , leading to the conclusion that ω is
required for correct RNAP folding and σ -factor binding (Mukherjee et al., 1999). Overall, this line of research describes how the
structural effects of ω are required for RNAP integrity and functionality, which leads to a role in fine-tuning transcription by
adjusting affinity for central transcriptional regulators such as
σ factors. These results were all obtained in Gram-negative organisms, thus highlighting the need for further investigation in
Gram-positive species.
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The ω subunit of Gram-positive bacteria
As detailed above, in E. coli the ω subunit mediates folding of
the β  subunit, influences assembly of RNAP, orchestrates gene
expression during the stringent response and plays a role in ordering transcriptional specificity. In Gram-positive bacteria, the
functional role of ω is much less clear. Since ppGpp does not
bind RNAP in B. subtilis, the ω subunit is unlikely to be directly
involved in the stringent response of this organism. This raises
the question of additional functions for the Gram-positive ω subunit outside of ppGpp binding and β  folding. Whilst studies have
been conducted for various Gram-negative bacteria beyond E.
coli, including Sinorhizoboium meliloti (Krol and Becker 2011), Xanthomonas campestris (Jie, JiLiang and DongJie 2010) and cyanobacteria species (Gunnelius et al., 2014a, 2014b), thus far the role of
ω in Gram-positive bacteria has only been extensively examined
in two Streptomyces species and M. smegmatis.
When exploring the role of the ω subunit in Streptomyces kasugaensis, it was found that an rpoZ mutant had diminished synthesis of the antibiotic kasugamycin, and that the strain was
also deficient for aerial hyphae generation (Kojima et al., 2002).
A genetic basis for this latter phenotype was not reported; however, the kasugamycin biosynthetic genes were found to have
decreased expression in the mutant strain. This decrease in
expression appears to be mediated by reduced production of
the KasT regulator, which is known to positively regulate kasugamycin production (Ikeno et al., 2002, 2006). Interestingly,
when kasT was expressed under the control of a different promoter (ermEp), it was transcribed at wild-type levels in the
rpoZ mutant, and resulted in expression of the kasugamycinproducing operon (Kojima et al., 2002, 2006). Although the underlying mechanism for this regulation is not currently understood,
these results do indicate that ω is capable of having promoterspecific transcriptional effects.
Subsequent to this, the role of ω was also analyzed in Streptomyces coelicolor. Interestingly, the ω proteins of S. kasugaensis
and S. coelicolor display 98% sequence similarity, with the protein from the latter being able to complement rpoZ loss in S. kasugaensis (Kojima et al., 2002). Santos-Beneit et al. (2011) have detailed pleiotropic phenotypes for a S. coelicolor rpoZ mutant, including slow growth, absent spore-pigmentation and increased
sensitivity to heat, with temperatures above 40◦ C leading to
an aerial hyphae-null phenotype. Additionally, the mutant displayed altered expression of two antibiotics, actinorhodin (ACT)
and undecylprodigiosin (RED). Whilst ACT was produced earlier

during growth in an rpoZ-depleted strain, the mutant failed to
produce the antibiotic in later growth phases, showing overall
reduced levels after 70 h. For RED, it was reported that production was essentially abolished in the mutant strain, akin to kasugamycin synthesis in S. kasugaensis. While there is no clear
explanation for how deletion of rpoZ simulatiously modulates
expression of these structurally unrelated metabolites, or leads
to pleiotropic phenotypic alterations in S. coelicolor, it was shown
that rpoZ has a PhoP-binding site (PHO box) (Sola-Landa et al.,
2005) upstream of its transcriptional starts site (Santos-Beneit
et al., 2011). The repressor PhoP is known to inversely regulate
the expression of secondary metabolites in response to the availability of phosphate (Sola-Landa, Moura and Martin 2003). For
rpoZ, it was shown that PhoP does indeed bind to its promoter region, and that deletion of phoP results in an increased abundance
of the subunit. Whilst these experiments suggest that ω itself
can be regulated in an environment-depenent manner, it is not
completely understood how the subunit exerts its effects on a
plethora of different genes and cellular processes. Furthermore,
the notion that rpoZ expression is controlled by an environmentresponsive regulator is challenged, at least in part, by findings
in B. subtilis. In this organism, Delumeau et al. (2011) described
that during sporulation, or following stress in vegetative cells,
no changes in RNAP subunit stoichiometry are observed. This is
in line with findings from Nicolas et al. (2012), who report that
expression of the subunit is stable under 104 different growth
conditions in B. subtilis, suggesting constant and environmentindependent abundance of ω. These opposing findings may represent species-specific differences, highlighting not only the
need to investigate how ω mediates its effects on gene expression but also how its production within the cell is controlled.
In M. smegmatis, it was first shown that rpoZ deletion causes
changes in colony morphology, and a slower growth phenotype
similar to that reported for E. coli (Mukherjee et al., 1999; Mathew,
Ramakanth and Chatterji 2005). Further studies described that
ω-depleted strains present additional pleiotropic alterations, including a decrease in sliding motility, and diminished biofilm
formation due to an altered biofilm matrix and cell surface resulting from shorter chain mycolic acids (Mathew et al., 2006).
With regard to this latter point, ω-deficient strains of M. smegmatis are unable to manipulate their mycolic acid and glycopeptidolipide profiles to that required for biofilm maturation; indeed,
even after the onset of biofilm formation, rpoZ mutants maintain
mycolates only found in the wild type during planktonic growth
(Mathew et al., 2006; Mukherjee and Chatterji 2008). Two possible
explanations for these findings have been suggested: firstly, the
onset and maturation of biofilms requires significant changes
in transcription (Sauer 2003), which are facilitated by various
regulatory mechanisms, including alternative σ factors (Rachid
et al., 2000; Bateman et al., 2001; Knobloch et al., 2001, 2004). Secondly, such events are governed by stress adaption through the
stringent response and ppGpp (Balzer and McLean 2002; Taylor
et al., 2002; Lemos, Brown and Burne 2004; Gjermansen, Ragas
and Tolker-Nielsen 2006; He et al., 2012). Both of these processes
are controlled by ω in Gram-negative species, although, as suggested above, there appears to be disparate function for this subunit between the two classes of bacteria. Indeed, an alignment
of the ω protein between M. smegmatis and E. coli reveals that
the conserved residues required for ppGpp binding are, as with
B. subtilis (Ross et al., 2013), not conserved (our unpublished observation). As such, it seems more probable that, as with E. coli
and cyanobacteria, the binding of ω to RNAP in M. smegmatis
results in an altered affinity for different σ factors, and therefore
negatively influences the ability to express genes required for
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biofilm formation. This highlights the variable nature and, more
importantly, the need to study ω in a wider range of Grampositive bacteria, before drawing general conclusions about its
function.

The ε subunit

phage infection assays, has yet been established. Additionally,
no phenotypes or effects on transcription in vitro or in vivo were
reported upon ε deletion. This makes the ε subunit of RNAP an
interesting target for future experimentation in B. subtilis and
other Gram-positive bacteria in general.

CONCLUDING REMARKS
With the wealth of information available on small RNAP subunits in Gram-positive bacteria, it is clear that these proteins
present an important part of the transcriptional machinery.
Studies describing the role of δ, ε and ω have been conducted
over several decades, and considerable progress has been made.
These subunits have been shown by countless groups to possess
vital functions, ranging from guiding the assembly and structural integrity of RNAP, σ factor selectivity, influencing promoter
specificity and potential roles in protecting cells against phage
infection. Their significance is mirrored by their presence and
conservation within nearly all of the Gram-positive genomes
thus far sequenced. With modern high-throughput transcriptomic and proteomic approaches, as well as structural studies,
information has been brought to light that allows explanation
of the numerous phenotypes observed for null mutants of the
subunits in various bacterial species. Nevertheless, the underlying mechanism by which these proteins mediate their function
is still incompletely understood. It will be fascinating to observe
how new approaches and studies, combined with this existing
body of knowledge, will guide future work to reveal the precise
role of these subunits within bacterial cells.
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Supplemental Table S1: Species names, IMG Gene IDs and protein length for δ
sequences contained with the Figure 1A alignment. All protein information was obtained
from the Integrated Microbial Genome (IMG) system (https://img.jgi.doe.gov) (Markowitz et al.,
2014).

# in Figure 1A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

IMG Gene ID
645482284
650788107
2511470775
640209387
651578560
2509275160
641688320
644183400
642323807
642191922
646240522
643184683
650272364
2514580865
646852895
2523747826
643658815
2517443193
643727220
2520306012
647470149
646636532
637888727
642562690
2518442252
644194367
639707453
2514158098
2520299204
2514553789
651443943
651429677

Species
Selenomonas flueggei
Carnobacterium sp.
Pelosinus sp.
Thermosinus carboxydivorans
Acetonema longum
Desulfosporosinus orientis
Exiguobacterium sibiricum
Catenibacterium mitsuokai
Clostridium spiroforme
Clostridium ramosum
Mollicutes bacterium
Eubacterium biforme
Clostridium sp.
Eubacterium sp.
Bacillus selenitireducens
Jeotgalicoccus marinus
Macrococcus caseolyticus
Staphylococcus massiliensis
Staphylococcus carnosus
Staphylococcus sp.
Staphylococcus epidermidis
Staphylococcus lugdunensis
Staphylococcus aureus
Staphylococcus haemolyticus
Allofustis seminis
Listeria grayi
Listeria welshimeri
Listeria monocytogenes
Catellicoccus marimammalium
Dolosigranulum pigrum
Fructobacillus fructosus
Leuconostoc fallax

Protein length (aa)
109
205
122
121
125
136
174
111
114
113
110
113
106
107
174
170
173
176
184
179
178
173
176
172
180
182
176
178
188
172
180
186

33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72

644429341
641604257
651010218
2520072467
650764460
644363720
2514611694
650258718
651114493
2511651893
650788107
646090746
2523707725
2514413459
650345384
638493971
650333312
2515219321
650086157
2512471342
2515263509
2519825720
2523205322
650855100
2523948014
648821780
2515275679
2515731753
2515297213
648815525
650330852
2512479078
2515262707
2511692614
2515485516
650845241
2519529468
2514448739
2522028557
651430688

Leuconostoc mesenteroides
Leuconostoc citreum
Leuconostoc sp.
Leuconostoc gelidum
Aerococcus urinae
Catonella morbi
Facklamia languida
Eremococcus coleocola
Lactococcus lactis
Lactococcus garvieae
Carnobacterium sp.
Granulicatella adiacens
Bavariicoccus seileri
Lactobacillus versmoldensis
Streptococcus vestibularis
Streptococcus pneumoniae
Streptococcus infantis
Streptococcus massiliensis
Streptococcus anginosus
Streptococcus constellatus
Streptococcus ovis
Streptococcus minor
Streptococus plurextorum
Streptococcus parauberis
Streptococcus castoreus
Streptococcus pyogenes
Streptococcus didelphis
Streptococcus mutans
Streptococcus caballi
Streptococcus bovis
Streptococcus equinus
Streptococcus macacae
Streptococcus ferus
Tetragenococcus halophilus
Enterococcus columbae
Melissococcus plutonius
Enterococcus faecalis
Enterococcus saccharolyticus
Enterococcus hirae
Weissella cibaria

192
193
193
193
213
225
221
227
187
186
205
204
214
213
191
197
191
196
195
195
196
194
197
187
197
202
188
194
193
190
190
193
194
203
201
210
208
201
203
197

73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112

651432316
643927141
2514683090
2523925542
2524573453
644905590
646291449
2514646519
641713578
650245840
2500070755
648250028
2514643970
651443154
2514648593
644307024
637796229
644358292
639672085
2514731674
637622251
637060510
641380263
2519373257
637508443
639751904
642460509
637326668
2514400189
2514123921
2520240165
639313077
642878827
643431281
644800105
650287269
2520841753
641573981
2520890491
2514700644

Lactobacillus coryniformis
Lactobacillus paracasei
Lactobacillus zeae
Lactobacillus harbinensis
Lactobacillus saerimneri
Lactobacillus plantarum
Lactobacillus coleohominis
Lactobacillus suebicus
Lactobacillus fermentum
Lactobacillus oris
Lactobacillus reuteri
Lactobacillus salivarius
Lactobacillus mali
Lactobacillus animalis
Lactobacillus malefermentas
Lactobacillus hilgardii
Lactobacillus sakei
Lactobacillus acidophilus
Lactobacillus gasseri
Lactobacillus sp.
Bacillus clausii
Bacillus halodurans
Bacillus weihenstephanensis
Bacillus cereus
Bacillus anthracis
Bacillus thuringiensis
Bacillus anthracis
Oceanobacillus
Ornithinibacillus sp.
Halobacillus halophilus
Salimicrobium sp.
Bacillus licheniformis
Bacillus pumilus
Anoxybacillus flavithermus
Geobacillus sp.
Planococcus donghaensis
Bacillus isronensis
Lysinibacillus sphaericus
Lysinibacillus fusiformis
Bacillus smithii

186
223
224
228
190
202
190
195
195
165
185
208
191
189
206
211
202
184
186
181
168
164
175
176
175
176
175
173
187
178
183
171
179
199
186
188
194
184
183
182

113
114

642982695
2529279564

115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130

2506240325
2506612322
645028913
651560222
643788320
646752012
651607961
2512925420
2511571733
2516613897
650065345
2507047969
650134438
2508845954
2516584637
646320341

Bacillus coahuilensis
Sporosarcina sp.
Sulfobacillus
thermosulfidooxidans
Sulfobacillus acidophilus
Alicyclobacillus acidocaldarius
Caldalkalibacillus thermarum
Brevibacillus brevis
Bacillus tusciae
Desmospora sp.
Saccharibacillus sacchari
Paenibacillus terrae
Paenibacillus sp.
Paenibacillus vortex
Paenibacillus lactis
Paenibacillus larvae
Thermobacillus composti
Cohnella panacarvi
Bacillus subtilis

177
188
105
97
174
165
186
167
147
186
182
187
188
185
179
193
200
173
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Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, Florida, USA

B

acterial gene transcription is a complex, multifactorial process
that involves several key enzymes and regulatory elements. It
is driven by the activity of DNA-dependent RNA polymerase
(RNAP) and its associated proteins, which form a multisubunit
enzyme consisting of one ␤ subunit, one ␤= subunit, two identical
␣ subunits, and one  subunit (reviewed in reference 1). Together
these form the RNAP apoenzyme, which is able to perform RNA
elongation and termination; however, initiation requires the involvement of a  factor. Typically, most bacterial species harbor
several different  factors, a primary one (A or 70) that mediates
housekeeping gene transcription and a variety of alternative sigma
factors, which aid in the response to unfavorable environmental
conditions and stress.
In certain Gram-positive species and particularly the Firmicutes (see Fig. S1 in the supplemental material), an additional
RNAP subunit is present, termed the ␦ factor, or RpoE (2). In
Bacillus subtilis, the 173-amino-acid delta subunit has been shown
to reduce nonspecific binding of RNAP to DNA and lead to an
elevated preference for DNA regions that include promoter sequences (3, 4). In early experiments, it was shown that RpoE has a
role specifically confined to promoter selection and influences the
ability of RNAP to form open promoter complexes (5, 6). Fulllength RpoE has also been described as displacing nucleic acids
from RNAP-DNA or RNAP-RNA complexes in vitro, which may
explain the decreased affinity of RNAP-RpoE for nonpromoter
regions. This feature of RpoE activity has additionally been attributed to its ability to stimulate RNAP recycling by enhancing the
release of the complex from terminator sequences (6).
The effects of RpoE are far from arbitrary, since it has been
shown that the ␦ subunit of RNAP not only distinguishes between
promoter and nonpromoter sequences but also is important in the
recognition of individual promoter features. A comparison of two
29 promoters by transcription runoff revealed selective, promoter-dependent effects of RpoE (7). While the stronger of these
two promoters was largely unaffected by RpoE, the weaker pro-
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moter showed significantly decreased expression in the presence
of this factor. In order to explain the effect of RpoE on promoter
selection, Rabatinova et al. (8) investigated the role of initiating
nucleotide triphosphate (iNTP) recognition by RNAP and RNAPRpoE complexes. iNTP is required to stabilize open complex formation and therefore to initiate transcription. It is thought that by
destabilizing DNA-RNAP complexes, RpoE increases the amount
of iNTP required to transcribe from certain promoters. Finally, in
an approach aiming to identify functional regions of RpoE, Lopez
de Saro et al. (9) created several truncated variants of the protein.
In doing so, they showed that the N-terminal portion is required
for binding to RNAP and also guides the correct orientation of the
disordered and polyanionic C-terminal region. A limitation of
these studies regarding RpoE function, however, is that they were
performed in vitro, using only single promoters. Therefore, the
true extent of ␦-subunit influence on genome-wide transcriptional effects is still somewhat restricted at this point.
Phenotypically, rpoE mutants of B. subtilis have an extended
lag phase upon subculturing of stationary-phase cells in fresh medium, as well as a moderately changed cell morphology (10). Furthermore, competition experiments revealed that when cocul-
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In Gram-positive bacteria, and particularly the Firmicutes, the DNA-dependent RNA polymerase (RNAP) complex contains an
additional subunit, termed the ␦ factor, or RpoE. This enigmatic protein has been studied for more than 30 years for various organisms, but its function is still not well understood. In this study, we investigated its role in the major human pathogen Staphylococcus aureus. We showed conservation of important structural regions of RpoE in S. aureus and other species and demonstrated binding to core RNAP that is mediated by the ␤ and/or ␤= subunits. To identify the impact of the ␦ subunit on
transcription, we performed transcriptome sequencing (RNA-seq) analysis and observed 191 differentially expressed genes in
the rpoE mutant. Ontological analysis revealed, quite strikingly, that many of the downregulated genes were known virulence
factors, while several mobile genetic elements (SaPI5 and prophage SA3usa) were strongly upregulated. Phenotypically, the
rpoE mutant had decreased accumulation and/or activity of a number of key virulence factors, including alpha toxin, secreted
proteases, and Panton-Valentine leukocidin (PVL). We further observed significantly decreased survival of the mutant in whole
human blood, increased phagocytosis by human leukocytes, and impaired virulence in a murine model of infection. Collectively,
our results demonstrate that the ␦ subunit of RNAP is a critical component of the S. aureus transcription machinery and plays
an important role during infection.

RpoE Controls Virulence in Staphylococcus aureus

MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains used for experimental
procedures are listed in Table 1. An rpoE transposon mutant in S. aureus
USA300 strain JE2 was acquired from the Nebraska transposon library
(NARSA). This mutation was transferred via 11 transduction to our
USA300 Houston wild-type strain (18). Successful transduction of this
mutation was confirmed by PCR, using gene-specific (OL1709 and
OL1710) and transposon-specific (OL14721 and OL1472) primers. Cultivation of bacteria was performed in tryptic soy broth (TSB) at 37°C.
Where required, erythromycin (5 mg/ml), lincomycin (10 mg/ml), or
chloramphenicol (10 mg/ml) was added to the medium. Synchronous
cultures were obtained as described by us previously (19).
Construction of an rpoE complemented strain. The rpoE gene and its
promoter were amplified via PCR, using primer pair OL1973 and
OL1975, which are located 200 bp upstream from the rpoE translational
start codon and at the 3= end of the rpoE coding region, respectively. In
addition to the native rpoE sequence, a hexahistidine (His6) tag was included in the reverse primer (OL1975) to create a fusion protein that
could be used for downstream purification. For the cloning of truncated
rpoE-His6 fragments, primers 2931 (half of the N terminus only, amino
acids 1 to 159), 2932 (the N-terminal half of the protein, amino acids 1 to
264), and 2933 (the N-terminal half of the protein and half of the C
terminus, amino acids 1 to 396) were used instead of 1975. The PCR
products were cloned into shuttle vector pMK4 and transformed into
chemically competent Escherichia coli DH5␣. Clones were confirmed via
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PCR using the same set of oligonucleotides used for cloning. Additionally,
Sanger sequencing using primers for the pMK4 multiple cloning site
(M13Fw and M13Rv) was performed to confirm fidelity of the construct.
The plasmids were transformed into S. aureus RN4220 by electroporation
and confirmed by PCR. Correct clones were used to generate a 11 lysate
for transduction into the S. aureus USA300 Houston rpoE transposon
mutant, which was again confirmed as described above.
Mapping the rpoE promoter. Rapid amplification of cDNA ends
(RACE) was used to identify the rpoE transcriptional start site. For this
approach, we used the 5=RACE core set (TaKaRa) and primers OL2018,
OL2019, OL2020, OL2021, and OL2022 (Table 1). PCR products were TA
cloned using the StrataClone PCR cloning kit (Agilent). The transcriptional start site was identified by sequencing (MWG operon) 10 plasmids
that originated with the TA cloning using the universal primers M13Fw
and M13Rv.
qPCR. Quantitative real-time PCR (qPCR) analysis was conducted as
described previously (20) using the rpoE gene-specific primers OL1976
and OL1978 and OL2981 and OL2982 and 16S rRNA primers OL1184 and
OL1185. Three independent replicates were used to calculate final values.
Zymograms and Western blot analysis. S. aureus strains were grown
as described above, with samples taken at the time points specified. Zymograms were performed with culture supernatants as described by us
previously (21). Intracellular and secreted protein fractions were harvested and subjected to SDS-PAGE and Western blot analysis as described
by us previously (21). Immunoblotting was performed with a mouse
monoclonal anti-His6 (Covance) or anti-LukS (IBT) antibody at a 1:1,000
or 1:20.000 dilution, respectively, overnight at 4°C. Secondary antibodies
were affinity-purified horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG or goat anti-rabbit IgG (Cell Signaling Technology).
RpoE pulldown assay. A coprecipitation was performed to identify
proteins that interact with RpoE. Briefly, rpoE-negative strains carrying
pMK4::rpoE-His6 or pMK4::rpoEtrunc1-His6 were harvested after 3 h of
growth, and intracellular fractions were isolated as described previously
(22). Cellular extracts were mixed with nickel-nitrilotriacetic acid (NiNTA) agarose beads (Qiagen), and samples were incubated with agitation
at 37°C for 1 h. Beads were then washed 5 times (50 mM NaH2PO4, 300
mM NaCl, and 20 mM imidazole, pH 8.0) while rotating for 10 min at
37°C. After each wash step, beads were allowed to settle for 10 min, the
supernatant was removed, and fresh washing buffer was added. RpoE and
any interacting proteins were recovered by the addition of elution buffer
(50 mM NaH2PO4, 300 mM NaCl, and 250 mM imidazole, pH 8.0).
Isolated proteins were then used either to perform SDS-PAGE with subsequent silver staining or for mass-spectrometric analysis, as described by
us previously (23).
Transcriptomic analysis via RNA-seq. For both the wild-type and
mutant strains, three independent cultures were grown as described
above. Synchronized cultures were harvested after 3 h, and RNA was isolated using a Qiagen RNeasy kit (Qiagen). To ensure complete removal of
genomic DNA, RNA was treated with DNase I (Turbo DNA free; Ambion). The concentration and purity of RNA were determined using an
Agilent 2100 bioanalyzer. Following quantification, equimolar amounts
of RNA, from each of the three replicate preparations, were pooled, and
rRNA was removed using the MICROBExpress (Invitrogen) and RiboZero (Epicentre) kits. Removal of rRNA was confirmed, again employing
the Agilent 2100 bioanalyzer. rRNA-depleted samples were then used for
RNA-seq analysis using the IonTorrent Total RNAseq kit v2 according to
the manufacturer’s instructions (Life Technologies). Templated ion
sphere particles were generated using the Ion OneTouch 200 template kit,
v2. Sequencing was performed on an IonTorrent 318 chip using an Ion
PGM 200 sequencing kit. Data generated were exported to the CLC
Genomics Workbench software package for analysis. Reads were aligned
to the USA300 FPR genome, and expression values for each gene were
determined as RPKM (reads per kilobase per million reads) values. An
RPKM threshold of detection value of 10 was imposed as a lower-level
cutoff, and data were normalized using the quantile normalization ap-
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tured with the wild type, ␦-factor-lacking strains show decreased
fitness and are outcompeted during growth over several days (8).
Finally, a role for RpoE in sporulation has been suggested, since
rpoE loss was shown to suppress a mutation (pdhC) that negatively
influences sporulation (11).
The role of RpoE has also been addressed for a small number of
pathogenic organisms, most notably in streptococcal species.
RpoE in Streptococcus mutans is most abundant during exponential and early stationary phases of growth, and rpoE deletion causes
an extended lag phase. S. mutans rpoE mutants are also more sensitive to environmental stresses (H2O2 stress and acid stress) and
show alterations in biofilm formation and virulence (12). Interestingly, rpoE deletion was also reported to increase self-aggregation, coaggregation with other oral microorganisms (13), and an
elevated ability to bind human extracellular matrix proteins. For
Streptococcus agalactiae, there have been a limited number of studies which show greatest rpoE expression during exponential
growth (14) and attenuated virulence of rpoE mutants in a rat
sepsis model (15, 16) and human whole-blood survival assays.
In Staphylococcus aureus, the only information thus far regarding RpoE is that strains lacking this factor display defects in starvation-induced stationary-phase survival/recovery and slightly
increased acid sensitivity (17). Notably, however, no investigation
of its role in cellular physiology and virulence has been performed.
Therefore, in this study, we investigated the role of RpoE in promoter selectivity using transcriptome sequencing (RNA-seq)
technology and determined that in S. aureus, the ␦ subunit specifically guides RNAP toward strongly expressed promoters. Deletion of this factor results in a normalizing of transcriptional activity across genes, guiding RNAP away from key virulence-affecting
loci. Such effects strongly impair the pathogenic potential of S.
aureus, leading to diminished infection using a systemic model of
sepsis and increased phagocytosis by human leukocytes. Collectively, our results suggest that rpoE is involved in orchestrating the
ability of S. aureus to react and adapt to environmental changes
and thus plays a critical role during virulence.

Weiss et al.

TABLE 1 Strains, plasmids, and primers used in this study
Genotype and/or description or sequencea

Reference or source

E. coli
DH5␣

Cloning strain

47

S. aureus
RN4220
USA300 HOU
NE 646
JAI1287
JAI1607
JAI1569
JAI1570

Restriction-deficient strain
USA300-HOU MRSA isolate cured of pUSA300-HOU-MRSA
USA300 JE2 rpoE::Bursa, rpoE mutant
USA300 HOU rpoE::Bursa, rpoE mutant
USA300 HOU rpoE::Bursa, pMK4::rpoE-His6, rpoE⫹
USA300 HOU rpoE::Bursa, pOS1sGFP-PsarA-sod, rpoE mutant
USA300 HOU pOS1sGFP-PsarA-sod

Lab stocks
19
NARSA
This study
This study
This study
This study

Plasmids
pMK4
pJAI101
pAW102
pAW103
pAW104
pOS1sGFP-PsarA-sod

Gram-positive shuttle vector
pMK4::rpoE-His6
pMK4::rpoE-His6trunc1, truncated RpoE, N terminus and half-C terminus
pMK4::rpoE-His6trunc2, truncated RpoE, N terminus
pMK4::rpoE-His6trunc3, truncated RpoE, half-N terminus
sarA promoter controlling expression of gfp

48
This study
This study
This study
This study
25

Primers
OL1471
OL1472
OL1709
OL1710
OL1184
OL1185
OL1973
OL1975
OL1976
OL1978
OL2018
OL2019
OL2020
OL2021
OL2022
OL2931
OL2932
OL2933
OL2981
OL2982

TTTATGGTACCATTTCATTTTCCTGCTTTTTC
AAACTGATTTTTAGTAAACAGTTGACGATATTC
ATGAAAATTCAAGATTATACAAAAC
AATAGTTGGTGCGATTTTCTCTTC
AGCCGACCTGAGAGGGTGA
TCTGGACCGTGTCTCAGTTCC
CGCGGATCCAAGGACCAATTGGCAAAGAACGAC
ACCGGAGTCGACTTAATGGTGATGGTGATGGTGATCGTTGAAGTCTTCTTCGTCTTC
GAGCGTTAGGTGATTATGAGTACG
CACTTCTTCGTCTTCGTCTAGTTC
TTAATCGTTGAAGTC
GTTTTGTATAATCTTGAATTTTC
CAATAAATGATTTTTCATCAACC
CAATCATTCGGATATAGTCATTG
GATGAAGATGAACTAGACGAAG
ATGGTCGACTTAGTGGTGATGGTGATGATGATTTTCAATTTCTTCGTACTC
ATGGTCGACTTAGTGGTGATGGTGATGATTTCAATATCATCTACCGAATACC
ATGGTCGACTTAGTGGTGATGGTGATGATGTTGATCATCTGTTTGAGCTGG
TCGTACTCATAATCACCTAAC
GGCGAAACAATGAACTTAT

49
49
This study
This study
50
50
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

a

Underline denotes restriction enzyme site.

proach (24). Genes demonstrating changes in expression lower than
2-fold were excluded from further analysis.
Assay to detect alpha-hemolysin activity. The activity of alpha-hemolysin was determined as described by us previously (25) using pooled,
whole human blood (Bioreclamation). Hemolysin activity (Ha) was calculated using the following equation: Ha ⫽ (OD543 ⫻ 1,000)/(vol. of
sample ⫻ 15 min ⫻ OD600 ⫻ 0.5).
Coinfection of whole human blood. The ability of strains to survive in
human blood was determined by seeding equal amounts of exponentially
growing wild-type and rpoE mutant bacteria into pooled, whole human
blood (Bioreclamation). Pooled blood was used to minimize effects that
result from single-donor samples, such as being preconditioned by S.
aureus infection or variation due to the immune status of the donor.
Samples were incubated with shaking at 37°C, with aliquots withdrawn
hourly to determine the bacterial burden by serial dilution and plating on
TSA and TSA supplemented with erythromycin. Bacteria growing on TSA
reflect the total number of cells in the sample, while TSA containing erythromycin allows only rpoE mutants to grow.
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Analysis of differential phagocytosis by human leukocytes using
flow cytometry. Phagocytosis of wild-type and mutant cells was determined using pooled, whole human blood (Bioreclamation) and flow cytometry, as described by us previously (25). Experiments comparing the
wild type and mutant were conducted using the same batch of blood in
order to exclude variations resulting from different blood samples. These
studies were facilitated by the generation of green fluorescent protein
(GFP)-expressing variants of the USA300 Houston wild type and its rpoE
mutant using plasmid pOS1sGFP-PsarA-sod RBS (26). Cells were analyzed
using forward and side scattering in a fluorescence-activated cell sorting
(FACS) Excalibur cytometer (BD Biosciences). FACSDiva version 6.1.3
software (BD Biosciences) was used to analyze the data. Results represent
the averages for three independent experiments and are presented as the
percentages of GFP-positive cells plus or minus standard errors of the
means (SEM).
Coinfection model of murine sepsis and dissemination. In order to
determine the virulence of strains, a murine coinfection model of sepsis
was employed. These experiments were conducted as described previ-
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Strain, plasmid, or primer

RpoE Controls Virulence in Staphylococcus aureus

Workbench software. (A) Comparison of RpoE sequences between S. aureus and other Gram-positive organisms. Colors represent the degree of similarity, with
red being the most identical and blue/black the most divergent. Broken black lines next to the species names represent alignment of proteins to the consensus
sequence. The green rectangle denotes the region of highest conservation among different species; the red arrow marks the HARE-HTH motif identified by Pfam
search using the S. aureus protein; blue and yellow arrows represent ␣-helices and ␤-sheets, respectively, identified previously in the B. subtilis protein (28). (B)
Comparison of RpoE between staphylococci.

ously (27), with the following modifications. Briefly, 6-week-old, female
CD-1 Swiss mice were purchased from Charles River Laboratories and
housed in the vivarium at the College of Medicine, University of South
Florida. Ten mice were inoculated by tail vein injection with 100 l bacterial suspension (1 ⫻ 108 CFU/ml), containing the wild type and the rpoE
mutant in a 1:1 ratio. The infection was then allowed to proceed for 7 days
before mice were euthanized and the kidneys were collected. Each organ
was homogenized in 3 ml sterile PBS, and the numbers of CFU/kidneys
for the wild type and its rpoE mutant were determined via serial dilution,
as described above. This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by
the Institutional Animal Care and Use Committee of the University of
South Florida (permit number A-4100-01).

RESULTS

S. aureus RpoE shows homology to delta subunit proteins of
other Gram-positive bacteria. The majority of information regarding the ␦ subunit of RNAP comes from studies in B. subtilis
and streptococcal species. We therefore compared the primary
structure of the S. aureus counterpart to those of its homologs in
other organisms to determine if differences in sequence were apparent (Fig. 1A). Interestingly, the proteins analyzed show significant variation across their sequences yet retain homology in the N
terminus, with a conserved region between amino acid residues 14
and 91 (S. aureus amino acid numbering). A sequence search
(pfam.sanger.ac.uk) revealed this region as containing a predicted
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helix-turn-helix (HARE-HTH) DNA-binding motif, which is also
found in the B. subtilis version of the protein. Notably, the N-terminal region of the HTH motif (residues 14 to 57) shows decreased similarity between proteins from various species, while
the C-terminal portion of the motif (residues 58 to 91) displays a
high degree of homology. The presence of such an ␣-helix-rich
region has previously been discussed for B. subtilis (28); however,
its biological function is currently unknown. We also analyzed the
similarity of RpoE between various staphylococci (Fig. 1B). As
expected, we observed a much larger degree of similarity for protein sequences within the genus, although again, the C terminus
displayed less conservation than the N terminus.
rpoE is transcribed from a single A-dependent promoter
during exponential growth. To investigate the role of rpoE in S.
aureus, we first began by defining its promoter. Using 5= RACE, we
detected a single transcriptional start site 68 bp upstream of the
translation initiation codon, which is preceded by a strong Atype promoter, comprised of a ⫺35 sequence of TTGcgA (lowercase letters represent divergence from the consensus), followed by
a perfect 17-nucleotide (nt) spacer and a consensus ⫺10 sequence (TATAAT). Additionally, a strong ribosome binding
site (AGGAaG) 9 nt upstream of the ATG initiation codon was
observed. To track the growth phases and situations in which the
S. aureus cell deploys RpoE, we next analyzed its transcription
using quantitative real-time PCR (Fig. 2). We detected strongest
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FIG 1 Protein alignment of the ␦ subunit of RNAP. Alignments of representative RpoE proteins from different species were prepared using CLC Main
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kDa
250
130
100
70

Control

RpoE-His6

RpoC (135 kDa)
RpoB (133 kDa)

55

35

Tuf (43 kDa)

25

RpoE (21 kDa)

FIG 2 rpoE expression in S. aureus is maximal during exponential growth. (A)
Quantitative real-time PCR analysis was used to measure rpoE expression from
3 independent cultures. Error bars ⫾ SEM are shown. (B) Western blot analysis using an anti-His antibody. Samples were standardized using the Bradford
assay, and an equal amount of protein for each time point was loaded onto gels.
Shown is a representative image of 3 independent experiments.

expression of rpoE during exponential growth, with a peak between 1 and 2 h and a subsequent decline at later time points. To
correlate these findings with protein stability, we assessed the
abundance of RpoE using a His6-tagged variant expressed from its
own promoter on the shuttle vector pMK4. Consistent with our
transcriptional findings, we identified high protein levels during
exponential growth, which again declined over time.
RpoE interacts directly with RNA polymerase. To determine
whether the ␦ subunit binds to core RNAP in S. aureus, we performed a pulldown assay using a plasmid-encoded, His-tagged
variant of the RpoE protein. Intracellular lysates were generated
from exponentially growing rpoE mutants bearing either the
pMK4::rpoE-His6 construct or pMK4 alone (control). RpoE-His6
and its interacting partners were then purified by pulldown assay
and analyzed by SDS-PAGE and mass spectrometry. We identified
3 major protein bands on SDS-PAGE gels compared to control
samples with molecular weights that correlate to those expected
for RNA polymerase subunit ␤ (RpoB), ␤= (RpoC), and ␦ itself
(Fig. 3). Using mass spectrometry, we confirmed that the identities of these bands did indeed correspond to the suggested components of RNAP. A fourth protein was also identified in test
samples and was found to be elongation factor Tu (Tuf). Collectively, our results demonstrate that RpoE is part of the S. aureus
transcription machinery and most likely interacts directly with the
␤ and/or ␤= subunit of RNAP, although we cannot rule out that
weaker interactions with other subunits of this complex also occur.
To explore which components of RpoE mediate this interaction, we generated 3 His6-tagged, truncated forms of the protein
on the shuttle vector pMK4 in the rpoE mutant background. These
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FIG 3 RpoE interacts with the S. aureus RNAP complex. A His-tagged version
of RpoE was purified by pulldown assay from S. aureus cell lysates, alongside
empty vector control samples, and run on an SDS-polyacrylamide gel (silver
stained). Samples were subjected to mass-spectrometric analysis for protein
identification. Shown are the identities of bands, alongside their molecular
masses.

contained the following: (i) the N terminus and half of the C
terminus (amino acids 1 to 369), (ii) only the N terminus (amino
acids 1 to 264), or (iii) half of the N terminus only (amino acids 1
to 159). Abundances of the truncated proteins were first measured
by Western blotting (see Fig. S2A in the supplemental material).
Interestingly, only the longest of the truncated versions was detected in these studies. To identify if this lack of protein resulted
from a lack of truncated protein expression, we performed qPCR
analysis (see Fig. S2B in the supplemental material). Importantly,
we observed robust expression for all variants of rpoE. Since the
proper construction of all plasmids was confirmed by Sanger sequencing, we concluded that the shortest variants of RpoE are
likely characterized by protein instability. We next repeated our
pulldown experiments using the longest of the RpoE truncated
proteins to examine RNAP binding. Upon doing so, we observed
results identical to those for the full-length RpoE protein (data not
shown). As such, we were able to show that the C terminus of
RpoE, at least in part, is dispensable for interaction with RNAP,
further supporting the hypothesis that ␦ subunit-RNAP interactions are mediated by the RpoE N terminus. Interestingly, we also
showed that in S. aureus, deleting the entire RpoE C terminus
results in inherent instability for the entire protein and a lack of
functionality for the S. aureus ␦ subunit.
The S. aureus ␦ subunit of RNAP strongly influences expression of virulence determinants and genes encoded on mobile
genetic elements. Given that RpoE functions as a component of
the transcriptional complex, we next set out to assess its role in
influencing gene expression in S. aureus. This was achieved using
RNA sequencing (RNA-seq) technologies and our rpoE mutant
strain. Samples of the wild type and mutant were taken during
exponential growth (3 h), and the changes in gene expression were
compared. Upon analysis, we observed 191 differentially expressed genes in the rpoE mutant strain compared to expression in
the parent (Fig. 4), with 83 positively regulated and a further 108
that are repressed (see Table S1 in the supplemental material). To
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confirm data derived from our RNA-seq experiments, we performed qPCR with a representative subset of genes, which confirmed the direction and fold change of expression observed (see
Fig. S3 in the supplemental material).

40

When genes with decreased expression were reviewed by ontology (Fig. 5), one of the most striking observations was that the
transcription of a very large number of known virulence factors is
reduced in the rpoE mutant. These include 9 of the 10 major se-
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FIG 5 Ontological grouping of genes influenced by RpoE activity in S. aureus. A total of 191 genes showed at least a 2-fold alteration of expression in the rpoE
mutant compared to that in the parental strain. Genes are grouped according to known or predicted ontologies.
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FIG 4 Genomic map of altered transcription profiles upon rpoE deletion. The outermost circle (yellow) represents a heat map comparing changes in gene
expression for the rpoE mutant compared to results for the wild type. The middle circle (black) depicts RPKM values for the wild type, while the inner circle (red)
represents RPKM values for the rpoE mutant (see Materials and Methods for an explanation). SA3usa and SA2usa denote both prophages found in S. aureus
USA300.
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creted proteases, components of 3 of the 4 bipartite toxins, nuclease, several phenol-soluble modulins (PSMs), alpha-hemolysin, beta-hemolysin, and a number of known immune evasion
factors. To ensure that changes in gene expression for virulence
factors was not due to unintended mutations in global regulatory
systems, we sequenced the agr operon, RNAIII, and the sae
operon. No alteration in gene sequence was found between the
rpoE mutant and the wild-type strain, indicating that the observed
changes were due to ablation of RpoE activity. Changes in the
expression of key virulence regulation loci were noted (RNAII and
RNAIII, ⬃1.4-fold; saeR, 2.8-fold), although to a significantly
lesser extent than that observed for most virulence factors (4- to
8-fold). This suggests that the changes in expression of agr and sae
do not completely explain the major alterations observed in virulence factor expression upon rpoE deletion.
Analysis of genes with increased expression in the mutant revealed, quite remarkably, that almost the entire SA3usa prophage is upregulated (39 genes; increases ranging from 2.9- to
29-fold). Additionally, for the SaPI5 pathogenicity island, another
mobile genetic element, expression of 9 genes was increased. Further, we observed upregulation of the nar-nir operon, as well as a
variety of membrane and lipoproteins.
rpoE disruption leads to a normalizing of gene expression in
S. aureus. When a heat map of the changes in gene expression is
reviewed (Fig. 4), it is apparent that those genes with altered expression in the mutants are for the most part evenly distributed
over the entire genome (with the exception of phage SA3usa,
SaPI5, and the nar-nir operon). Interestingly, however, upon rpoE
disruption, a normalizing of expression appears to occur. Specifically, the majority of genes that had decreased expression in the
mutant are typically highly transcribed in the wild-type strain.
Furthermore, genes that are typically expressed at a low level in the
parent are significantly upregulated in the rpoE-lacking strain
(Fig. 6). Therefore, the difference in expression between strongly
and weakly transcribed genes becomes dampened, and due to the
normalizing effect of rpoE disruption, growth-phase-specific ex-
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FIG 6 RpoE influences RNAP promoter selectivity based on promoter
strength. The 191 genes identified as being differently expressed in the rpoE
mutant were evenly separated into four groups based on strength of expression
in the wild type. Specifically, the first quartile represents the 47 genes most
highly expressed under standard conditions (3 h of growth in TSB) from the
pool of 191. Conversely, the fourth quartile refers to the 47 genes expressed at
the lowest levels from the pool of 191. Upon rpoE disruption, a normalizing
affect is observed whereby highly expressed genes are overwhelmingly downregulated and low-expression genes are significantly upregulated.

pression patterns are less pronounced. These data support the
suggestions from other organisms that RpoE influences promoter
selectivity of RNAP based on promoter strength (6), whereby
RpoE enhances the transcription of strong promoters and limits
expression from weaker elements. In S. aureus such a function
appears to have evolved to include the favoring of virulence factor
promoters, which are commonly among the most highly expressed genes.
RpoE disruption leads to the decreased accumulation and
activity of key virulence factors. Given that virulence factors were
among the most profoundly affected upon rpoE disruption, we
next sought to determine if these changes led to alterations in
protein abundance and activity. As such, we first assessed PantonValentine leukocidin (PVL) protein levels via Western blotting
(Fig. 7A). We determined that, much like the case with RNA-seq
data, a significant decrease in the LukS signal was detected in culture supernatants from the rpoE mutant compared to results for
the parental and complemented strains. Following this, we next
performed activity profiling for alpha-hemolysin using whole human blood. Upon analysis of the hemolytic capacity of culture
supernatants, we observed a 3-fold decrease in hemolytic activity
upon rpoE disruption, which was largely restored by supplying
rpoE in trans (Fig. 7B). Finally, given that 9 of the 10 secreted
proteases had diminished expression in the mutant strain, we performed protease activity assays. When the mutant strain was cultured on casein nutrient agar, we observed a decrease in clearing
around the rpoE mutant in comparison to results for the parent
(Fig. 7C). Using zymography with gelatin as a substrate, we observed even more pronounced effects, with a significant reduction
in proteolytic activity and with several key proteolytic bands proving to be absent in the mutant strain (Fig. 7D). Collectively, these
findings confirm not only the RNA-seq observations that RpoE
preferentially influences RNAP toward highly expressed virulence
factor genes but that rpoE ablation leads to the diminished transcription, protein synthesis, and activity of central pathogenic determinants.
An rpoE-defective strain demonstrates decreased virulence
in both human and murine models of infection. To determine if
these global alterations in virulence factor production led to measurable outcomes for pathogenesis, we next investigated the ability of an rpoE mutant to survive and compete against the wild type
in whole human blood. Accordingly, exponentially growing wildtype and rpoE mutant cells were inoculated into whole human
blood in a 1:1 ratio. Aliquots were then withdrawn every hour for
3 h, and the number of CFU/ml of each strain was determined via
plating on TSA alone or TSA containing erythromycin (which
selects for the antibiotic resistance cassette in the mutant strain).
Over the infection period, the percentage of rpoE mutant cells
continually decreased (Fig. 8A), with a 1:0.46 ratio observed at 2 h
(31.6% recovery of the mutant inoculum) and a 1:0.2 ratio observed at 3 h (17% recovery of the mutant inoculum). By comparison, identical studies performed with TSB over a similar 3-h period revealed no changes in viability for the rpoE mutant strain
(see Fig. S4 in the supplemental material). This suggests that a
virulence defect, rather than decreased fitness, mediates the impaired survival in whole human blood.
In order to explore this survival defect in human blood more
closely, we next assessed interaction of the rpoE mutant and wildtype strains with human leukocytes. Accordingly, GFP-expressing
variants of each strain were used to separately infect whole human
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blood. Samples were withdrawn at 2 h and 4 h, and the percentage
of each strain present in granulocyte cells was determined using
FACs analysis, as described by us previously (25). We determined
that at both time points, there were significantly more rpoE mutant cells within human granulocytes than cells of the parental
strain (Fig. 8B). These increased rates of phagocytosis are likely
mediated by decreased virulence factor expression seen in the ␦
subunit mutant and explain the survival defect observed in whole
human blood.
To determine if these ex vivo human findings were recapitulated in vivo, we assessed the infectious capacity of an rpoE mutant
using a murine model of sepsis. Accordingly, we coinfected mice
with 1 ⫻ 107 CFU/ml of the wild-type and rpoE mutant strains in
a 1:1 ratio. After 7 days, mice were euthanized, the kidneys were
harvested, and the bacterial burdens of the wild-type and mutant
were determined. Three mice died before the end of the infection
period and were excluded from analysis. When determining bacterial loads within the kidneys of surviving mice (Fig. 8C), we
found a 10-fold decrease in rpoE mutant cells from the inoculum,
with only 10% of the total bacterial burden resulting from the ␦
subunit mutant (Fig. 8D). These findings demonstrate that RpoEmediated guidance of RNAP toward highly expressed promoters,
including virulence factors, is required for successful S. aureus
infection.
DISCUSSION

In this study, we sought to explore the role of the delta subunit of
RNAP in the major human pathogen S. aureus. Despite being first
identified as a unique, Gram-positive specific component of the
RNAP apoenzyme more than 30 years ago (2), very little is understood about its role and function. Herein we show that in S. au-

April 2014 Volume 82 Number 4

reus, it is highly expressed early in growth and seemingly interacts
with the ␤ and ␤= subunits of RNAP, suggesting they might be its
binding partners in vivo. Interestingly, other subunits of RNAP
were not copurified, leading to the conclusion that a direct interaction with the ␣, , and  subunits is perhaps unlikely. Importantly, these data are the first evidence from any organism that
points to putative interaction partners for RpoE, providing muchneeded understanding of its functional role.
As a component of the RNAP complex, the role of the ␦ subunit is clearly confined to activities concerning gene expression.
Therefore, we sought to understand and analyze its target genes in
S. aureus, using RNA-seq technologies, during exponential
growth (a time when RpoE is highly abundant in the S. aureus
cell). We identified almost 200 genes that were changed in expression upon rpoE disruption. Interestingly, these genes displayed a
strong pattern in terms of RpoE influence, with typically highly
expressed genes in the wild type being strongly downregulated in
the mutant, while many low-expression genes were upregulated.
As such, loss of the ␦ subunit in S. aureus appears to lead to a
normalization of gene expression, abrogating the more variable,
temporal expression patterns typically observed. Such a finding is
in line with the hypothesis that RpoE weakens binding of RNAP
and DNA and therefore influences weaker promoters more than
stronger ones (7). In support of this, Juang and Helmann (6, 29)
distinguished 3 different kinds of promoters affected by RpoE: (i)
weak promoters that are repressed by RpoE, (ii) moderatestrength promoters that show decreased open complex formation
in the presence of the delta subunit, and (iii) strong promoters
that are resistant to RpoE inhibition.
Such a role for the delta subunit of RNAP also appears to be
conserved in S. aureus based on our findings, and this opens up an
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FIG 7 RpoE ablation leads to decreased accumulation and activity of key virulence factors. (A) LukS (33 kDa) Western blot using supernatant (15 h) from an
rpoE mutant and its parental and complemented strains. The amount of protein loaded was standardized using a Bradford assay. (B) Hemolytic activity assay
using culture supernatants and pooled, whole human blood. Data presented are from at least three independent replicates, with error bars ⫾ SEM shown; P values
were determined using Student’s t test ⴱ, P ⬍ 0.05; ⴱⴱ, P ⬍ 0.005; ns, not significant). (C and D) Protease activity assay using casein nutrient agar (C) or gelatin
zymography (D). W, wild type; M rpoE mutant; C, complemented rpoE mutant.
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FIG 8 The ␦ subunit of RNAP is required for virulence in both human and murine models of infection. (A) Both the WT and mutant strains were inoculated
into pooled (5 donors) whole human blood at a 1:1 ratio and incubated for 3 h at 37°C. Aliquots were withdrawn at the times specified, and the numbers of
CFU/ml were determined by plating on either TSA or TSA containing erythromycin (to select for the mutant strain). Data are generated from three independent
replicates; error bars ⫾ SEM are shown. (B) Wild-type and rpoE mutant strains harboring a constitutively expressing GFP gene were separately incubated in
whole human blood. Samples were withdrawn, and the percentage of GFP⫹ granulocytes was measured by FACs. Data are generated from three independent
replicates; error bars ⫾ SEM are shown. (C and D) Mice were infected with an equal ratio of rpoE mutant and wild-type cells. After 7 days, mice were euthanized
and bacterial loads in the kidneys were assessed. Box-and-whisker plots represent the minimum and maximum values (whiskers), as well as the 25th to 75th
percentiles (boxes). The median for each group is indicated as a solid black line. ⴱ, P ⬍ 0.05; ⴱⴱ, P ⬍ 0.005; ⴱⴱⴱ, P ⬍ 0.001; determined using Student’s t test.

interesting point of evolution. It is believed that the influence of
RpoE in selectively guiding RNAP toward important promoters is
to mediate rapid changes in gene expression, and thus survival,
during stress. Such a notion is supported by observations from
both B. subtilis (8) and S. mutans (30), which demonstrate that
rpoE ablation leads to an impaired ability to recover from stresses.
Specifically, in S. mutans (30), it has been shown that an rpoE
mutant has decreased accumulation of oxidative-stress defense
proteins upon hydrogen peroxide challenge and a concomitant
reduction in survival. These lower levels of protective proteins are
not caused by downregulation in the mutant per se but rather a
stronger, RpoE-influenced stress response in the parent, leading
to increased accumulation of key protective proteins. This demonstrates that in the absence of RpoE, cells are less primed to
respond transcriptionally to unfavorable conditions and mount a
sufficiently protective response.
In S. aureus a lone study that references the ␦ subunit of RNAP,
where an rpoE mutant was identified as having a markedly decreased ability to recover following prolonged starvation, exists
(17). Herein we show (see Fig. S5 in the supplemental material)
that such an effect is true even after overnight growth, since we
observe an extended lag phase of our rpoE mutant similar to those
described for other low-G⫹C Gram-positive organisms. It seems
that such a defect is confined to the initial adaptation to new
environments, since we observed otherwise unimpaired growth
after entrance into log phase, with equal numbers of viable wildtype and mutant bacteria (data not shown). As such, it appears
that RpoE may have evolved in Gram-positive bacteria, and the
Firmicutes specifically, to facilitate a rapid switching of gene expression profiles that is geared toward the natural expression level
of genes within a cell. The reason for this could be that by central-
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izing such a response within a key protein within the transcription
complex, specific and global alteration in gene expression can be
rapidly achieved upon environmental change, leading to expedient and efficient adaption and survival. Given that S. aureus is a
highly human-adapted pathogen, much of its gene expression is
dedicated to survival within the human host. Consequently, we
contend that the ␦ subunit of RNAP has evolved in S. aureus along
these virulence-adapted lines, since a large number of the most
highly expressed genes in this organism are virulence specific.
Therefore, RpoE provides S. aureus with a survival advantage
upon entering the human host, which results in a survival defect
upon the abrogation of its activity.
With that said, the manner by which RpoE mediates its function cannot be explained solely by mere promoter strength, since
there are highly and low-level-expressed loci in S. aureus that are
not influenced by its activity. When one compares RpoE protein
sequences between various Gram-positive bacteria, there does appear to be a large variation in similarity other than in regions of the
collected N termini. The N-terminal regions are characterized by
the presence of several ␣-helices and ␤-sheets that were previously
identified in the B. subtilis protein (28, 31) and are predicted to be
present in the S. aureus counterpart (www.predictprotein.org).
Such conservation is perhaps to be expected, since the N terminus
is thought to be the component that mediates interaction with
core RNA polymerase (9), which is itself a highly conserved protein complex. Unusually, this conserved region of ␣-helices and
␤-sheets is predicted to form a winged HTH domain (HAREHTH). Although they have a wide range of functions in nature,
including transcriptional regulation, DNA degradation, and restriction modification (32), all functions studied thus far for
HARE-HTH domains involve some form of DNA binding. Thus,
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how these changes are mediated, we first ensured (by Sanger sequencing and analysis of mRNA transcript fidelity from the RNAseq reads) that unintended mutations were not present in key
global regulators. We next assessed expression of key virulence
regulators and found the agr locus to be unaffected by ⌬rpoE deletion. We did observe downregulation of saeR (⫺2.8-fold) in our
RNA-seq experiment, which may explain some of the effects observed (45). Indeed, Nygaard et al. (46) show that deletion of
saeRS results in a downregulation of various virulence factors,
many of which were also affected in the rpoE mutant. However,
the limited alteration in saeR expression in the rpoE mutant is
unlikely to be the sole reason for the effects observed. Specifically,
the changes observed by Nygaard et al. result from complete loss
of the saeRS locus (⬃120- and 178-fold downregulation). In our
results, we see similar effects on virulence factor synthesis, with
much smaller changes in sae system expression (e.g., for splE,
⌬saeRS led to a ⫺1.16-fold change in expression; ⌬rpoE led to
⫺2.89-fold change). Furthermore, rpoE deletion causes changes
in gene expression that are not seen in the saeRS mutant. For
example, aureolysin and several other virulence factors (e.g., V8
protease and PSMs) are either positively affected or unaffected in
the saeRS mutant, while being negatively affected in the rpoE mutant. Accordingly, the effects observed in the rpoE mutant appear
to be direct and gene specific rather than being caused solely by the
differential expression of major virulence regulators.
In summary, we herein demonstrate the importance of the
RNAP ␦ subunit for gene regulation and virulence in S. aureus. We
reveal that rpoE loss results in an uncoupling of well-ordered regulatory circuits, resulting in viable yet less-fit S. aureus cells that
are unable to rapidly adapt to stress, such as that encountered
during infection. We describe a new layer of transcriptional
regulation in S. aureus that, as in other bacteria, functions in a
promoter-specific manner to deploy its global effects and, in this
highly human-adapted pathogenic organism, uniquely targets
those regions of the genome that are associated with virulence.
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Supplemental Table S1: Changes in gene expression upon rpoE disruption. Listed
are genes that show differential expression in the rpoE mutant from RNAseq analysis.
Annotations were retrieved from NCBI (http://www.ncbi.nlm.nih.gov/). For hypothetical
proteins, bioinformatic analyses were performed and used to complement NCBI
annotations.
Gene product

Accession Number

Fold
Change
(Ma/WTb)

Virulence Factors
immunoglobulin G binding protein A precursor, Spa
complement inhibitory protein, Ehb
V8 Protease, SspA
cysteine protease precursor, SspB
zinc metalloproteinase aureolysin, Aur
anti protein, PSMβ2
alpha-hemolysin, Hla
serine protease, SplC
thermonuclease, Nuc
IgG-binding protein, SBI
serine protease, SplA
anti protein, PSMβ1
serine protease, SplD
gamma hemolysin, HlgC
serine protease, SplF
delta-hemolysin, Hld
serine protease, SplE
cysteine protease precursor, SspC
serine protease, SplB
leukotoxin, LukD
Scin-b
MAP/EAP domain protein
Staphylococcal complement inhibitory protein A
leukotoxin, LukE
truncated beta-hemolysin, Hlb
fibrinogen-binding protein, EfbB
secretory antigen precursor, SsaA
Panton-Valentine leukocidin, LukF-PV
Ear Protein
Panton-Valentine leukocidin, LukS-PV

SAUSA300_0113
SAUSA300_1052
SAUSA300_0951
SAUSA300_0950
SAUSA300_2572
SAUSA300_1068
SAUSA300_1058
SAUSA300_1756
SAUSA300_0776
SAUSA300_2364
SAUSA300_1758
SAUSA300_1067
SAUSA300_1755
SAUSA300_2366
SAUSA300_1753
SAUSA300_1988
SAUSA300_1754
SAUSA300_0949
SAUSA300_1757
SAUSA300_1768
SAUSA300_1056
SAUSA300_2164
SAUSA300_1919
SAUSA300_1769
SAUSA300_1918
SAUSA300_1055
SAUSA300_2249
SAUSA300_1381
SAUSA300_0815
SAUSA300_1382

12.67
-2.00
-2.05
-2.05
-2.07
-2.15
-2.20
-2.34
-2.37
-2.41
-2.44
-2.52
-2.55
-2.57
-2.87
-2.89
-2.89
-2.95
-3.22
-3.31
-3.42
-3.60
-3.68
-4.01
-4.17
-4.64
-5.37
-6.55
-6.80
-8.02

Hypothetical Proteins
hypothetical protein
hypothetical protein
hypothetical protein

SAUSA300_2158
SAUSA300_1215
SAUSA300_0793

3.25
2.98
2.37

hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein

SAUSA300_1746
SAUSA300_0575
SAUSA300_0668
SAUSA300_1532
SAUSA300_1335
SAUSA300_2543
SAUSA300_0779
SAUSA300_0300
SAUSA300_2447
SAUSA300_0471
SAUSA300_0302
SAUSA300_2522
SAUSA300_2524
SAUSA300_0409
SAUSA300_2482
SAUSA300_0048
SAUSA300_1380

2.35
2.30
2.22
2.19
2.10
2.08
2.02
-2.25
-2.46
-2.50
-2.64
-3.05
-3.72
-4.67
-5.05
-5.31
-10.83

Transporters
Na+/H+ antiporter, MnhA component
ABC transporter, ATP-binding protein
maltose ABC transporter, permease protein
osmoprotectant transporter, BCCT family
glycerol uptake facilitator protein, GlpF
ABC transporter, substrate-binding protein
ABC transporter, ATP-binding protein
truncated calmodulin exporting ATPase
peptide ABC transporter, ATP-binding protein
ABC transporter, ATP-binding protein
peptide ABC transporter, permease protein
peptide ABC transporter, permease protein
xanthine permease, PbuX
copper-translocating P-type ATPase, CopA

SAUSA300_0856
SAUSA300_2399
SAUSA300_0211
SAUSA300_2549
SAUSA300_1191
SAUSA300_0618
SAUSA300_0271
SAUSA300_0068
SAUSA300_2407
SAUSA300_0620
SAUSA300_0202
SAUSA300_0201
SAUSA300_0387
SAUSA300_0078

2.22
2.07
2.05
2.02
-2.03
-2.10
-2.13
-2.34
-2.37
-2.50
-2.80
-2.91
-3.34
-3.73

Regulators
staphylococcal accessory regulator S, SarS
sigma factor, SigS
regulatory protein, GntR family
sensor histidine kinase, SaeS
transcriptional regulator, DeoR family
arsenical resistance operon repressor, ArsR
DNA-binding response regulator, SaeR

SAUSA300_0114
SAUSA300_1722
SAUSA300_1914
SAUSA300_0690
SAUSA300_0683
SAUSA300_1717
SAUSA300_0691

2.03
-2.07
-2.30
-2.33
-2.35
-2.53
-2.82

tRNAs
tRNA
tRNA

SAUSA300_0447
SAUSA300_1823

-2.07
-2.12

tRNA
tRNA

SAUSA300_1811
SAUSA300_1772

-2.12
-2.76

Transposases
putative transposase
IS431 transposase/integrase
IS431mec, transposase

SAUSA300_2263
SAUSA300_0069
SAUSA300_0028

-2.82
-6.28
-24.83

Capsule Proteins
capsular polysaccharide biosynthesis protein, Cap5G
capsular polysaccharide biosynthesis protein, Cap5F

SAUSA300_0158
SAUSA300_0157

-2.06
-2.18

Ribosomal Proteins
30S ribosomal protein S5, RpsE
ribosomal protein L33, RpmG
ribosomal protein L33, RpmG

SAUSA300_2187
SAUSA300_1511
SAUSA300_1233

2.81
2.13
-2.27

PTS System Components
PTS system, IIABC components, PtsG
hypothetical protein
PTS system, IIC component

SAUSA300_0191
SAUSA300_0331
SAUSA300_1809

4.43
3.87
2.01

SAUSA300_2342

10.18

SAUSA300_2341
SAUSA300_2343
SAUSA300_2345
SAUSA300_2333
SAUSA300_2346
SAUSA300_2347
SAUSA300_0711
SAUSA300_2340

8.27
6.03
5.42
4.84
4.67
3.68
2.12
2.12

SAUSA300_0809
SAUSA300_0811
SAUSA300_0810
SAUSA300_0808
SAUSA300_0812
SAUSA300_0804
SAUSA300_0805
SAUSA300_0806
SAUSA300_0807

3.19
3.14
3.10
2.94
2.83
2.72
2.64
2.46
2.44

Nitrite/ Nitrate Metabolism
respiratory nitrate reductase, beta subunit, NarH
anaerobic ribonucleoside-triphosphate reductase
activating protein, NarJ
respiratory nitrate reductase, alpha subunit
nitrite reductase [NAD(P)H], small subunit, NirD
nitrite extrusion protein, NarK
nitrite reductase [NAD(P)H], large subunit, nirB
transcriptional regulator, NirR
hypothetical protein
respiratory nitrate reductase, gamma subunit, NarI
SaPI5
Putative DNA primase, pathogenicity island
hypothetical protein, pathogenicity island
hypothetical protein, pathogenicity island
hypothetical protein, pathogenicity island
hypothetical protein, pathogenicity island
hypothetic XRE type regulator, pathogenicity island
hypothetical protein, pathogenicity island
hypothetical protein, pathogenicity island
hypothetical protein, pathogenicity island

Membrane Proteins/ Lipoproteins
membrane protein, putative
membrane protein
membrane protein
membrane protein
membrane protein, putative
membrane protein, putative
membrane spanning protein
lipoprotein, putative
lipoprotein, putative
putative lipoprotein
membrane Protein
xanthine phosphoribosyltransferase, Xpt
Other
uroporphyrinogen III methylase SirB, putative
transferrin receptor
acetyltransferase
UDP-N-acetylglucosamine--N-acetylmuramyl(pentapeptide) pyrophosphoryl-undecaprenol Nacetylglucosamine transferase, MurG
bifunctional acetaldehyde-CoA/alcohol dehydrogenase,
AdhE
anaerobic ribonucleotide reductase, small subunit, NrdG
general stress protein 13
S1 RNA Binding Domain Protein
lantibiotic epidermin biosynthesis protein, EpiA
cytochrome d ubiquinol oxidase, subunit I
hypothetical protein
acetyltransferase, GNAT family
histidine ammonia-lyase, HutH
acetyltransferase, GNAT family
anaerobic ribonucleoside-triphosphate reductase, NrdD
tributyrin esterase, EstA
glycerol kinase, GlpK
penicillin-binding protein 2, MecA
pyrimidine-nucleoside phosphorylase, Pdp
threonine dehydratase, IlvA
N-acetyl-gamma-glutamyl-phosphate reductase, ArgC
oligoendopeptidase F, PepF
amidophosphoribosyltransferase, PurF
cystathionine gamma-synthase, MetB
riboflavin biosynthesis protein, RibBA
cysteine synthase/cystathionine beta-synthase family
protein, CysM
GMP synthase, GuaA

SAUSA300_0111
SAUSA300_2056
SAUSA300_0823
SAUSA300_0872
SAUSA300_0393
SAUSA300_2642
SAUSA300_2454
SAUSA300_0203
SAUSA300_0693
SAUSA300_0079
SAUSA300_0692
SAUSA300_0386

2.80
2.32
2.31
2.30
2.16
2.10
2.07
-2.28
-2.47
-3.50
-3.53
-3.92

SAUSA300_2344
SAUSA300_0721
SAUSA300_1312
SAUSA300_1311

5.35
2.83
2.65
2.56

SAUSA300_0151
SAUSA300_2550
SAUSA300_1862
SAUSA300_0486
SAUSA300_1767
SAUSA300_0986
SAUSA300_1310
SAUSA300_2468
SAUSA300_0008
SAUSA300_0662
SAUSA300_2551
SAUSA300_2564
SAUSA300_1192
SAUSA300_0032
SAUSA300_2091
SAUSA300_1330
SAUSA300_0186
SAUSA300_0902
SAUSA300_0972
SAUSA300_0434
SAUSA300_1713
SAUSA300_0433

2.48
2.45
2.29
2.29
2.25
2.24
2.21
2.20
2.18
2.07
2.07
2.07
2.06
2.06
2.05
2.03
-2.00
-2.04
-2.07
-2.08
-2.12
-2.15

SAUSA300_0389

-2.16

6,7-dimethyl-8-ribityllumazine synthase, RibH
choline dehydrogenase, BetA
glutamate synthase, large subunit, GltB
glutamate synthase, small subunit, GltD
betaine aldehyde dehydrogenase, BetB
methionine aminopeptidase, Map
Phage Proteins
phi083 ORF027-like protein
phiPVL ORF39-like protein
phiPVL ORF044-like protein
phi77 ORF031-like protein
phiPVL ORF41-like protein
single-strand binding protein
phiPVL ORF046-like protein
dUTP diphosphatase
putative phage transcriptional regulator
hypothetical phage protein
phi77 ORF014-like protein, phage anti-repressor protein
phi77 ORF069-like protein
phi77 ORF040-like protein
hypothetical phage protein
phiSLT ORF53-like protein
putative phage-related DNA recombination protein
phiPVL ORF051-like protein
phi77 ORF026-like protein, phage transcriptional activator
hypothetical phage protein
phi77 ORF004-like protein, putative phage tail component
phi77 ORF100-like protein
holin
phiPVL ORF050-like protein
phi77 ORF015-like protein, putative protease
phi77 ORF003-like protein, phage terminase, large subunit
phi77 ORF006-like protein, putative capsid protein
phage portal protein
phi77 ORF029-like protein
Autolysin
phi77 ORF001-like protein, phage tail tape measure
protein
hypothetical phage protein
phi77 ORF020-like protein, phage major tail protein
phi77 ORF109-like protein
phi77 ORF045-like protein
hypothetical phage protein
hypothetical phage protein
phi77 ORF002-like protein, phage minor structural protein

SAUSA300_1712
SAUSA300_2545
SAUSA300_0445
SAUSA300_0446
SAUSA300_2546
SAUSA300_1869

-2.24
-2.48
-2.50
-2.55
-3.08
-3.39

SAUSA300_1952
SAUSA300_1962
SAUSA300_1959
SAUSA300_1947
SAUSA300_1961
SAUSA300_1958
SAUSA300_1957
SAUSA300_1949
SAUSA300_1968
SAUSA300_1964
SAUSA300_1966
SAUSA300_1948
SAUSA300_1943
SAUSA300_1942
SAUSA300_1429
SAUSA300_1960
SAUSA300_1953
SAUSA300_1944
SAUSA300_1963
SAUSA300_1929
SAUSA300_1931
SAUSA300_1924
SAUSA300_1954
SAUSA300_1939
SAUSA300_1941
SAUSA300_1938
SAUSA300_1940
SAUSA300_1935
SAUSA300_1923

29.2
26.58
19.69
18.42
16.24
14.87
12.92
12.36
11.98
11.79
11.45
10.83
9.87
9.63
9.4
9.15
8.37
8.29
8.07
7.86
7.85
7.4
7.36
7.13
7.13
6.19
6.09
5.74
5.73

SAUSA300_1930

5.59

SAUSA300_1967
SAUSA300_1934
SAUSA300_1927
SAUSA300_1937
SAUSA300_1932
SAUSA300_1936
SAUSA300_1928

5.56
5.45
5.38
4.55
4.49
4.31
4.14

phi77 ORF044-like protein
hypothetical phage protein
phiPVL ORF17-like protein
Phage, phiSLT ORF151-like protein, major tail protein
Phage, phiSLT ORF412-like protein, portal protein
a
b

USA300 HOU rpoE mutant
USA300 HOU wild-type

SAUSA300_1926
SAUSA300_1933
SAUSA300_1925
SAUSA300_1396
SAUSA300_1403

3.26
3.14
2.92
2.9
2.8

APPENDIX III

129

American Society for Microbiology  Journals LICENSE
TERMS AND CONDITIONS
Apr 05, 2017

This is a License Agreement between Andy Weiss ("You") and American Society for
Microbiology - Journals ("American Society for Microbiology - Journals") provided by
Copyright Clearance Center ("CCC"). The license consists of your order details, the terms
and conditions provided by American Society for Microbiology - Journals, and the payment
terms and conditions.
All payments must be made in full to CCC. For payment instructions, please see
information listed at the bottom of this form.
License Number

4053651266117

License date

Feb 19, 2017

Licensed content publisher

American Society for Microbiology  Journals

Licensed content title

Journal of bacteriology

Licensed content date

Jan 1, 1916

Type of Use

Thesis/Dissertation

Requestor type

Author of requested content

Format

Print, Electronic

Portion

chapter/article

Title or numeric reference of If permission is granted this article would be used as chapter of my
the portion(s)
dissertation. The article, as well as the supplementals, would appear
in the appendix of the dissertation
Title of the article or chapter The ω Subunit Governs RNA Polymerase Stability and
the portion is from
Transcriptional Specificity in Staphylococcus aureus
Editor of portion(s)

N/A

Author of portion(s)

Andy Weiss, Brittney D. Moore, Miguel H.J. Tremblay, Dale Chaput,
Astrid Kremer and Lindsey N. Shaw

Volume of serial or
monograph.

JB.0045916

Issue, if republishing an
article from a serial

N/A

Page range of the portion
Publication date of portion

31 October 2016 (posted online)

Rights for

Main product and any product related to main product

Duration of use

Life of current edition

Creation of copies for the
disabled

no

With minor editing privileges yes
For distribution to

Worldwide

In the following language(s) Original language of publication
With incidental promotional
use

no

The lifetime unit quantity of Up to 499
new product
Made available in the
following markets

education

Specified additional
information

Including minor editing privileges.

The requesting
person/organization is:

Andy Weiss

Order reference number
Author/Editor

Andy Weiss

The standard identifier of
New Work

University of South Florida

Title of New Work

Nonclassical regulators in Staphylococcus aureus

Publisher of New Work

University of South Florida

Expected publication date

May 2017

Estimated size (pages)

130

Total (may include CCC user 0.00 USD
fee)
Terms and Conditions

TERMS AND CONDITIONS
The following terms are individual to this publisher:
We ask that you review the copyright information associated with the article that you are
interested in, as some articles in the ASM Journals are covered by creative commons
licenses that would permit free reuse with attribution.
Please note that ASM cannot grant permission to reuse ﬁgures or images that are credited to
publications other than ASM journals. For images credited to non-ASM journal publications,
you will need to obtain permission from the journal referenced in the ﬁgure or table legend
or credit line before making any use of the image(s) or table(s). ASM is unable to grant
permission to reuse supplemental material as copyright for the supplemental material
remains with the author.
Other Terms and Conditions:
STANDARD TERMS AND CONDITIONS
1. Description of Service; Deﬁned Terms. This Republication License enables the User to
obtain licenses for republication of one or more copyrighted works as described in detail on
the relevant Order Conﬁrmation (the “Work(s)”). Copyright Clearance Center, Inc. (“CCC”)
grants licenses through the Service on behalf of the rightsholder identiﬁed on the Order
Conﬁrmation (the “Rightsholder”). “Republication”, as used herein, generally means the
inclusion of a Work, in whole or in part, in a new work or works, also as described on the
Order Conﬁrmation. “User”, as used herein, means the person or entity making such
republication.
2. The terms set forth in the relevant Order Conﬁrmation, and any terms set by the
Rightsholder with respect to a particular Work, govern the terms of use of Works in
connection with the Service. By using the Service, the person transacting for a republication
license on behalf of the User represents and warrants that he/she/it (a) has been duly
authorized by the User to accept, and hereby does accept, all such terms and conditions on
behalf of User, and (b) shall inform User of all such terms and conditions. In the event such
person is a “freelancer” or other third party independent of User and CCC, such party shall
be deemed jointly a “User” for purposes of these terms and conditions. In any event, User
shall be deemed to have accepted and agreed to all such terms and conditions if User
republishes the Work in any fashion.
3. Scope of License; Limitations and Obligations.
3.1 All Works and all rights therein, including copyright rights, remain the sole and
exclusive property of the Rightsholder. The license created by the exchange of an Order
Conﬁrmation (and/or any invoice) and payment by User of the full amount set forth on that
document includes only those rights expressly set forth in the Order Conﬁrmation and in
these terms and conditions, and conveys no other rights in the Work(s) to User. All rights not
expressly granted are hereby reserved.
3.2 General Payment Terms: You may pay by credit card or through an account with us
payable at the end of the month. If you and we agree that you may establish a standing

account with CCC, then the following terms apply: Remit Payment to: Copyright Clearance
Center, 29118 Network Place, Chicago, IL 60673-1291. Payments Due: Invoices are payable
upon their delivery to you (or upon our notice to you that they are available to you for
downloading). After 30 days, outstanding amounts will be subject to a service charge of 11/2% per month or, if less, the maximum rate allowed by applicable law. Unless otherwise
speciﬁcally set forth in the Order Conﬁrmation or in a separate written agreement signed by
CCC, invoices are due and payable on “net 30” terms. While User may exercise the rights
licensed immediately upon issuance of the Order Conﬁrmation, the license is automatically
revoked and is null and void, as if it had never been issued, if complete payment for the
license is not received on a timely basis either from User directly or through a payment
agent, such as a credit card company.
3.3 Unless otherwise provided in the Order Conﬁrmation, any grant of rights to User (i) is
“one-time” (including the editions and product family speciﬁed in the license), (ii) is nonexclusive and non-transferable and (iii) is subject to any and all limitations and restrictions
(such as, but not limited to, limitations on duration of use or circulation) included in the
Order Conﬁrmation or invoice and/or in these terms and conditions. Upon completion of the
licensed use, User shall either secure a new permission for further use of the Work(s) or
immediately cease any new use of the Work(s) and shall render inaccessible (such as by
deleting or by removing or severing links or other locators) any further copies of the Work
(except for copies printed on paper in accordance with this license and still in User's stock at
the end of such period).
3.4 In the event that the material for which a republication license is sought includes third
party materials (such as photographs, illustrations, graphs, inserts and similar materials)
which are identiﬁed in such material as having been used by permission, User is responsible
for identifying, and seeking separate licenses (under this Service or otherwise) for, any of
such third party materials; without a separate license, such third party materials may not be
used.
3.5 Use of proper copyright notice for a Work is required as a condition of any license
granted under the Service. Unless otherwise provided in the Order Conﬁrmation, a proper
copyright notice will read substantially as follows: “Republished with permission of
[Rightsholder’s name], from [Work's title, author, volume, edition number and year of
copyright]; permission conveyed through Copyright Clearance Center, Inc. ” Such notice
must be provided in a reasonably legible font size and must be placed either immediately
adjacent to the Work as used (for example, as part of a by-line or footnote but not as a
separate electronic link) or in the place where substantially all other credits or notices for the
new work containing the republished Work are located. Failure to include the required notice
results in loss to the Rightsholder and CCC, and the User shall be liable to pay liquidated
damages for each such failure equal to twice the use fee speciﬁed in the Order Conﬁrmation,
in addition to the use fee itself and any other fees and charges speciﬁed.
3.6 User may only make alterations to the Work if and as expressly set forth in the Order
Conﬁrmation. No Work may be used in any way that is defamatory, violates the rights of
third parties (including such third parties' rights of copyright, privacy, publicity, or other
tangible or intangible property), or is otherwise illegal, sexually explicit or obscene. In
addition, User may not conjoin a Work with any other material that may result in damage to
the reputation of the Rightsholder. User agrees to inform CCC if it becomes aware of any
infringement of any rights in a Work and to cooperate with any reasonable request of CCC
or the Rightsholder in connection therewith.
4. Indemnity. User hereby indemniﬁes and agrees to defend the Rightsholder and CCC, and
their respective employees and directors, against all claims, liability, damages, costs and
expenses, including legal fees and expenses, arising out of any use of a Work beyond the
scope of the rights granted herein, or any use of a Work which has been altered in any
unauthorized way by User, including claims of defamation or infringement of rights of
copyright, publicity, privacy or other tangible or intangible property.
5. Limitation of Liability. UNDER NO CIRCUMSTANCES WILL CCC OR THE
RIGHTSHOLDER BE LIABLE FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL OR
INCIDENTAL DAMAGES (INCLUDING WITHOUT LIMITATION DAMAGES FOR
LOSS OF BUSINESS PROFITS OR INFORMATION, OR FOR BUSINESS
INTERRUPTION) ARISING OUT OF THE USE OR INABILITY TO USE A WORK,

EVEN IF ONE OF THEM HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. In any event, the total liability of the Rightsholder and CCC (including their
respective employees and directors) shall not exceed the total amount actually paid by User
for this license. User assumes full liability for the actions and omissions of its principals,
employees, agents, afﬁliates, successors and assigns.
6. Limited Warranties. THE WORK(S) AND RIGHT(S) ARE PROVIDED “AS IS”. CCC
HAS THE RIGHT TO GRANT TO USER THE RIGHTS GRANTED IN THE ORDER
CONFIRMATION DOCUMENT. CCC AND THE RIGHTSHOLDER DISCLAIM ALL
OTHER WARRANTIES RELATING TO THE WORK(S) AND RIGHT(S), EITHER
EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION IMPLIED
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR
PURPOSE. ADDITIONAL RIGHTS MAY BE REQUIRED TO USE ILLUSTRATIONS,
GRAPHS, PHOTOGRAPHS, ABSTRACTS, INSERTS OR OTHER PORTIONS OF THE
WORK (AS OPPOSED TO THE ENTIRE WORK) IN A MANNER CONTEMPLATED
BY USER; USER UNDERSTANDS AND AGREES THAT NEITHER CCC NOR THE
RIGHTSHOLDER MAY HAVE SUCH ADDITIONAL RIGHTS TO GRANT.
7. Effect of Breach. Any failure by User to pay any amount when due, or any use by User of
a Work beyond the scope of the license set forth in the Order Conﬁrmation and/or these
terms and conditions, shall be a material breach of the license created by the Order
Conﬁrmation and these terms and conditions. Any breach not cured within 30 days of
written notice thereof shall result in immediate termination of such license without further
notice. Any unauthorized (but licensable) use of a Work that is terminated immediately upon
notice thereof may be liquidated by payment of the Rightsholder's ordinary license price
therefor; any unauthorized (and unlicensable) use that is not terminated immediately for any
reason (including, for example, because materials containing the Work cannot reasonably be
recalled) will be subject to all remedies available at law or in equity, but in no event to a
payment of less than three times the Rightsholder's ordinary license price for the most
closely analogous licensable use plus Rightsholder's and/or CCC's costs and expenses
incurred in collecting such payment.
8. Miscellaneous.
8.1 User acknowledges that CCC may, from time to time, make changes or additions to the
Service or to these terms and conditions, and CCC reserves the right to send notice to the
User by electronic mail or otherwise for the purposes of notifying User of such changes or
additions; provided that any such changes or additions shall not apply to permissions already
secured and paid for.
8.2 Use of User-related information collected through the Service is governed by CCC’s
privacy policy, available online here:
http://www.copyright.com/content/cc3/en/tools/footer/privacypolicy.html.
8.3 The licensing transaction described in the Order Conﬁrmation is personal to User.
Therefore, User may not assign or transfer to any other person (whether a natural person or
an organization of any kind) the license created by the Order Conﬁrmation and these terms
and conditions or any rights granted hereunder; provided, however, that User may assign
such license in its entirety on written notice to CCC in the event of a transfer of all or
substantially all of User’s rights in the new material which includes the Work(s) licensed
under this Service.
8.4 No amendment or waiver of any terms is binding unless set forth in writing and signed
by the parties. The Rightsholder and CCC hereby object to any terms contained in any
writing prepared by the User or its principals, employees, agents or afﬁliates and purporting
to govern or otherwise relate to the licensing transaction described in the Order
Conﬁrmation, which terms are in any way inconsistent with any terms set forth in the Order
Conﬁrmation and/or in these terms and conditions or CCC's standard operating procedures,
whether such writing is prepared prior to, simultaneously with or subsequent to the Order
Conﬁrmation, and whether such writing appears on a copy of the Order Conﬁrmation or in a
separate instrument.
8.5 The licensing transaction described in the Order Conﬁrmation document shall be
governed by and construed under the law of the State of New York, USA, without regard to
the principles thereof of conﬂicts of law. Any case, controversy, suit, action, or proceeding
arising out of, in connection with, or related to such licensing transaction shall be brought, at

CCC's sole discretion, in any federal or state court located in the County of New York, State
of New York, USA, or in any federal or state court whose geographical jurisdiction covers
the location of the Rightsholder set forth in the Order Conﬁrmation. The parties expressly
submit to the personal jurisdiction and venue of each such federal or state court.If you have
any comments or questions about the Service or Copyright Clearance Center, please contact
us at 978-750-8400 or send an e-mail to info@copyright.com.
v 1.1
Questions? customercare@copyright.com or +18552393415 (toll free in the US) or
+19786462777.

RESEARCH ARTICLE

crossm
The  Subunit Governs RNA Polymerase
Stability and Transcriptional Speciﬁcity
in Staphylococcus aureus
University of South Florida, Department of Cell Biology, Microbiology and Molecular Biology, Tampa, Florida,
USA

ABSTRACT Staphylococcus aureus is a major human pathogen that causes infection

in a wide variety of sites within the human body. Its ability to adapt to the human
host and to produce a successful infection requires precise orchestration of gene expression. While DNA-dependent RNA polymerase (RNAP) is generally well characterized, the roles of several small accessory subunits within the complex have yet to be
fully explored. This is particularly true for the omega ( or RpoZ) subunit, which has
been extensively studied in Gram-negative bacteria but largely neglected in Grampositive counterparts. In Escherichia coli, it has been shown that ppGpp binding, and
thus control of the stringent response, is facilitated by . Interestingly, key residues
that facilitate ppGpp binding by  are not conserved in S. aureus, and consequently,
survival under starvation conditions is unaffected by rpoZ deletion. Further to this,
-lacking strains of S. aureus display structural changes in the RNAP complex, which
result from increased degradation and misfolding of the ␤= subunit, alterations in ␦
and  factor abundance, and a general dissociation of RNAP in the absence of .
Through RNA sequencing analysis we detected a variety of transcriptional changes
in the rpoZ-deﬁcient strain, presumably as a response to the negative effects of 
depletion on the transcription machinery. These transcriptional changes translated to
an impaired ability of the rpoZ mutant to resist stress and to fully form a bioﬁlm.
Collectively, our data underline, for the ﬁrst time, the importance of  for RNAP stability, function, and cellular physiology in S. aureus.
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IMPORTANCE In order for bacteria to adjust to changing environments, such as

within the host, the transcriptional process must be tightly controlled. Transcription
is carried out by DNA-dependent RNA polymerase (RNAP). In addition to its major
subunits (␣2␤␤=) a ﬁfth, smaller subunit, , is present in all forms of life. Although
this small subunit is well studied in eukaryotes and Gram-negative bacteria, only limited information is available for Gram-positive and pathogenic species. In this study,
we investigated the structural and functional importance of , revealing key roles in
subunit folding/stability, complex assembly, and maintenance of transcriptional integrity. Collectively, our data underline, for the ﬁrst time, the importance of  for
RNAP function and cellular harmony in S. aureus.
KEYWORDS RNA polymerase subunit omega, RpoZ, Staphylococcus aureus, gene

regulation

T

ranscription in all forms of life is a tightly controlled process, necessitated by the
essentiality of correct temporal and spatial expression of genes for survival. All
transcriptional activity within a cell is maintained by the DNA-dependent RNA polymerase (RNAP). This multiprotein complex is structurally and functionally similar in
distant forms of life, displaying only minor variations in composition, e.g., the presence/
absence of certain subunits (1, 2). In bacteria RNAP consists of four main subunits, i.e.,
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two ␣ (RpoA) subunits and one subunit each of ␤ (RpoB) and ␤= (RpoC), forming the
␣2␤␤= complex. Together they facilitate transcriptional elongation, but they require a 
factor to initiate the process. Interestingly, a large number of bacteria, and particularly
the Firmicutes, possess several other accessory RNAP subunits (3–6). These are considerably smaller than the major subunits, ranging from 8.5 to 21.5 kDa, and include the
␦ (RpoE),  (RpoY), and  (RpoZ) subunits. Deletion of these subunits does not result in
lethality for the cell, and thus their diminutive size and nonessential nature have
resulted in their being classiﬁed as the “small accessory subunits” (reviewed in reference 6). Nevertheless, for the ␦ factor it has been shown that, in various species,
deletion is accompanied by a deregulation of the transcriptional process, leading to
decreased ﬁtness and impaired virulence in pathogenic organisms (7, 8). While there is
an extensive history of research for ␦,  has only recently been described as an RNAP
subunit, with only a single study thus far performed in Bacillus subtilis (5), which
suggested a role in phage immunity. While the presence of these two subunits is largely
conﬁned to the Firmicutes, homologs of , the smallest of the three subunits, can be
found not only in bacteria but also in eukaryotes (RPB6) and archaea (RpoK) (6, 9).
Although this conservation might suggest a vital role and perhaps similar function
across widely different species, there are in fact marked differences in how this subunit
inﬂuences cells across the various kingdoms (6, 10). Most strikingly is the observation
that while it is accessory in bacteria, the  subunit is essential in eukaryotic organisms
(11).
The majority of studies on  have been carried out in Gram-negative bacteria, with
a focus on the model organism Escherichia coli (10). In this organism it has been shown
that  inﬂuences the transcriptional machinery, and thus the transcriptional process, in
a variety of ways. Most notably,  is known to interact with ␤= to ensure correct folding
of the subunit, as well as to facilitate docking to the ␣2␤ complex (9, 12–14). Accordingly, deletion of  leads to misfolding as well as degradation of ␤= (13, 15), which is
also observed in Mycobacterium smegmatis (16). The crystal structure of  in complex
with the other RNAP subunits of both E. coli and Thermus aquaticus has been solved
and conﬁrms the binding of  to ␤= (17, 18). Interestingly, these structures also reveal
species-speciﬁc differences in the interaction of these two proteins, again highlighting
the heterogeneous nature of  function in different organisms. In contrast, no such
crystal structure is available for , or RNAP at large, in Gram-positive organisms.
Quite strikingly, in terms of functional difference, is the ﬁnding that in E. coli, the
stringent response, and thus adaption to nutrient-limiting conditions, is dependent on
. Speciﬁcally, the stringent response-inducing molecule ppGpp is recognized by and
binds to the interface of ␤= and  (19–21), which in turn leads to the adjustment of
transcriptional proﬁles to promote survival under nutrient-limiting conditions. While
this role is true for E. coli, the  protein in B. subtilis has been suggested to have no such
role in the stringent response, due to an alternative mechanism of ppGpp recognition.
Instead of binding to , the adaption to limiting conditions in B. subtilis is mediated by
ppGpp-induced alterations of GTP concentrations within the cell (22, 23). Subsequently,
these changes lead to alterations in gene expression, driven by the sensitivity of certain
promoters to GTP availability as an initiating nucleotide. In line with this model, where
onset of the stringent response does not require the interaction of ppGpp with the
RNAP complex, is the observation that the conserved E. coli residues required for
ppGpp binding to RNAP are largely absent in the B. subtilis  and ␤= subunits (20).
The ﬁnal major function of  described in the literature is a putative role in
facilitating  factor biding to the RNAP complex. For E. coli and cyanobacteria, it has
been reported that depletion of  can lead to increased binding of alterative  factors
and in turn to increased expression of genes within alternative  factor regulons (24,
25). Again, structural differences within the -depleted RNAP have been implicated in
this alteration of  factor afﬁnity for the complex. As with many of the other 
phenotypes, no in-depth studies have been performed in Gram-positive bacteria
regarding this role, further underscoring the need to characterize this diverse protein.
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For Gram-positive organisms, only a limited number of studies exist, detailing a few
phenotypic effects resulting from the abrogation of  activity. Indeed, none of these
studies have unraveled the molecular basis for alterations in mutant strains, meaning
that the role of  in Gram-positive species is still relatively elusive. Those effects that
have been detailed for rpoZ mutants include alterations in cell wall morphology, cell
motility, protein secretion, and bioﬁlm formation (16, 26–29). Importantly, the role of
this subunit in the virulence of pathogenic species has yet to be evaluated. Therefore,
in this study we explored the role of  in Staphylococcus aureus, demonstrating that it
is not involved in the stringent response but instead mediates structural integrity of the
RNAP complex. Deletion of this factor leads to individual RNAP subunit degradation
and an induction of cellular stress responses. The latter effect was characterized by
global transcriptional analyses, revealing that a signiﬁcant number of the observed
changes were due, at least in part, to altered  factor abundance in the RNAP complex.
Finally, we demonstrate that deletion of rpoZ inﬂuences the ability of S. aureus to form
bioﬁlms, a process that mediates persistent infections and the capacity to resist
antibiotic treatment. We suggest that collectively, our data underline the importance of
 for RNAP stability, function, and cellular physiology in S. aureus.
RESULTS
 is cotranscribed with gmk and is highly expressed throughout growth.
Analysis of RNA sequencing data previously generated by our laboratory (31) reveals
that the -encoding gene, rpoZ, is highly expressed during all phases of growth and is
seemingly cotranscribed with its upstream gene, gmk, encoding a guanylate kinase (see
Fig. S2A in the supplemental material). To validate the latter observation, we performed
Northern blot analysis on RNA extracted from wild-type S. aureus cells grown to
mid-exponential phase using rpoZ-speciﬁc probes. In so doing, a band of ⬃1100
nucleotides (nt) was observed, indicating that rpoZ and gmk are indeed organized in a
bicistronic operon (Fig. S2B). In order to study the role of  in S. aureus, we next created
an unmarked deletion mutant, removing the majority of the rpoZ-encoding gene and
leaving gmk intact. Validation of this arrangement and that no deleterious effects were
observed on gmk expression was obtained by RNA sequencing analysis of the mutant
strain and by Northern blotting (Fig. S2A and B). RNA sequencing data for the
-depleted strain showed the expected deletion of the rpoZ gene but conﬁrmed that
there were no unintended effects on transcript abundance for gmk (see Table S1 in the
supplemental material).
The S. aureus  and ␤= proteins lack conserved residues required for ppGpp
binding. In E. coli the interaction of ppGpp with RNAP is mediated by conserved
residues within the  and ␤= subunits, thus controlling the stringent response. Such
residues are absent in B. subtilis, suggesting an alternate mechanism for stringent
response regulation in Gram-positive organisms (20, 32). In corroboration of this,
alignment analysis of  and ␤= subunits from E. coli, B. subtilis, and S. aureus (Fig. 1A)
reveals that, although there is partial conservation of the ␤= and  proteins for all three
organisms, the residues for ppGpp binding are almost entirely absent (a single aspartic
acid is conserved in ␤= region 2) at the primary sequence level and in the biochemical
characteristics of each amino acid. This ﬁnding is further validated by the observation
that growth of a ΔrpoZ strain is not impaired under standard, nutrient-limiting, or
stringent response-inducing conditions. Speciﬁcally, in addition to growth in complex
medium (tryptic soy broth [TSB]) (Fig. 1B), we investigated growth during amino acid
limitation (Fig. 1C) as well as in amino acid-limiting medium completely depleted of
valine and leucine (Fig. 1D). Importantly, the rpoZ mutant showed growth rates similar
to those of the wild type in both TSB and amino acid-limiting medium and only a minor
growth defect in medium devoid of valine and leucine. This defect, however, suggests
an impaired ability to adapt to changing growth conditions rather than a stringent
response defect, as stringent response-deﬁcient mutants display a characteristic stalling
of growth during the stringent response, rather than delayed growth (33). To further
validate this ﬁnding, we assessed sensitivity to mupirocin of the rpoZ mutant alongside
January 2017 Volume 199 Issue 2 e00459-16
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FIG 1 Inﬂuence of the S. aureus  subunit on survival during nutrient-limiting conditions. (A) Alignment of select RNAP subunits from E. coli, B. subtilis, and S.
aureus, showing conservation and divergence of amino acids sequences for RpoC (␤=) and RpoZ (). For E. coli, the conserved ␤= (arrows) and  (boxed) regions
important for ppGpp binding are shown. (B to D) S. aureus growth under standard conditions (TSB) (B), in amino acid-limiting medium (CDM) (C), and in CDM
completely depleted of valine and leucine (D). Error bars show the standard error of the mean (SEM).

its parental strain and a codY mutant strain, as it has previously been shown that S.
aureus mutants impaired in the stringent response display decreased resistance to this
stringent response-inducing antibiotic (34). In so doing, we found that the ΔrpoZ strain
has a mupirocin MIC (0.32 g/ml) similar to that of the wild type, while the codY mutant
has a 2-fold decrease in MIC (⬃0.16 g/ml), comparable to that of stringent responsedeﬁcient mutants documented elsewhere (34).
Depletion of rpoZ leads to destabilization of the RNAP complex. We next
assessed whether  has a role in maintaining RNAP complex integrity in S. aureus and,
more precisely, in the folding of its subunits, as described for M. smegmatis and E. coli
(13, 16). We isolated cytoplasmic proteins from exponentially growing cells and determined the abundances of the intact RNAP complex in the wild-type and mutant strains.
This was achieved by concentrating fractions using a 100-kDa-cutoff ﬁlter, ensuring that
the resulting retentate harbored only proteins of ⬎100 kDa in size. As ␤ and ␤= are the
only RNAP subunits larger than 100 kDa, any subunit found in the concentrated fraction
must originate from protein in complex with other RNAP subunits. Consequently, ␤ and
␤= are expected to be present independently and in complex with RNAP and thus
should demonstrate no alteration within the mutant even if complex instability is
observed. As expected, we consistently observed equimolar amounts of ␤ for both the
wild type and the rpoZ mutant in tested samples (Fig. 2A), which was conﬁrmed by
Western blotting using a ␤-speciﬁc antibody (Fig. 2B). Conversely, we found a marked
decrease in ␤= abundance in the mutant compared to the parent in the same samples.
Given the large size of ␤=, these results point not only toward a release of the subunit
from the complex but also to its likely degradation in the absence of , as observed in
other organisms. Similar to ␤=, but to a lesser extent, the ␣ subunit, the housekeeping
 factor, A, and the small subunit ␦ were also decreased in abundance in the mutant
strain. In order to investigate the fate of each subunit, we performed additional
January 2017 Volume 199 Issue 2 e00459-16
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FIG 2 Cells lacking the  factor have altered RNAP composition and individual subunit stability. Free or
complex-bound subunits were separated according to their molecular masses via size selection before
analysis using mass spectrometry. (A) In the ⬎100-kDA fraction only large RNAP subunits (␤ and ␤=) and
subunits within the RNAP complex should be found. (B) Data were validated by Western blotting using a
␤ subunit antibody. (C) Protein degradation in the ΔrpoZ strain is highlighted by the presence of larger
subunits within the ⬍30-kDa fraction. (D) Transcriptional changes as a cause of alterations in RNAP
composition were excluded by analyzing expression of RNAP genes from RNA sequencing data sets. Shown
are the fold changes for each RNAP gene in the mutant strain compared to the wild type. Where relevant,
error bars show SEM. Statistical signiﬁcance was determined using Student’s t test (*, P ⬍ 0.05; **, P ⬍ 0.01).

concentration experiments using a 30-kDa-cutoff ﬁlter and again isolated proteins from
the wild-type and rpoZ mutant strains (Fig. 2C). Interestingly, while only trace amounts
of ␤ were detected in these fractions (as expected), we observed signiﬁcant levels of ␤=
in the rpoZ mutant strain, again suggesting ␤= instability upon  deletion. With regard
to ␦, which should always be found in the ⬍30-kDa fraction, the amount of this protein
was signiﬁcantly higher in the ΔrpoZ strain than in the wild type. This would tend to
indicate disassembly and release of this subunit from the RNAP complex upon 
depletion.
To exclude the possibility that alterations in subunit abundance were caused by
differential expression patterns for RNAP-encoding genes in the rpoZ-depleted strain,
we analyzed RNA sequencing data sets of the USA300 parent and its corresponding
rpoZ mutant (Fig. 2D). The rpoZ gene was included as an internal control for our data
set, as a portion of the locus is still present in the mutant strain (Fig. S2A), and therefore
an expression value is generated from the RNA sequencing experiment. Of note, all of
the subunits were shown to have a moderate increase in expression in the mutant
strain. Importantly, ␤=, which displayed the strongest decrease in protein abundance,
showed the strongest upregulation, with a 2.6-fold increase in transcription. This
perhaps suggests a possible attempt by the cell to counteract ␤= degradation by
enhancing transcriptional activity of the rpoC gene within the rpoZ mutant strain.
The ␦ and  factors of RNAP have distinct and contrasting inﬂuences on S.
aureus gene expression. When further exploring the RNA sequencing comparison of
the wild-type and rpoZ mutant strains, we observed 232 genes with altered expression
at ⱖ2-fold and 63 genes at ⱖ3-fold (Fig. 3; Table S1). In order to validate these
alterations, we performed quantitative reverse transcription-PCR (RT-qPCR) for a subset
of differentially expressed genes (Fig. S3A and B), revealing similar changes in this and
the RNA sequencing data sets. Since our RNAP composition studies showed that rpoZ
deletion also results in ␦ depletion from RNAP, we next assessed whether removal of ␦
from the transcription complex was the driving force behind the observed changes.
This is particularly important, as our previous studies have shown that ␦ is a key factor
January 2017 Volume 199 Issue 2 e00459-16
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FIG 3 The ␦ and  factors of RNAP have distinct and contrasting inﬂuences on S. aureus gene expression. (Top) Genomic
map of altered transcription in the rpoZ mutant strain. The outermost circle (gray) represents annotations for the S. aureus
USA300 genome. Blue (upregulation) and red (downregulation) bars show genes with differential expression in the rpoZ
mutant (a maximum change of ⫾7-fold is displayed). Labels represent either gene names or USA300 gene numbers.
(Bottom right) Number of genes changed in expression upon rpoZ depletion at ⱖ2-fold (232) or ⱖ3-fold (63). (Bottom left)
Comparison of RNA sequencing data sets for ΔrpoE (␦) and ΔrpoZ () strains. Shown are the number of genes within each
regulon and the overlap between the two data sets (only ⬃10% was detected).

for maintaining transcriptional speciﬁcity within the S. aureus cell (8). Upon comparing
RNA sequencing-derived transcriptional changes of the rpoE and rpoZ mutants, we
found an overlapping regulon of only 24 genes (Fig. 3). Comparing these 24 genes to
the overall number of genes changed in both mutants, only ⬃10.5% (ΔrpoZ) or 12.5%
(ΔrpoE) of each data set is identical. This low level of regulon overlap indicates that the
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FIG 4  affects  factor recruitment to the S. aureus RNAP complex. A comparison of RNA sequencing
data sets from sigB::tet (B) and ΔrpoZ strains is depicted. Shown are the most highly repressed (A) or
highly induced (B) genes in the sigB::tet strain and their concomitant change in expression upon rpoZ
deletion. Genes with a change of less than 10% between the rpoZ mutant and its parental strain were
considered unchanged.

changes seen in an rpoZ mutant are not the result of an inability of ␦ to exert its
inﬂuence on RNAP.
 inﬂuences  factor recruitment to the S. aureus RNAP complex. In E. coli and
the cyanobacterium Synechocystis, it is known that depletion of  causes alterations in
 factor abundance within the RNAP complex. Therefore, we next investigated if the
multifaceted transcriptional changes of the rpoZ mutant were inﬂuenced by alterations
in  factor binding to the -less RNAP. Since B is the major alternative  factor in S.
aureus, we compared transcriptome changes upon rpoZ deletion to those observed in
a sigB mutant. This was facilitated using wild-type and sigB mutant RNA sequencing
data sets previously produced in our lab in the SH1000 background. SH1000 was
chosen for this study as it is known to have a B overexpression phenotype. Subsequent comparison of these data sets detected an inverse relationship between the
regulons of  and B. Speciﬁcally, for the 20 most strongly downregulated genes in the
sigB mutant, the majority (70%) demonstrated increased expression upon rpoZ disruption (Fig. 4; Tables S2 and S3). Conversely, for the 20 most strongly upregulated genes
in the sigB mutant, most (60%) were found to be decreased in expression in the ΔrpoZ
strain.
It is noted that the comparison of regulons between different strains is not without
drawbacks. Our rationale was that by choosing a sigB-overexpressing strain such as
SH1000, we could obtain better resolution for the identiﬁcation of B-dependent genes.
Nevertheless, there remains the possibility that additional genomic differences between SH1000 and USA300 drive strain-speciﬁc expression patterns and thereby inﬂuence their corresponding B regulons. However, the strongly correlated inverse relationship observed suggests that there are indeed higher levels of B within the
-lacking RNAP complex, which corroborates effects seen in other bacterial species.
Accordingly, it appears that  not only is required to maintain RNAP integrity but also
plays a role in association of the complex with available  factors, thereby inﬂuencing
transcriptional stringency in S. aureus.
Depletion of rpoZ leads to decreased transcriptional speciﬁcity that inﬂuences
multiple cellular processes within the S. aureus cell. We next used functional
clustering to investigate alterations in gene expression upon rpoZ disruption (Fig. 5).
While a variety of cellular processes were shown to be affected by rpoZ deletion, we
noted major changes in genes related to central dogma. Speciﬁcally, genes related to
transcription and translation, as well as cellular processes connected to DNA, RNA, or
protein synthesis, were strongly affected by the loss of . These include changes within
purine and pyrimidine metabolism, enzymes for DNA replication and repair, and amino
acid biosynthesis. Additionally, genes in more general ontological categories, such as
genes for sugar uptake systems (phosphotransferase system [PTS]), the general stress
January 2017 Volume 199 Issue 2 e00459-16
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FIG 5 Ontological grouping for genes altered in expression upon rpoZ disruption. The transcriptional changes from
Fig. 3 were analyzed and organized into ontological groups.

response, regulators, transporters, and metabolism, displayed altered expression. Interestingly, the changes also negatively affect several well-characterized virulence determinants of S. aureus. These include aureolysin (⫺3.7-fold) and the Panton-Valentine
leukocidin-encoding operon (LukSF, ⫺3.4-fold and ⫺3.1-fold, respectively). Lastly, a
signiﬁcant number of phage genes were altered in their expression. This point is
particularly interesting as we have previously described this phenomenon to be one of
the hallmarks of rpoE deletion (8); thus, these effects could result from its depletion
from the RNAP complex. Therefore, although overlap of the ␦ and  regulons is limited
(as described above) and unlikely to be causative for the majority of transcriptional
changes observed in the ΔrpoZ strain, it cannot be entirely excluded that a number of
effects seen in the rpoZ mutant are driven, at least in part, by ␦ depletion from RNAP.
Disruption of the  subunit results in an impaired ability to circumvent
multiple forms of environmental stress. To explore the physiological outcome of
these ﬁndings, we sought to determine if the mutant was impaired in resisting the
impact of environmental stressors. In so doing, we observed that the mutant shows an
augmented sensitivity toward various antibacterial compounds with unrelated mechanisms of action. These include increased sensitivity to triclosan (2-fold; a fatty acid
biosynthesis inhibitor), erythromycin and pyrogallol (both ⬃4-fold; a translation inhibitor and a reducing agent, respectively), and diamide (8-fold; creates disulﬁde stress). As
these compounds all affect different cellular targets, it would appear that depletion of
 leads to widespread ﬁtness defects, highlighting its global importance within the S.
aureus cell.
The  subunit of RNAP is required for bioﬁlm formation in S. aureus. We next
set out to investigate whether the observed changes in gene expression inﬂuence
pathophysiologically relevant processes. Thus, we determined whether the formation
of a bacterial bioﬁlm, a key hallmark of S. aureus infection (35), was inﬂuenced by rpoZ
depletion in vitro. Importantly, upon analysis we observed that loss of  does indeed
lead to an approximately 3-fold reduction in bioﬁlm formation that could be restored
via complementation in trans (Fig. 6). As bioﬁlm formation is strongly inﬂuenced by
extracellular proteins in S. aureus (36), we analyzed the secretomes of the wild-type and
rpoZ mutant strains. Although the vast majority of proteins appeared to be unchanged
in abundance, we noted a marked decrease in a major protein band at around 75 kDa
in the mutant strain (see Fig. S4 in the supplemental material). In order to identify this
protein, we excised the corresponding band from gels and performed mass spectrometric (MS) analysis. It was identiﬁed as two separate tributyrin lipases (the products of
January 2017 Volume 199 Issue 2 e00459-16
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FIG 6 The  subunit of RNAP is required for bioﬁlm formation in S. aureus. Bioﬁlm formation by the
wild-type, rpoZ mutant, and complemented strains was measured using a 24-well plate bioﬁlm assay.
Error bars show SEM, with statistical signiﬁcance measured using Student’s t test (**, P ⬍ 0.01).

SAUSA300_0320 and SAUSA300_2603), with molecular masses of 76 and 77 kDa,
respectively. Interestingly, a recent report on the role of lipase activity in S. aureus
demonstrated that deleting these enzymes results in drastically impaired bioﬁlm
formation (37). This may provide some explanation for these ﬁndings, although given
the complex process of bioﬁlm formation in S. aureus, it is likely that other factors are
also involved.
DISCUSSION
The  subunit of RNAP is a widely distributed protein that is found in all branches
of life. While it is well studied in Gram-negative bacteria (10) and eukaryotes (9), a
recent review by our group highlighted the need for  to be examined in a wider range
of species, and particularly Gram-positive bacteria (6). This is especially true since (i) the
subunit has a variety of possible roles that have received only limited attention in
Gram-positive species, including RNAP subunit folding (9, 12, 13, 15) and stability (16),
complex assembly/stabilization (10, 13, 14), maintenance of  factor speciﬁcity (24, 25),
and ppGpp binding (19–21), and (ii) Gram-positive species, and particularly the Firmicutes, include several epidemiologically relevant human pathogens. To the latter point,
an understanding of cellular factors that are required for transcription and to maintain
transcriptional stringency is crucial in order to better comprehend the physiology of
pathogens and thus potentially aid in counteracting and preventing the spread of
disease. Here we describe the role of  within S. aureus for the ﬁrst time. Our study
explores previously documented functions from other bacterial species, assessing its
impact on the global transcriptome as well as its key role in ﬁtness and, most
importantly, virulence, which to our knowledge has not yet been examined.
It has previously been suggested that the stringent response in Firmicutes is
independent of ppGpp recognition by  (32). Here we demonstrate that under amino
acid-limiting conditions, as well as during exposure to stringent response-inducing
compounds, the ΔrpoZ strain does not exhibit typical stringent response deﬁciency
phenotypes. This is consistent with ﬁndings in B. subtilis, where ppGpp, instead of
directly binding to  as in Gram-negative species, exerts its function indirectly. Instead,
the generation of ppGpp from GTP and ATP (38) in B. subtilis leads to diminished GTP
pools within the cell (39, 40), which in turn causes decreased transcription of GTPsensitive promoters (i.e., those with GTP at position ⫹1 [22, 41, 42]) and interferes with
the role of GTP as a corepressor for CodY (43). These ﬁndings are mirrored in S. aureus,
where CodY- and GTP-regulated genes are similarly inﬂuenced by the nutritional status
of the cell in a ppGpp-dependent manner (33, 44). Therefore, we hypothesize that
rather than resulting from a dysfunctional stringent response, the diminished ability of
a ΔrpoZ strain to survive challenging conditions is a consequence of basal stress levels
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FIG 7 Model for the role of  in the Gram-positive RNA polymerase.
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experienced by the cell upon loss of the subunit. This is supported by our ﬁndings that
S. aureus lacking the rpoZ gene displays a reduced-growth phenotype not only when
exposed to nutrient-limiting and stringent response-inducing conditions but also
during growth at elevated temperatures (data not shown).
To investigate how a lack of  affects the transcriptional process and integrity of
RNAP, we performed complex stability analysis and determined that rpoZ deletion
causes decreased levels of intact RNAP, perhaps as a result of reduced ␤= within the
complex. This is consistent with ﬁndings in other organisms, which describe a
chaperone-like function for , assisting in the folding of ␤= and its subsequent docking
to RNAP (9, 10, 12–15). Indeed, the likely misfolding of ␤= leads not only to degradation
of the subunit but also to impaired assembly and/or dissolution of RNAP and the
proteolysis of several other subunits. Importantly, in addition to this apparent failure of
␤= to fully associate with RNAP,  deletion leads to a jettisoning of ␦ from the
transcription complex and an increase in alternative  factor binding. Indeed, the
ﬁnding that ␦ and A are preferentially released from -less, and presumably structurally unstable, RNAP suggests that -deﬁcient RNAP can provide a unique insight into
the effects of stress on the transcription complex and, more broadly, the role of the
accessory subunits. Based on the current literature, as well as our ﬁndings here, we
propose a model whereby stress within the cell leads to RNAP instability, resulting in
an alteration of subunits present within the transcription complex that speciﬁcally
facilitates survival during unfavorable conditions (Fig. 7). In support of this, those sigma
factors that have increased binding to RNAP upon  deletion (S in E. coli [24], B/F
in cyanobacteria [25], and B in S. aureus) are all major components of the general
stress response in their respective organism (45–49). Furthermore, as with  factors, the
release of ␦ from RNAP has the potential for profound alterations in gene expression,
as a recent publication demonstrates the ability of ␦ to selectively affect individual
promoters (7, 8) via binding to speciﬁc promoter elements (50). As the disruption of
rpoE results in slower bacterial growth in a variety of organisms (e.g., an extended lag
phase [8, 51, 52]), removal of this subunit from RNAP may actually present a survival
advantage during stress, redirecting resources away from division and toward repair
and cellular maintenance. In agreement with this is a recent study with Streptococcus
pneumoniae bioﬁlms, where there appears to be selective pressure for rpoE mutations
leading to small-colony variant (SCV) phenotypes (53). SCV formation is a common
mechanism used by many different bacteria which would initially appear to present a
defect in viability but in actuality results in enhanced survival (54) and antibiotic
resistance and the development of persister cells (55). Interestingly, our group has
observed similar effects in S. aureus, where ␦-deﬁcient mutants display variable, and
decreased, colony size after recovery from murine models of infection (unpublished
observation). Thus, it would appear that the signiﬁcant compositional rearrangement
within -less RNAP is far from random. Rather, these changes in binding of accessory
factors are seemingly directed to speciﬁcally adjust promoter selectivity and preference
to facilitate survival. Furthermore, these ﬁndings regarding subunit swapping within
the transcription complex appear to conﬁrm long-made contentions regarding a level
of cooperativity for ␦ and  factor binding within RNAP (56–58).
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In spite of these changes in subunit abundance, which we suggest are utilized by
the cell as a survival strategy, rpoZ deletion itself results in wide-reaching cellular stress
that is associated with an impaired transcriptional process. This contention is supported
by our RNA sequencing data, which demonstrate the upregulation of various genes
coding for transcriptional and translational factors, putatively in an attempt to overcome diminished or inefﬁcient RNAP function. Furthermore, we identiﬁed increased
expression of genes involved in the general stress response, sugar uptake pathways,
and energy metabolism, all of which may be designed to overcome unfavorable
conditions (59). The latter group emphasizes that intracellular stress resulting from 
deletion, and the subsequent countermeasures it elicits (e.g., production of chaperones,
RNAP subunits, and ribosomal subunits), consumes energy and therefore has the
potential to deplete cellular energy pools. This in turn leads to the upregulation of
sugar uptake and energy metabolism, which in our study resulted in a minor increase
in ATP pools (data not shown). In accordance with this, studies investigating S. aureus
heat stress demonstrate that following exposure to elevated temperatures, cellular
energy levels are in fact not depleted, but rather a steady (60) or transient (61) increase
in ATP pools is observed, presumably due to the upregulation of energy-generating
processes. It is perhaps not surprising that the transcriptional and physiological
changes observed from our in vitro experiments also translate into the impairment of
virulence-related processes, as shown by the impaired bioﬁlm formation in the rpoZ
mutant.
We suggest that, collectively, our ﬁndings extend the existing knowledge regarding
 and its role within RNAP, provide a unique insight into structural rearrangements
within the transcription complex in response to stress, and demonstrate the necessity
of this important subunit for the cellular homeostasis.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All bacterial strains used in this study are listed in Table
1. Unless otherwise indicated, cultures were grown as described by Shaw et al. (62). Brieﬂy, S. aureus was
grown at 37°C with shaking (250 rpm) in tryptic soy broth (TSB) or chemically deﬁned medium (CDM)
(45), while E. coli was cultivated in lysogeny broth (LB) with agitation (250 rpm) at 37°C. Overnight
cultures of S. aureus were seeded at a 1:100 dilution into fresh medium. After 3 h of growth, cultures were
used to inoculate fresh TSB to an optical density at 600 nm (OD600) of 0.05 and grown to the desired
density in a Synergy2 plate reader (BioTek) in 96-well plates.
Mutant construction. In order to investigate the role of the  subunit, a strain carrying a markerless
deletion of the rpoZ gene was created, using a method based on the plasmid pJB38 as outlined by Bose
and coworkers (63). Brieﬂy, the majority of the rpoZ gene was removed via allelic replacement, as initially
described elsewhere (64). To do this, both the 5= and 3= ends of the rpoZ gene, together with ⬃1 kb of
up- and downstream DNA, were PCR ampliﬁed using primers OL2889 to OL2892 and fused together
using MluI sites contained in the ampliﬁcation primers. This was then cloned into pJB38 using SacI and
KpnI sites in primers OL2889 and OL2892. Following several selection and counterselection steps in S.
aureus as described previously (63), rpoZ deletion was conﬁrmed using internal (OL2991 and OL2992) and
external (OL3008 and OL3009) primer pairs relative to the deleted region within the gene.
Complement construction. In order to exclude that secondary mutations were causative for
phenotypic changes observed in the ΔrpoZ strain, a plasmid was constructed to complement the rpoZ
gene in trans. Here, the complete rpoZ operon, including its native promoter, was PCR ampliﬁed using
primers OL3753 and OL3807. After BamHI digestion of the amplicon and the pMK4 shuttle vector, the
PCR fragment and plasmid were ligated together and transformed into chemically competent E. coli
DH5␣. The plasmid isolated from ampicillin-resistant clones was conﬁrmed via Sanger sequencing (using
standard M13 primers). Correct plasmids were transformed into electrocompetent S. aureus RN4220 (65)
and ﬁnally transduced into the S. aureus USA300 rpoZ mutant using 11 (66).
RNA isolation and Northern blots. The detection of RNA transcripts was performed using a
Northern blotting protocol outlined by Caswell et al. (67). Brieﬂy, RNA from cultures grown for 3 h was
isolated using an RNeasy kit (Qiagen), with DNA removed using a Turbo DNA-free kit (Ambion). RNA
concentrations were determined using an Agilent 2100 Bioanalyzer and an RNA 6000 Nano kit (Agilent).
RNA (15 g) was separated by gel electrophoresis (10% polyacrylamide containing 7 M urea and 1⫻
Tris-borate-EDTA [TBE]) before being transferred to an Amersham Hybond N⫹ membrane (GE Healthcare) by electroblotting. In order to cross-link samples, membranes were exposed to UV radiation.
Following this, membranes were prehybridized (1 h, 43°C) in ULTRAhyb-Oligo buffer (Ambion) and
incubated (16 h, 43°C) with a [␥-32]ATP-end-labeled oligonucleotide (OL3377) speciﬁc to the rpoZ target
sequence. Labeling was carried out using T4 polynucleotide kinase (Thermo Scientiﬁc) according to the
manufacturer’s protocol. After overnight incubation, each membrane was washed (30 min, 43°C) with
decreasing (2⫻, 1⫻, and 0.5⫻) concentrations of SSC buffer (300 mM sodium chloride, 30 mM sodium
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TABLE 1 Strains, plasmids, and primers
Strain, plasmid, or
primer
Species and strains
E. coli DH5␣
S. aureus
RN4220
USA300 HOU
HKM850
SH1000
MJH502
BM2393
AW2394

Primers
OL2889
OL2890
OL2891
OL2892
OL2991
OL2992
OL3008
OL3009
OL3377
OL3753
OL3807
OL2393
OL2394
OL1297
OL1298
OL2129
OL2130
OL3136
OL3137
OL3747
OL3748
OL4099
OL4100
OL4109
OL4110
aMRSA,

Reference or
source

Cloning strain

79

Restriction-deﬁcient transformation recipient
MRSA isolate cured of pUSA300-HOU-MRSA
USA300 HOU codY mutant; codY::tet
8325-4 derivate with functional rsbU; rsbU⫹
SH1000 sigB mutant; sigB::tet
USA300 HOU ΔrpoZ mutant
USA300 HOU ΔrpoZ/pMK4::rpoZ rpoZ⫹

Lab Stocks
72
75
80
80
This study
This study

Gram-positive shuttle vector
Counterselectable plasmid to create silent
mutations in S. aureus

81
63

ATGGAGCTCGCCATAATTTATCTTCCACCTTC
ATGACGCGTGCAGTTGTTGCAATTAAATAC
ATGACGCGTGTTTCGACCATTAAAAATATGTG
ATGGGTACCCATTTCTTCAGCACTTTGAAC
GCGTGAAATTGATGAACAAC
CAGCAATTTCTTCTAACGCTC
AGAAGATTAGCTTAGAGAGGTC
GAAATGCTAATGGTGTCACA
CGTCAGCAATTTCTTCTAACGCTCTACCAAC
ATGGGATCCATCGCCAATTTCATCTTT
ATGGGATCCATCTCCCTTAAATATCACTATG
TCGTATGTTGTGTGGAATTG
GTGCTGCAAGGCGATTAAG
GTGGTGGCGTTTGTGC
CCGACAGCAAACACACCCAT
TAACATTCTCTGATGAAGTTG
TTAAGTCTACAGCAGCTTG
TCAATATTATCGGTGGATTTA
GCAAATTATGATGTTGAAATAG
CGTAGATGCAAATTATTACG
CGTTAATGAAACAATTGGAC
GGTTCACGTTCCTTTATC
CAGGTTTACCATCTTTAGG
GTTAAATGGTTTAATGCAGAA
GTATCCATCTTCAGCGA

This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
This
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Plasmids
pMK4
pJB38

Description or sequencea

study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study
study

methicillin-resistant S. aureus. Underlining denotes restriction sites.

citrate). Finally, membranes were exposed to X-ray ﬁlm in order to detect the size and abundance of the
rpoZ transcript.
RNA sequencing and data analyses. RNA sequencing was performed for rpoZ and sigB mutants and
their respective parental strains as previously outlined by our group (8, 68–70). Brieﬂy, RNA was isolated
and the quality determined as described for Northern blot experiments. Following this, RNA from three
biological replicates was pooled in equimolar amounts and rRNA removed by consecutive treatment
with the MICROBExpress (Ambion) and RiboZero (Epicentre) kits. Removal of rRNA was conﬁrmed using
an Agilent 2100 Bioanalyzer (RNA 6000 Nano kit; Agilent). The rRNA-depleted RNA samples were
prepared for sequencing with an Ion Personal Genome Machine (PGM) system as described previously
(68). First, cDNA libraries were constructed with an Ion Total RNA-seq kit, v2 (Ion Torrent). The prepared
libraries were then used to generate template-positive ion sphere particles (ISPs) using an Ion PGM
Template OT2 200 kit (Ion Torrent) in combination with an Ion OneTouch 2 system (Ion Torrent). The
template-positive ISPs were loaded onto Ion 318 v2 chips (Ion Torrent) and sequencing runs performed
with an Ion PGM Sequencing 200 kit, v2 (Ion Torrent). Raw data ﬁles in fastq format were exported and
analyzed using the CLC Genomics Workbench software (Qiagen) and the USA300_FPR3757 and NCTC
8325 reference genomes (GenBank accession numbers CP000255 and NC_007795, respectively). Expression values for each gene were calculated as reads per kilobase per million mapped reads (RPKM), and
a quantile normalization approach was applied (71) with a lower limit of 10 RPKM. Genes that displayed
fold changes of ⱖ2 when comparing expression in the mutant to that in the wild-type strain were
included in further analyses.
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RT-qPCR. In order to conﬁrm expression values that were generated by RNA sequencing, a subset
of genes were chosen to conﬁrm transcriptional changes via quantitative reverse transcription-PCR
(RT-qPCR), as described by us previously (8, 69, 72, 73). PCR ampliﬁcation was performed using primers
for each gene (Table 1) (glpF, OL1297/OL1298; asp23, OL2129/OL2130; SAUSA300_0174, OL3136/OL3137;
aur, OL3747/OL3748; rpoC, OL4099/OL4100; and SAUSA300_0777, OL4109/OL4110), alongside 16S rRNAspeciﬁc primers as standard controls (OL1184/OL1185) (74).
Investigation of RNA polymerase composition. In order to determine the effects of  loss on the
stability and composition of RNAP, we adopted an approach ﬁrst outlined by Gunnelius et al. (an
overview of this procedure can be found in Fig. S1 in the supplemental material) (25). Wild-type and
ΔrpoZ strains were grown to exponential phase, and their cytoplasmic protein fractions were isolated as
outlined previously (75). In order to differentiate between RNAP subunits unbound or within the RNAP
complex, we performed two size selection steps. To do so, we ﬁrst added 10 ml of phosphate-buffered
saline (PBS) to the isolated protein fraction and loaded the complete mixture onto an Amicon Ultra-15
centrifugal ﬁlter unit (EMD Millipore) with a 100-kDa cutoff. After centrifugation (4,000 ⫻ g, 45 min), the
approximately 300 l of remaining protein fraction was washed with 10 ml of PBS and the centrifugation
step repeated. The fraction on top of the ﬁlter was then recovered and stored (⫺80°C) for further analysis.
The complete ﬂowthrough of the ﬁrst ﬁlter step was then applied to a second Amicon Ultra-15
centrifugal ﬁlter unit (EMD Millipore) with a 30-kDa cutoff. The ﬂowthrough was collected and trichloroacetic acid (TCA) precipitated (overnight, 4°C). The pelleted proteins were washed three times in
ice-cold absolute ethanol and subsequently resuspended in PBS. The different fractions were then
subjected to either mass spectrometry or Western blot analysis.
Characterization of protein content using mass spectrometry. Protein extracts isolated via the
size selection protocol outlined above were processed by ﬁlter-aided sample preparation (FASP), as
described by us previously (73, 75). Proteins were reduced with dithiothreitol (DTT), alkylated with
iodoacetamide (IAA), and digested with trypsin–Lys-C (Promega) overnight at 37°C. Peptides were
collected by centrifugation, desalted using Pierce SPE C18 columns with a Supelco vacuum manifold, and
dried in a vacuum concentrator (Labconco). Peptides were resuspended in H2O– 0.1% formic acid and
separated using a 75-m by 10-cm C18 reversed-phase high-pressure liquid chromatography (HPLC)
column (New Objective) on a NanoLC Ultra (Eksigent) with a 120-min gradient (4 to 40% acetonitrile
[ACN] with 0.1% formic acid). Fractions were analyzed on a linear ion trap Orbitrap instrument (Orbitrap
XL; Thermo Fisher Scientiﬁc), with full MS survey scans acquired at 60,000 resolution. The top 10 most
abundant ions were selected for tandem MS (MS/MS) analysis in the linear ion trap. Raw data ﬁles were
processed in MaxQuant (www.maxquant.org) and searched against the UniProtKB S. aureus USA300
protein sequence database. Search parameters included constant modiﬁcation of cysteine by carbamidomethylation and the variable modiﬁcation methionine oxidation. Proteins were identiﬁed using
ﬁltering criteria of 1% protein and peptide false-discovery rates. Protein levels were normalized to the
overall protein content in each of the investigated fractions.
Western blotting. The assessment of ␤ subunit abundance was performed as described by us
previously (66). Size-selected protein fractions containing proteins and protein complexes of ⬎100 kDa
were prepared as for experiments determining RNAP composition. Samples were separated using 12%
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), as described by us previously (76). Separated
proteins were then transferred to a polyvinylidene diﬂuoride (PVDF) membrane and detected using a
monoclonal mouse RNAP ␤ antibody (8RB13; Santa Cruz Biotechnology) and a horseradish peroxidase
(HRP)-conjugated secondary antibody. HRP activity was assessed using the SuperSignal West Pico
substrate (Thermo Fisher Scientiﬁc) and visualized on X-ray ﬁlm.
MIC assessment assay. To determine whether transcriptional changes observed within the mutant
strain resulted in detectable physiological sensitivities, we assessed MICs for various antibacterial agents,
as described by our group previously (77). Brieﬂy, overnight cultures were diluted 1:1,000 into fresh
medium in 96-well plates, and antibiotics at various concentrations were added at amounts no greater
than 2% of the ﬁnal volume. Plates were incubated for 12 h (static, 37°C), and turbidity, as a sign of
bacterial growth, was manually assessed. MICs were deﬁned as the minimum concentration of a given
agent to result in no detectable turbidity in individual wells.
Secretome analysis. To evaluate alterations in secreted proteins, bacteria were grown for 24 h
before being centrifuged (6,000 ⫻ g, 10 min). Supernatants were removed and subjected to 12%
SDS-PAGE as described by us previously (76). Gels were assessed either by silver staining using a Pierce
silver stain kit (Thermo Fisher Scientiﬁc) according to the manufacturer’s instructions or by Coomassie
brilliant blue staining, in-gel trypsin digestion, and mass spectrometric analysis, as described by us
previously (76). Brieﬂy, gel pieces were minced and destained before reduction and alkylation with
dithiothreitol (DTT) and iodoacetamide (IAA), respectively. Proteins were digested with trypsin–Lys-C
overnight at 37°C, and peptides were extracted using 50:50 ACN and H2O– 0.1% formic acid and dried in
a vacuum concentrator (Labconco). Peptides were resuspended in H2O– 0.1% formic acid for LC-MS/MS
analysis, which was performed as described above.
Bioﬁlm assay. The ability of strains to form bioﬁlms was assessed as described by us previously (78).
The wells of non-tissue-culture treated 12-well polystyrene plates were incubated for 48 h (static, 4°C)
with 1 ml of human serum in order to facilitate attachment of cells. Concurrently, bacteria were cultured
overnight in bioﬁlm medium (BFM) (TSB supplemented with 0.5% [wt/vol] dextrose and 3% [wt/vol]
NaCl) and used to seed fresh BFM to an OD600 of 0.05. After removal of the human serum from the wells
of plates, 1 ml of these fresh cultures was transferred into each well and incubated for 48 h (static, 37°C).
After incubation, supernatants were gently removed from each well and the bioﬁlm washed twice with
PBS before ﬁxation with absolute ethanol. Bioﬁlms were stained with crystal violet solution (2% [wt/vol])
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for 10 min, followed by two more rounds of washing with PBS. Residual supernatants were aspirated, and
plates were dried overnight. After this time, 300 l of absolute ethanol was added to the wells and
incubated for 10 min before being removed, and the absorbance was measured at 570 nm using a
Synergy2 plate reader (BioTek).
Accession number(s). All data sets have been deposited to the NCBI Gene Expression Omnibus
(GEO) (accession numbers GSE87033 and GSE87036).

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
JB.00459-16.
TEXT S1, PDF ﬁle, 1.3 MB.
TEXT S2, PDF ﬁle, 0.1 MB.
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Table S1: Differentially expressed genes in the ΔrpoZ mutant strain
Gene name/designation

Fold Change in ΔrpoZ

Function

Hypothetical proteins
SAUSA300_0431

+∞

Hypothetical protein

SAUSA300_1205

7.54

Hypothetical protein

SAUSA300_2493

7.32

Hypothetical protein

SAUSA300_2132

5.81

Hypothetical protein

SAUSA300_1606

5.42

Hypothetical protein

SAUSA300_0575

3.88

Hypothetical protein

SAUSA300_1739

3.83

Hypothetical protein

SAUSA300_0465

3.29

Hypothetical protein

SAUSA300_1335

3.22

Hypothetical protein

SAUSA300_1742

3.11

Hypothetical protein

SAUSA300_1746

2.92

Hypothetical protein

SAUSA300_0392

2.88

Hypothetical protein

SAUSA300_1740

2.84

Hypothetical protein

SAUSA300_1180

2.73

Hypothetical protein

SAUSA300_2131

2.58

Hypothetical protein

SAUSA300_1857

2.41

Hypothetical protein

SAUSA300_0779

2.4

Hypothetical protein

SAUSA300_1743

2.34

Hypothetical protein

SAUSA300_1759

2.31

Hypothetical protein

SAUSA300_1247

2.23

Hypothetical protein

SAUSA300_1915

2.21

Hypothetical protein

SAUSA300_0814

2.2

Hypothetical protein

SAUSA300_1701

2.12

Hypothetical protein

SAUSA300_0642

2.08

Hypothetical protein

SAUSA300_1582

2.07

Hypothetical protein

SAUSA300_2527

2.06

Hypothetical protein

SAUSA300_2236

-2.04

Hypothetical protein

SAUSA300_0824

-2.08

Hypothetical protein

SAUSA300_0177

-2.09

Hypothetical protein

SAUSA300_1863

-2.18

Hypothetical protein

SAUSA300_1748

-2.21

Transposase, frameshift

SAUSA300_1230

-2.39

Hypothetical protein

SAUSA300_1380

-2.62

Hypothetical protein

SAUSA300_0048

-2.9

Hypothetical protein

SAUSA300_0174

-3.02

Hypothetical protein

SAUSA300_0192

2.19

Hypothetical protein

SAUSA300_0805

-2.19

Hypothetical protein

Transport
glpF

8.74

Glycerol uptake facilitator

SAUSA300_0208

4.17

Putative maltose ABC transporter, ATP-binding protein

ptsG

3.76

Glucose transporter subunit IIABC

SAUSA300_2466

3.67

ABC transporter permease protein

SAUSA300_0209

3.65

Putative maltose ABC transporter, maltose-binding protein

SAUSA300_2408

3.37

Oligopeptide permease, ATP-binding protein

SAUSA300_0941

3.07

SAUSA300_0210

2.98

Putative ferrichrome ABC transporter
Maltose ABC transporter, permease protein

4.5S RNA

2.74

Signal recognition particle

SAUSA300_2407

2.6

Peptide ABC transporter, ATP-binding protein

fhuA

2.4

opuD

2.39

Ferrichrome transport ATP-binding protein
Glycine betaine transporter

gntP

2.35

Gluconate permease

SAUSA300_2409

2.25

Oligopeptide permease

SAUSA300_0211

2.21

Maltose ABC transporter, permease protein

SAUSA300_0068

2.02

SAUSA300_2454

-2.05

Cadmium-exporting ATPase, truncation
ABC Transporter

tatC

-2.07

SAUSA300_2453

-2.1

Sec-independent protein translocase
ABC Transporter

SAUSA300_0176

-2.27

ABC transporter, permease protein

SAUSA300_0173

-2.33

Dipeptide/oligopeptide/nickel ABC transporter permease

SAUSA300_2557

-2.49

ABC transporter protein

SAUSA300_0613

-2.57

Putative Na /H antiporter, MnhD component

SAUSA300_0175

-2.58

Putative lipoprotein/ transporter

SAUSA300_0614

-2.6

Putative Na /H antiporter, MnhE component

7.99

HNH nucleases

+

+

+

+

Other
SAUSA300_0045
SAUSA300_0471

4

sbrB

3.87

Veg protein
Small peptide encoding gene

comK

3.83

SAUSA300_0538

3.7

Competence transcription factor
Uncharacterized epimerase/dehydratase

SAUSA300_0328

2.74

Lipoate-protein ligase

SAUSA300_1198

2.53

Putative GTP-binding protein

cap5E

2.29

Capsular polysaccharide biosynthesis protein

SAUSA300_0821

2.23

SUF system FeS assembly protein

SAUSA300_2503

2.23

pknB

2.19

Secretory antigen SsaA
Serine/threonine kinase

typA

2.19

GTP-binding protein

SAUSA300_0474

2.1

Putative endoribonuclease, L-PSP

SAUSA300_0464

2.06

Predicted O-methyltransferase

scpB

2.04

Chromosome segregation and condensation protein B

SAUSA300_2512

2.01

SAUSA300_0135

-2.04

Glyoxalase family protein
Superoxide dismutase

SAUSA300_0534

-2.04

Putative amidohydrolases

SAUSA300_0795

-2.25

Thioredoxin like protein

SAUSA300_0985

-2.26

Hypothetical protein

SAUSA300_0234

-2.51

pcp

-3.52

Putative flavohemoprotein
CDD-2,6-dichloro-p-hydroquinone 1,2-dioxygenase

SAUSA300_0043

-9.73

Metallo-beta-lactamase/Zn-dependent hydrolase

gap

4.65

Glyceraldehyde-3-phosphate dehydrogenase 2

SAUSA300_0170

4.56

Aldehyde dehydrogenase

SAUSA300_0229

3.45

Acyl-CoA transferase

SAUSA300_0662

2.73

Acetyltransferase, GNAT family

sdhC

2.67

Succinate dehydrogenase, cytochrome b-558 subunit

acsA

2.45

Acetyl-coenzyme A synthetase

SAUSA300_0425

2.44

NADH dehydrogenase I, F subunit

SAUSA300_2484

2.38

3-hydroxy-3-methylglutaryl CoA synthase

gltA

2.37

Citrate synthase II

SAUSA300_0945

2.34

Isochorismate synthase family protein

SAUSA300_0424

2.32

Putative Cobalamin protein

sucB

2.21

Dihydrolipoyllysine-residue succinyltransferase

icd

2.14

Isocitrate dehydrogenase

sdhB

2.12

Succinate dehydrogenase, iron-sulfur subunit

SAUSA300_1986

2.05

Nitroreductase family protein

sucA

2.03

2-oxoglutarate dehydrogenase, E1 component

SAUSA300_1894

-2

SAUSA300_2316

-2.15

Acetyltransferase

Metabolism general

Nicotinate phosphoribosyltransferase

SAUSA300_2475

-2.27

Acyl-CoA thioester hydrolase

budA 2736735..2737440)

-2.32

Alpha-acetolactate decarboxylase

folP

-2.53

Dihydropteroate synthase

panB

-2.83

3-methyl-2-oxobutanoate hydroxymethyltransferase

SAUSA300_0343

-2.84

Acetyltransferase

gntR

5.78

Transcriptional regulator, GntR family

malR

4.94

Transcriptional regulator, maltose operon repressor

Regulation

scrR

3.3

Sucrose operon repressor

SAUSA300_0621

2.92

MntR Mn Repressor

treR

2.78

Trehalose operon Repressor

SAUSA300_2310

2.77

Putative transcriptional regulator

nsaS

2.74

NsaS Histidine Kinase

sarA

2.66

Staphylococcal accessory regulator A

SAUSA300_0954

2.61

Transcriptional regulator, MarR family

SAUSA300_0095

2.26

LysR Regulator, LysR family

SAUSA300_0023

2.2

YycI protein

SAUSA300_2530

2.08

Transcriptional regulator, TetR family

SAUSA300_0090

2.05

Hypothetical protein

SAUSA300_1583

-2

SAUSA300_2509

-2.07

Transcriptional regulatory, TetR family

Cystine metabolism regulator

nirR

-2.12

Nitrite reductase transcriptional regulator

argR

-2.19

Arginine repressor homolog

SAUSA300_0110

-2.41

Transcriptional Regulator, GntR family

Translation
rpsO

5.08

30S ribosomal protein S15

rpmB

3.5

50S ribosomal protein L28

rumA

3.41

SAUSA300_2037

3.31

RNA methyltransferase
ATP-dependent RNA helicase

rpsB

2.91

30S ribosomal protein S2

infC

2.91

Translation initiation factor IF-3

rplA

2.67

Ribosomal protein L1

rplM

2.48

50S ribosomal protein L13

rpsI

2.37

30S ribosomal protein S9

rluB

2.3

Pseudouridine synthase B

rplT

2.28

50S ribosomal protein L20

rpmJ

2.27

50S ribosomal protein L36

rpsT

2.19

30S ribosomal protein S20

SAUSA300_0531

2.13

30S ribosomal protein S7

rpsD

2

30S ribosomal protein S4

SAUSA300_1823

-2.38

tRNA-Ser

SAUSA300_1827

-2.42

tRNA-Met

SAUSA300_1981

4.03

Phage terminase family protein

SAUSA300_1959

3.48

PhiPVL ORF044-like protein

SAUSA300_1943

2.94

Phi77 ORF040-like protein

SAUSA300_1966

2.82

Phi77 ORF014-like protein, phage anti-repressor protein

SAUSA300_1933

2.67

Hypothetical phage protein

SAUSA300_1962

2.63

PhiPVL ORF39-like protein

SAUSA300_1968

2.05

Putative phage transcriptional regulator

SAUSA300_1926

-2.02

Phi77 ORF044-like protein

SAUSA300_1954

-2.13

PhiPVL ORF050-like protein

SAUSA300_1948

-2.21

Phi77 ORF069-like protein

SAUSA300_1412

-2.49

PhiSLT ORF 50-like protein

SAUSA300_1953

-2.68

PhiPVL ORF051-like protein

Phage proteins

SAUSA300_1951

-3.06

PhiPVL ORF052-like protein

SAUSA300_1952

-3.81

Phi083 ORF027-like protein

SAUSA300_1945

-7.94

Phi77 ORF071-like protein

mecA

2.78

Penicillin-binding protein 2a

SAUSA300_1059

2.64

Staphylococcal superantigen like protein 12

Virulence determinats

hlgA

2.53

Gamma-hemolysin, component A

SAUSA300_1058

2.42

Alpha-hemolysin

SAUSA300_0033

2.21

Methicillin resistance regulator protein

splE

-2.02

Serine protease

sak

-2.11

Staphylokinase

nuc

-2.13

Nuclease

splB

-2.44

Serine protease

SAUSA300_0883

-2.54

Eap/Map protein

SAUSA300_2087

-2.73

Putative peptidase

lukF-PV

-3.13

Panton-Valentine leukocidin, LukF-PV

lukS-PV

-3.4

Panton-Valentine leukocidin, LukS-PV

aur

-3.74

Zinc metalloproteinase aureolysin

deoD

3.79

Purine nucleoside phosphorylase

purD

2.76

Phosphoribosylamine--glycine ligase

purS

2.67

Phosphoribosylformylglycinamidine synthase

purN

2.55

Phosphoribosylglycinamide formyltransferase

purH

2.5

Bifunctional purine biosynthesis protein

xseB

2.44

Exodeoxyribonuclease VII, small subunit

purM

2.11

Phosphoribosylformylglycinamidine cyclo-ligase

purB

2.08

Adenylosuccinate lyase

SAUSA300_2234

-2.32

Purine nucleosidase

SAUSA300_0724

2.49

SAUSA300_2448

2.35

Putative lipoprotein
Putative membrane protein

SAUSA300_1685

2.23

Putativ membrane protein

SAUSA300_0922

2.1

Membrane protein

SAUSA300_2355

-2.23

Putative lipoprotein

pfoR

-2.47

SAUSA300_0443

-2.49

Perfringolysin O regulator protein
Putative Membrane protein

SAUSA300_0233

-2.64

Putative Membrane protein

SAUSA300_0410

-3.18

Staphylococcal tandem lipoprotein

Purine and pyrimidne metabolism

Membrane/lipoproteins

Sugar metabolism
pfkA

-2.79

6-phosphofructokinase

gpmA

-2.04

sdaAB

2.24

2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
L-serine dehydratase, beta subunit

gntK

3.14

Gluconate kinase

murQ

3.4

N-acetylmuramic acid-6-phosphate etherase

SAUSA300_2455

3.54

Fructose-1,6-bisphosphatase

treC

3.69

Alpha-phosphotrehalase

pckA

3.87

Phosphoenolpyruvate carboxykinase

SAUSA300_1456

5.52

Alpha-amylase

SAUSA300_0777

4.01

Cold shock protein C

SAUSA300_0816

3.44

CsbD-like protein

lexA

2.89

SAUSA300_2639

2.88

LexA repressor
Cold shock protein D

asp23

2.39

Alkaline shock protein 23

SAUSA300_1549

2.37

ComE operon protein I

clpB

2.31

Chaperone

recA

2.14

Recombinase A

putA

6.78

ald

2.08

Proline dehydrogenase
Alanine dehydrogenase

leuD

2.06

3-isopropylmalate dehydratase, small subunit

SAUSA300_0119

-2.05

SAUSA300_0952

-2.75

Ornithine cyclodeaminase
Aminotransferase, class I

treP

3.89

PTS system, trehalose-specific IIBC component

SAUSA300_2324

3.72

PTS system, sucrose-specific IIBC component

SAUSA300_0332

3.45

PTS system, IIA component

SAUSA300_0331

2.74

PTS IIB - ascorbate, lactose or cellobiose

ptsG

2.17

PTS system, glucose-specific IIABC component

SAUSA300_1702

4.86

Cell wall surface anchor family protein

SAUSA300_0703

2.84

Lipoteichoic acid synthase

lytN

2.31

Cell wall hydrolase

SAUSA300_2435

2.01

Cell wall surface anchor family protein

Stress response/repair

Amino acid metabolism

PTS system components

Cell wall

Replication
SAUSA300_1344

2.95

Putative DNA-replication protein, DnaD

SAUSA300_1042

2.15

nrdG

-3.48

DNA polymerase IV (family X)
Anaerobic ribonucleotide reductase, small subunit

nrdD

-4.59

Anaerobic ribonucleotide reductase, large subunit

lip

3.67

Triacyglycerol lipase

acpP

3.25

Acyl carrier protein

plsX
estA

2.11

Phosphate acyltrasferase

-2.33

Tributyrin esterase

2.6

RNAP Beta' subunit

nusA

2.11

Transcription elongation factor

rpoZ

-10.03

Lipid Metabolism

Transcription
rpoC

RNAP omega subunit

Table S2: List comparing the 20 most downregulated genes in a S. aureus
SH1000 σB mutant strain (which have homologues in USA300) to the alterations
in transcript abundance of the homologue genes in a USA300 ΔrpoZ strain.
Feature ID SH1000
SAOUHSC_00624
SAOUHSC_02442
SAOUHSC_02882
SAOUHSC_02443
SAOUHSC_00845
SAOUHSC_02441
SAOUHSC_02444
SAOUHSC_00356
SAOUHSC_01729
SAOUHSC_00358
SAOUHSC_02466
SAOUHSC_02387
SAOUHSC_03032
SAOUHSC_02774
SAOUHSC_01730
SAOUHSC_02772
SAOUHSC_00831
SAOUHSC_02880
SAOUHSC_02881
SAOUHSC_02812

Fold-Change
(sigB::tet)
-∞
-∞
-∞
-15,213.97
-4,178.80
-3,188.61
-1,540.56
-667.21
-546.86
-321.83
-142.55
-139.11
-97.75
-95.56
-89.95
-77.38
-75.12
-70.09
-62.08
-54.8

Feature ID USA300
SAUSA300_0609
SAUSA300_2143
SAUSA300_2502
SAUSA300_2144
SAUSA300_0816
SAUSA300_2142
SAUSA300_2145
SAUSA300_0372
SAUSA300_1581
SAUSA300_0374
SAUSA300_2164
SAUSA300_2097
SAUSA300_2629
SAUSA300_2418
SAUSA300_1582
SAUSA300_2416
SAUSA300_0786
SAUSA300_2500
SAUSA300_2501
SAUSA300_2447

Gene name

asp23

Fold Change
(ΔrpoZ)
-1.61
-1.10
1.41
1.31
3.44
2.39
-1.16
1.11
1.45
1.86
1.52
-1.39
-1.13
-1.08
2.07
1.13
1.19
1.64
1.44
1.90

Table S3: List comparing the 20 most upregulated genes in a S. aureus SH1000
σB mutant strain (which have homologues in USA300) to the alterations in
transcript abundance of the homologue genes in a USA300 ΔrpoZ strain.
Feature ID SH1000
SAOUHSC_00260
SAOUHSC_01315
SAOUHSC_00069
SAOUHSC_02821
SAOUHSC_00818
SAOUHSC_03002
SAOUHSC_02820
SAOUHSC_00674
SAOUHSC_00259
SAOUHSC_00913
SAOUHSC_00072
SAOUHSC_02461
SAOUHSC_00244
SAOUHSC_03004
SAOUHSC_00492
SAOUHSC_02639
SAOUHSC_00250
SAOUHSC_03036
SAOUHSC_01488
SAOUHSC_01941

Fold-Change
(sigB::tet)
∞
∞
80.09
75.93
29.22
21.68
16.26
13.42
11.98
11.1
10.88
10.74
9.97
9.64
9.19
7.73
7.03
6.24
6.23
6.02

Feature ID USA300
SAUSA300_0281
SAUSA300_1221
SAUSA300_0113
SAUSA300_2454
SAUSA300_0776
SAUSA300_2600
SAUSA300_2453
SAUSA300_0654
SAUSA300_0280
SAUSA300_0878
SAUSA300_0116
SAUSA300_2160
SAUSA300_0266
SAUSA300_2601
SAUSA300_0495
SAUSA300_2305
SAUSA300_0272
SAUSA300_2633
SAUSA300_1361
SAUSA300_1757

Gene name

spa
nuc
icaA
sarX

sirB

icaB

splB

Fold Change
(ΔrpoZ)
-1.45
1.20
-1.54
-2.05
-2.13
-1.06
-2.10
-1.50
1.01
-1.68
1.19
1.19
-1.77
-1.41
1.01
-1.21
1.07
1.00
-1.12
-2.44
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Genome-wide Annotation, Identification, and Global Transcriptomic
Analysis of Regulatory or Small RNA Gene Expression in
Staphylococcus aureus
Ronan K. Carroll,a Andy Weiss,b William H. Broach,b Richard E. Wiemels,a Austin B. Mogen,c Kelly C. Rice,c Lindsey N. Shawb
Department of Biological Sciences, Ohio University, Athens, Ohio, USAa; Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida,
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In Staphylococcus aureus, hundreds of small regulatory or small RNAs (sRNAs) have been identified, yet this class of
molecule remains poorly understood and severely understudied. sRNA genes are typically absent from genome annotation files,
and as a consequence, their existence is often overlooked, particularly in global transcriptomic studies. To facilitate improved
detection and analysis of sRNAs in S. aureus, we generated updated GenBank files for three commonly used S. aureus strains
(MRSA252, NCTC 8325, and USA300), in which we added annotations for >260 previously identified sRNAs. These files, the first
to include genome-wide annotation of sRNAs in S. aureus, were then used as a foundation to identify novel sRNAs in the
community-associated methicillin-resistant strain USA300. This analysis led to the discovery of 39 previously unidentified sRNAs. Investigating the genomic loci of the newly identified sRNAs revealed a surprising degree of inconsistency in genome annotation in S. aureus, which may be hindering the analysis and functional exploration of these elements. Finally, using our newly
created annotation files as a reference, we perform a global analysis of sRNA gene expression in S. aureus and demonstrate that
the newly identified tsr25 is the most highly upregulated sRNA in human serum. This study provides an invaluable resource to
the S. aureus research community in the form of our newly generated annotation files, while at the same time presenting the first
examination of differential sRNA expression in pathophysiologically relevant conditions.

ABSTRACT

Despite a large number of studies identifying regulatory or small RNA (sRNA) genes in Staphylococcus aureus,
their annotation is notably lacking in available genome files. In addition to this, there has been a considerable lack of crossreferencing in the wealth of studies identifying these elements, often leading to the same sRNA being identified multiple times
and bearing multiple names. In this work, we have consolidated and curated known sRNA genes from the literature and mapped
them to their position on the S. aureus genome, creating new genome annotation files. These files can now be used by the scientific community at large in experiments to search for previously undiscovered sRNA genes and to monitor sRNA gene expression
by transcriptome sequencing (RNA-seq). We demonstrate this application, identifying 39 new sRNAs and studying their expression during S. aureus growth in human serum.
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I

n recent years, a number of studies have been carried out, employing both experimental and computational methods to identify regulatory or small RNAs (sRNAs) in Staphylococcus aureus
(1–12). Hundreds of sRNAs have been identified, and many, in
addition to the agr effector RNAIII, have been shown to play a role
in gene regulation (while these molecules go by a variety of names
such as regulatory RNAs or noncoding RNAs, we will use sRNAs
to refer to them all, as previously recommended [13]). Despite
advancements in sRNA identification, the roles of most of these
molecules remain unknown, because in many cases, limited functional information can be gathered from analysis of their sequence
alone.
One additional factor that has hampered the study of sRNAs in
S. aureus has been the lack of a clear nomenclature and annotation

January/February 2016 Volume 7 Issue 1 e01990-15

system. This absence of a systematic identification and annotation
process has led to the repeated discovery of the same sRNAs on
multiple occasions, the reidentification of already known sRNAs
(e.g., RNAIII), and even to important protein-coding genes being
ascribed as sRNAs (e.g., the ␣-PSM transcript, which is not annotated in most S. aureus genome files). Recent work by Sassi et al.
(14) established an online database for staphylococcal sRNAs;
however, most sRNAs, including the well-studied RNAIII, are still
not included in annotated S. aureus GenBank genome files. This is
a marked oversight, as annotated genome files serve as the reference for global genomic and transcriptomic studies; thus, the absence of sRNAs from these files severely impedes their study and
prevents us from gaining an overarching picture of regulatory
circuits.
®
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In S. aureus, most sRNA identification studies have been performed in a single background, the hospital-acquired methicillinresistant S. aureus (MRSA) strain N315. The existence of many of
these sRNAs has been demonstrated experimentally in strain
N315 (1, 3, 4, 6, 7); however, very few of them have been investigated in other S. aureus strains, including the epidemic
community-associated MRSA (CA-MRSA) strain USA300 (15).
As such, their existence, location, and copy number in most S. aureus isolates is unknown, preventing us from gaining a sense of
their role in the physiological and pathogenic differences between
strains.
To better understand the sRNA content of multiple S. aureus
strains, we explored the genomes of three well-studied S. aureus
strains (USA300, MRSA252, and NCTC 8325). We identified the
location(s) of previously discovered sRNAs and created new
GenBank genome annotation files for each strain, inserting ~260
sRNAs. These newly annotated files serve as a valuable resource
allowing us to do the following: (i) search the genome of each
strain for as yet unidentified sRNAs without mistakenly reidentifying known species, and (ii) calculate expression values for these
genes using transcriptome sequencing (RNA-seq) data.
To demonstrate the application of these new files, we performed RNA-seq on CA-MRSA strain USA300 growing in laboratory media and human serum and aligned the data to our newly
created sRNA annotated genome files. Examining the data, we
identified 39 novel putative sRNAs that had not been previously
reported. These novel sRNAs were annotated, cross-referenced in
the genomes of strains NCTC 8325 and MRSA252, and added to
the newly created genome files as well. During the crossreferencing process, we observed numerous examples of inconsistent genome annotation in different S. aureus strains. We highlight examples clearly demonstrating genome misannotation and
demonstrate how this phenomenon is adversely affecting the
identification and characterization of sRNAs. Finally, we calculate
expression values and examine the global sRNA expression profile
of strain USA300, uncovering a wealth of molecules that display
differential expression in human serum. The latter point is of significant importance, as it gives us a unique look into the sRNA
transcriptome, not only during growth of S. aureus but also in a
pathophysiologically relevant growth environment. The new genome annotation files described in this work have been deposited
in the figshare depository and are freely available for download.
We suggest that these newly reannotated genomes will be a valuable resource to the S. aureus research community for sRNA identification and analysis hereafter, as they can be incrementally
added to as new sRNAs are discovered.
RESULTS

Annotation of sRNAs on the S. aureus genome. Previous studies
in our lab have utilized RNA-seq to determine the global transcriptomic profile of S. aureus in the community-associated
MRSA strain USA300 (16, 17). Analysis of these data sets revealed
a large number of S. aureus transcripts that map to intergenic
regions where no protein-coding genes have been annotated. We
hypothesized that many of these transcripts represent sRNAs because of the following. (i) Most S. aureus genome annotation files
do not contain annotations for sRNA genes. (ii) Recent studies
carried out in the S. aureus N315 background have demonstrated
that there are several hundred sRNAs encoded in the S. aureus
genome (12, 14). To facilitate improved global transcriptomic
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analysis of S. aureus by RNA-seq, we created new GenBank genome annotation files for three commonly used S. aureus strains,
NCTC 8325, MRSA252, and USA300. To do this, we elected to
expand the sRNA annotation and nomenclature system already
present for 25 sRNAs in strain MRSA252 (see Table S1 in the
supplemental material) and apply a similar annotation/nomenclature system to strains USA300 and NCTC 8325 (for details, see
supplemental material). To include annotations for known
sRNAs, we performed a literature search to identify studies in
which sRNAs in S. aureus were reported. A total of 12 papers that
employed a variety of methods to identify sRNAs, including computational approaches, microarray studies, cDNA cloning, and
high-throughput sequencing, were investigated (1–12). Using the
information provided in these publications, a list of 928 potential
sRNAs was assembled (Table S2) (1–12). In order to ensure accurate annotation of each sRNA from this list, RNA-seq experiments
were performed for each of the three strains growing under standard laboratory conditions. Reads generated from these works
were aligned to the respective genomes and used as a guide to
identify the specific location of each sRNA for each of the three
strains (see Fig. S1 in the supplemental material).
This work condensed the 928 putative sRNAs to a total of 248
annotations for strain MRSA252, 254 annotations for strain
NCTC 8325, and 264 annotations for strain USA300 (for a morecomprehensive explanation of how sRNAs were identified and
annotated, see Text S1 in the supplemental material). Such a dramatic reduction in the number of sRNAs points to the scale of
overlapping identification, reidentification, and duplicate naming
that was extant in the literature for these elements and the poor
state of sRNA curation in S. aureus genomes. Our newly generated
GenBank files for all three strains represent the first comprehensive list of sRNAs annotated directly in the S. aureus genome,
which will serve as a valuable reference point for future sRNA
discovery, and more broadly, global transcriptomic analyses of
S. aureus by RNA-seq.
Detection of novel sRNAs in strain USA300. The creation of
GenBank files containing annotations for previously identified
sRNAs provided us with a unique opportunity to examine RNAseq data for novel forms of these elements, without mistakenly
reidentifying those that are already known. Accordingly, we set
out to perform such an exploration using the communityassociated MRSA isolate USA300, an undeniably relevant clinical
strain for which no sRNA identification studies have yet been performed. To maximize the probability of identifying novel sRNAs,
we performed RNA-seq with USA300 grown under both laboratory conditions (tryptic soy broth [TSB]), and in media that was
more pathophysiologically relevant to its infectious lifestyle (human serum) (18).
RNA-seq reads from bacteria grown under these conditions
were mapped to the newly created USA300 GenBank file (containing 264 sRNA annotations), followed by a thorough examination
for the presence of novel sRNA transcripts. A total of 39 potential
sRNAs were identified from both conditions, which we named tsr1
to tsr39 for Tampa small RNA (Table 1) (for details regarding the
criteria used for our determination of novel sRNAs, see Text S1 in
the supplemental material). Although the majority of the tsr genes
were located in intergenic regions, a number were identified as
being antisense to annotated genes or as partially overlapping annotated coding DNA sequence (CDS) genes. The novel sRNAs
were also added to our newly created USA300 genome file, using
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TABLE 1 Novel sRNAs identified in strain USA300
Chromosomal location of tsr gene in strain:
sRNA designation

sRNA gene

Strand

SAUSA300s265
SAUSA300s266
SAUSA300s267
SAUSA300s268
SAUSA300s269
SAUSA300s270
SAUSA300s271
SAUSA300s272
SAUSA300s273
SAUSA300s274
SAUSA300s275
SAUSA300s276
SAUSA300s277
SAUSA300s278
SAUSA300s279
SAUSA300s280
SAUSA300s281
SAUSA300s282
SAUSA300s283
SAUSA300s284
SAUSA300s285
SAUSA300s286
SAUSA300s287
SAUSA300s288
SAUSA300s289
SAUSA300s290
SAUSA300s291
SAUSA300s292
SAUSA300s293
SAUSA300s294
SAUSA300s295
SAUSA300s296
SAUSA300s297
SAUSA300s298
SAUSA300s299
SAUSA300s300
SAUSA300s301
SAUSA300s302
SAUSA300s303

tsr1
tsr2
tsr3
tsr4
tsr5
tsr6
tsr7
tsr8
tsr9
tsr10
tsr11
tsr12
tsr13
tsr14
tsr15
tsr16
tsr17
tsr18
tsr19
tsr20
tsr21
tsr22
tsr23
tsr24
tsr25
tsr26
tsr27
tsr28
tsr29
tsr30
tsr31
tsr32
tsr33
tsr34
tsr35
tsr36
tsr37
tsr38
tsr39

⬎
⬍
⬍
⬎
⬍
⬎
⬎
⬍
⬍
⬎
⬍
⬎
⬎
⬎
⬎
⬍
⬍
⬍
⬍
⬍
⬍
⬎
⬎
⬎
⬎
⬎
⬍
⬍
⬍
⬎
⬍
⬎
⬍
⬎
⬎
⬍
⬎
⬍
⬍

a

Location

Size (nt)

USA300b

MRSA252b

NCTC 8325b

52438⫺53094
57712⫺57804
61388⫺61550
73511⫺74139
79346⫺79425
120785⫺120897
169903⫺170079
170013⫺170214
228412⫺228796
349895⫺350058
356689⫺356782
457272⫺457333
484942⫺485025
834340⫺834885
896563⫺897379
911246⫺911364
973559⫺973971
1074292⫺1074484
1080302⫺1080394
1154300⫺1154753
1154827⫺1156001
1165484⫺1165865
1256521⫺1256545
1429517⫺1429754
1442862⫺1443042
1641611⫺1641732
1642820⫺1642923
1715900⫺1715975
1954961⫺1955091
2126434⫺2126545
2244964⫺2245035
2337922⫺2338072
2410564⫺2410648
2591032⫺2591131
2608047⫺2608594
2608120⫺2608645
2620285⫺2620621
2664856⫺2664945
2811278⫺2811330

656
92
162
628
79
112
176
201
384
163
93
61
83
545
816
118
412
192
92
453
1174
381
24
237
180
121
103
75
130
111
71
150
84
99
547
525
336
89
52

IG
IG
IG
AS
AS
IG
IG
IG
IG
IG
OL
IG
OL
IG
AS
AS
IG
IG
IG
IG
CDS
IG
IG
IG
IG
IG
IG
OL
IG
IG
IG
IG
IG
IG
IG
IG
IG
IG
IG

⫺
⫺
⫺
AS
⫺
IG
⫺
⫺
CDS
OL
OL
OL
OL
IG
AS
OL
CDS
CDS
IG
⫺
CDS3
CDS
IG
⫺
AS
IG
IG
OL
⫺
⫺
IG
IG
IG
IG
CDS
AS
CDS
IG
IG

⫺
⫺
⫺
AS
⫺
IG
IG
IG
CDS
OL
OL
AS
OL
AS
AS
OL
CDS
CDS
IG
IG
CDS3
CDS
IG
IG
AS
⫺
⫺
OL
IG
⫺
IG
CDS
IG
IG
CDS
AS
CDS
IG
IG

⬎, forward strand; ⬍, reverse strand.
Characteristics of the chromosomal location of the tsr gene. IG, located in the intergenic region; ⫺, absent, deleted, or no homologue; AS, antisense to the annotated gene; CDS,
located within an existing annotated CDS; OL, partially overlaps CDS gene; CDS3, the corresponding locus contains three annotated CDSs.
a
b

the nomenclature system described in Text S1, resulting in a GenBank file with a total of 303 sRNAs in the USA300 genome. This
brings the total number of genes annotated on the USA300 genome from 2,850 to 3,153, representing an approximately 10%
increase in annotated genes.
To investigate the conservation of tsr genes in S. aureus, we
analyzed their corresponding chromosomal loci on the S. aureus
NCTC 8325 and MRSA252 genomes by performing a BLAST
search (Table 1). Of the 39 tsr genes, 29 were found in strain
MRSA252, while 32 were found in strain NCTC 8325. Annotations were again added to the MRSA252 and NCTC 8325 genome
files for each of the tsr genes identified using the nomenclature
outlined (see Text S1 in the supplemental material). Importantly,
five of the tsr genes appear to be unique to USA300 (tsr1, tsr2, tsr3,
tsr5, and tsr30), with no homologues found in either MRSA252 or
NCTC 8325. In addition, five tsr genes were present in USA300
and NCTC 8325 but absent in MRSA252 (tsr7, tsr8, tsr20, tsr24,
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and tsr29), while two were present in USA300 and MRSA252 but
absent in NCTC 8325 (tsr26 and tsr27) (see Fig. S2 in the supplemental material).
Northern blot analysis of tsr transcripts. To validate our
RNA-seq-based approach for sRNA discovery, five putative tsr
transcripts were examined by Northern blot analysis. The transcripts investigated had different expression patterns in TSB compared to human serum. Three of the transcripts investigated (tsr8,
tsr26, and tsr31) showed no alteration in expression between TSB
and human serum, one (tsr25) demonstrated an increase in expression, while another (tsr33) showed a decrease (see Table S3 in
the supplemental material). Northern blot analysis confirmed the
predicted size and orientation of tsr25, tsr26, and tsr31 (Fig. 1). In
the case of tsr8 and tsr33, bands were identified; however, they
were considerably larger than those predicted by RNA-seq analysis (Fig. 1). For example, the predicted size of tsr33 was 85 nucleotides (nt); however, the size observed by Northern blotting was
®
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FIG 1 Northern blot analysis of tsr transcripts. Northern blotting was performed using oligonucleotide probes specific for the tsr transcripts (tsr8, tsr25, tsr26,
tsr31, and tsr33). RNA-seq read alignments for each corresponding chromosomal location are shown, as are CDS genes (black arrows), and sRNAs (red arrows).
The depth of read coverage on the genome is shown by the blue histograms.

approximately 600 nt. When looking at the tsr33 transcript, one
observes that it is located at the 3= end of the sarR gene and is
transcribed in the same orientation. The combined size of sarR
and tsr33 would be around 600 nt, therefore suggesting that tsr33
represents a large 3= untranslated region (UTR) for the sarR gene.
However, RNA-seq alignment from strain USA300 growing in
human serum demonstrates a much greater depth of coverage
(and hence abundance) of tsr33 than of sarR, suggesting that a
tsr33-specific RNA may exist under these conditions (see Fig. S3 in
the supplemental material). On the basis of the above information, we predict that tsr33 is cotranscribed as a 3= UTR of sarR, but
under certain conditions (e.g., growth in human serum), it is possible that a tsr33 RNA may exist independently of sarR.
The second tsr demonstrating a size difference was tsr8, which
was predicted by RNA-seq to be 201 nt; however, two bands were
observed by Northern blotting with approximate sizes between
300 and 400 nucleotides. A possible explanation for this may come
from the fact that tsr8 and tsr7 are convergently transcribed, that
the two transcripts are complementary at the 3= ends, and that
these regions overlap. The density of reads, in both directions,
mapping to this region of complementarity make it difficult to
predict the precise location of each transcript based on RNA-seq
data, resulting in an underestimation of tsr8 size. Given our experimental findings, the size of tsr8 was amended to ~350 nt in the
GenBank files. It is interesting to note that this type of genetic
organization (convergent transcripts overlapping at the 3= end) is
common among toxin-antitoxin (TA) systems in S. aureus (19,
20), hence tsr7 and tsr8 could potentially represent a novel seruminduced TA system.
For some of the tsr elements expressed at low levels, Northern
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blot detection proved unsuccessful (data not shown); therefore,
we employed a reverse transcriptase PCR (RT-PCR)-based approach, which is inherently more sensitive. Using this methodology, we were able to validate the presence of an additional six
transcripts, tsr1, tsr2, tsr18, tsr24, tsr29, and tsr32 (see Fig. S4 in the
supplemental material), suggesting that our RNA-seq-based identification approach is effective at identifying legitimate sRNA molecules.
Inconsistent genome annotation in strains USA300, MRSA252,
and NCTC 8325. Twenty-seven tsr genes were found in the genomes of all three strains (USA300, MRSA252, and NCTC 8325).
For 14 of these genes, the corresponding genomic loci were similarly annotated in all three strains, e.g., tsr6 is located in an intergenic region in all three strains, while tsr15 is located antisense to
an annotated CDS. Interestingly, for 13 tsr genes, the genomic loci
in the three strains studied are differentially annotated (Table 1).
In many cases, the NCTC 8325 and MRSA252 genomes contain
annotations for CDS genes, while the USA300 genome specifies
these loci as being intergenic (e.g., tsr9, tsr17, tsr18, etc.). An open
reading frame (ORF) search reveals that 11 tsr genes have the
potential to encode proteins (of 30 amino acids or larger in size).
Seven of these genes are annotated as CDS in strains MRSA252
and NCTC 8325. This raises the possibility that some tsr genes may
in fact be protein-coding genes that were omitted from the
USA300 genome annotation. Conversely, it is also possible that
the NCTC 8325 and MRSA252 genomes may be incorrect and that
these annotated genes do not encode proteins. Upon close examination, our data clearly demonstrate that incorrect genome annotation accounts for at least some of the discrepancies observed.
For example, the tsr12 locus is annotated differently in all three
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FIG 2 Variation in genome annotation of the tsr12 locus. RNA-seq read alignment data are shown for strains USA300 (A), MRSA252 (B), and NCTC 8325 (C).
Annotations for CDS genes are shown by black arrows, and the depth of coverage is shown by the blue histograms. The location of tsr12 is shown by a red arrow.
(A) There is no CDS annotation at the tsr12 locus in strain USA300. (B) In strain MRSA252, a gene (SAR0432) is annotated in the forward direction at the tsr12
locus. (C) In strain NCTC 8325, a gene (SAOUHSC_00396) is annotated in the reverse direction at the tsr12 locus.

strains (Fig. 2). In strain USA300, tsr12 is located in an intergenic
region (between SAUSA300_0404 and hsdM). In strain
MRSA252, tsr12 incompletely overlaps with a CDS gene annotated in the same orientation, while in strain NCTC 8325, it partially overlaps with a CDS gene annotated in the opposite direction. Bioinformatic analysis of these CDS genes reveals that they
both specify very small proteins (43 amino acids in MRSA252 and
33 amino acids in NCTC 8325) that possess no known structural
motifs and have no homology to any protein in the database beyond counterparts in a handful of other S. aureus strains. Furthermore, in USA300 and NCTC 8325, the tsr12 locus is 100% identical at the nucleotide level, making large-scale differences in
coding sequences (e.g., inverse open reading frames) unlikely.
Collectively, this demonstrates that there is likely misannotation
in the genomes of MRSA252 and NCTC 8325 and that our suggested annotation of tsr12 as an sRNA is likely the correct one.
tsr12 is an example where incorrect genome annotation is
rather clear and raises important questions regarding how commonplace this type of genome misannotation may be. To investigate the issue of inconsistent genome annotation in S. aureus further, we selected another sRNA gene for additional study. Teg23
(SAUSA300s148, SARs145, SAOUHSCs144) was originally identified by Beaume et al. (7) as a potential 5= UTR of the SAS083 gene
in S. aureus strain N315. In strains NCTC 8325 and MRSA252, a
gene is annotated in the position corresponding to SAS083
(SAOUHSC_02572 and SAR2384, respectively), but no gene is
annotated in strain USA300 (Fig. 3A). Upon analysis, SAS083,
SAOUHSC_02572, and SAR2384 once again encode small, hypo-
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thetical proteins with no known structural features, functional
domains, or apparent homologues and are therefore likely misannotated genes (as noted above for the tsr12 locus).
Northern blot analysis using S. aureus USA300 grown in human serum (where Teg23 is strongly upregulated) detected a band
of around 310 nt (as predicted by RNA-seq), alongside an additional band of approximately 215 nt (Fig. 3B). The smaller band
(which we designated Teg23.1) was more abundant than the larger
band (designated Teg23.2) and was repeatedly detected in multiple Northern blots (data not shown), suggesting that two forms of
the transcript may exist within the cell. The CDS annotated in the
NCTC 8325 genome at the Teg23 position (SAOUHSC_02572)
potentially encodes a protein of 80 amino acids (Fig. 3C, red),
while the corresponding locus in strain MRSA252 (SAR2384) potentially encodes a protein of 64 amino acids (Fig. 3C, blue). The
difference is due to a 4-bp insertion in the MRSA252 genome that
results in the creation of a stop codon (Fig. 3C). The nucleotide
sequence of the 432-bp intergenic region from strain USA300 is
almost identical with the corresponding locus in strain NCTC
8325 (431/432 identical), and it does not contain the 4-bp insertion found in MRSA252 (Fig. 3C). Therefore, an 80-amino-acid
protein could potentially be generated from a transcript originating from this locus in USA300 (Fig. 3C, green), similar to NCTC
8325 (for simplicity, this potential protein will be referred to as
Teg23P for Teg23 protein).
To test whether Teg23P is produced in strain USA300, we
cloned a His6-tagged variant of its putative coding sequence, along
with its native promoter, into an S. aureus shuttle vector. Western
®
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FIG 3 Analysis of the Teg23 locus. (A) Teg23 locus in S. aureus strains N315, USA300, NCTC 8325, and MRSA252. Annotated CDS genes are shown in gray.
The previously reported location of Teg23 is shown in white. (B) Northern blot analysis of Teg23. The Teg23 transcript was detected by Northern blot analysis
with a strand-specific oligonucleotide probe. Two bands were detected and were designated Teg23.1 (approximately 215 nt) and Teg23.2 (approximately 310 nt).
(C) Alignment of Teg23 DNA sequence in strains USA300, NCTC 8325, and MRSA252. Sequence corresponding to the SAOUHSC_02572 and SAR2384 CDS
genes is highlighted in red and blue, respectively. Sequence potentially encoding an 80-amino-acid protein (Teg23P) in strain USA300 is highlighted in green. (D)
Western blot to detect histidine-tagged Teg23P. No Teg23P protein was detected in S. aureus expressing the Teg23P-his plasmid (lane 1) or in a wild-type
S. aureus strain without the plasmid (lane 2). Histidine-tagged RpoE was detected as a positive control (lane 3). (E) Quantitative RT-PCR analysis of Teg23
expression. Expression of Teg23 was analyzed in the wild-type S. aureus strain with or without the Teg23P-his plasmid. Approximately 3-fold-higher expression
of Teg23 was detected in the strain expressing the Teg23P-his plasmid. Statistical significance was determined using Student’s t-test. *, P ⬍ 0.05. (F) RNA-seq read
alignment at the Teg23 locus in strain NCTC 8325. RNA-seq reads aligned to the NCTC 8325 genome are shown in blue. The locations of annotated genes are
shown in gray. The locations of primers used for RT-PCR are shown in red. The predicted size and location of the Teg23.1 and Teg23.2 transcripts are shown by
red arrows. (G) RT-PCR analysis of Teg23 transcript. PCR was performed using the primer pairs indicated and S. aureus genomic DNA (gDNA) (lane 1), cDNA
from S. aureus containing the Teg23P-his plasmid (lane 2), cDNA from wild-type S. aureus (lane 3), or no DNA (lane 4). No PCR product was detected using
primers 1 and 3 with S. aureus cDNA as the template.

blots of USA300 strain bearing this construct revealed no detectable band using an antihistidine antibody, while the positive control (histidine-tagged RpoE) was detected (Fig. 3D). Quantitative
RT-PCR (qRT-PCR) to confirm that the construct was being expressed demonstrated a 2.92-fold-higher expression of Teg23 in
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S. aureus containing the Teg23P-his6 plasmid (Fig. 3E). These data
confirm that the plasmid gene-encoded Teg23 is expressed; however, no protein corresponding to Teg23P-his6 is generated. This
strongly suggests that no protein corresponding to Teg23P is produced in strain USA300.
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FIG 4 Location and comparative expression analysis of the 303 S. aureus USA300 sRNAs. The black outer ring shows the chromosomal locations of 303 sRNAs
in strain USA300 (the outer circle shows the forward strand, while the inner circle shows the reverse strand). The inner rings show sRNA gene expression profile
in TSB (outside, blue), human serum (inside, red), and heat map (middle) showing differences in expression. The heights of the blue or red bars are proportional
to the expression values (the maximum displayed expression value was 1,000).

The RNA-seq read alignment data demonstrate that ⬎99% of
the Teg23 reads in strain NCTC 8325 terminate 88 nucleotides
upstream of the annotated 3= end of the gene (Fig. 3F). Consequently, transcript generated at this locus terminates before the
end of the annotated gene, and therefore, an 80-amino-acid protein corresponding to the SAOUHSC_02572 gene is unlikely to be
made. A similar pattern of transcript termination is observed in
the S. aureus USA300 RNA-seq data set, further suggesting that the
Teg23P protein could not be produced in this strain (data not
shown). To test this further, we performed PCR using cDNA generated from total RNA from strain USA300. PCR performed using
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primers that bind within the Teg23 sequence (primers 2 and 3
[Fig. 4F]) generated products using template cDNA from USA300
and USA300 containing the Teg23P-his6 plasmid (Fig. 3G). In
contrast, no product was generated in PCRs using one primer
within the Teg23 sequence and a second primer located at the 3=
end of the Teg23P sequence (primers 1 and 3 [Fig. 3F]). These data
show that the Teg23 RNA is being generated but that it terminates
prior to the 3= end of Teg23P, confirming the results from the
Western blot analysis that Teg23 does not encode an 80-aminoacid protein.
While it is impossible to completely rule out the existence of a
®
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TABLE 2 42 sRNAs that are upregulated in human serum versus TSB
sRNA designation

sRNA gene name
or feature

TSB expression
value (RPKM)b

Serum expression
value (RPKM)

Fold change

SAUSA300s289
SAUSA300s046
SAUSA300s053
SAUSA300s119
SAUSA300s153
SAUSA300s066
SAUSA300s030
SAUSA300s026
SAUSA300s005
SAUSA300s148
SAUSA300s050
SAUSA300s226
SAUSA300s013
SAUSA300s260
SAUSA300s294
SAUSA300s027
SAUSA300s233
SAUSA300s003
SAUSA300s094
SAUSA300s099
SAUSA300s110
SAUSA300s282
SAUSA300s024
SAUSA300s117
SAUSA300s038
SAUSA300s120
SAUSA300s028
SAUSA300s210
SAUSA300s100
SAUSA300s002
SAUSA300s031
SAUSA300s021
SAUSA300s075
SAUSA300s091
SAUSA300s034
SAUSA300s016
SAUSA300s084
SAUSA300s042
SAUSA300s135
SAUSA300s163
SAUSA300s079
SAUSA300s151

tsr25
rsaOG
RsaG
ssr24
Teg16
Sau-63
sprC
ssrS
ffs
Teg23
RsaD
JKD6008sRNA173
Lysine riboswitch
JKD6008sRNA396
tsr30
sprA1
JKD6008sRNA205
T-box riboswitch
Teg108
Teg124
sprA3
tsr18
GlmS ribozyme
ssr8
sprG3
ssr28
sprA2
JKD6008sRNA071
Teg124
SAMa riboswitch
sprD
SAM riboswitch
rsaOL
Teg60
sprF3
T-box riboswitch
Teg27
rsaOC
ssr100
Teg28as
rsaOU
Teg134

60.67
90.99
80.85
130.78
71.05
104.99
149.58
2,991.16
929.74
256.6
2,737.91
50.05
659.93
16.13
470.64
1,097.34
96.96
158.5
19.39
37.1
36.05
105.4
185.53
12.13
191.04
188.03
99.08
136.39
469.39
56.06
804.11
239.09
273.5
95.9
1,227.97
316.76
15,788.22
26.75
322.65
46.74
0
0

35,374.06
34,267.77
3,463.09
3,217.86
1,174.01
1,690.95
2,144.32
37,212.81
11,188.00
2,950.59
30,473.59
539.79
6,917.84
150.26
4,383.00
9,306.35
717.53
1,156.13
132.54
245.19
233.31
653.5
1,064.95
67.9
1,049.33
1,012.53
504.62
691.13
2,313.98
268.4
3,810.91
941.21
1,010.42
350.09
4,261.30
1,059.28
52,571.03
88.89
1,050.22
149.53
85.01
204.13

583.02
376.61
42.83
24.6
16.52
16.11
14.34
12.44
12.03
11.5
11.13
10.78
10.48
9.31
9.31
8.48
7.4
7.29
6.83
6.61
6.47
6.2
5.74
5.6
5.49
5.39
5.09
5.07
4.93
4.79
4.74
3.94
3.69
3.65
3.47
3.34
3.33
3.32
3.26
3.2
⬁
⬁

a
b

SAM, S-adenosylmethionine.
RPKM, reads per kilobase of transcript per million mapped reads.

protein corresponding to Teg23P, these results strongly suggest
that the CDS annotations for Teg23P in strains N315, MRSA252,
and NCTC 8325 (i.e., SAS083, SAR2384, and SAOUHSC_02572,
respectively) are incorrect. Teg23 was originally identified as a 5=
UTR for the SAS083 gene (i.e., the gene encoding Teg23P in N315)
(7); however, the data presented herein demonstrates that this is
incorrect and Teg23 likely represents a nontranslated sRNA. This
comprehensively highlights how overannotation of genomes with
CDS genes may be masking the identification of transcripts that
encode sRNAs.
Global analysis of sRNA gene expression in strain USA300.
The inclusion of 303 sRNA gene annotations in the GenBank file
of strain USA300 allowed us to calculate global gene expression
values for sRNAs using our RNA-seq data sets. To examine variation in sRNA gene expression, we calculated and compared expression values for S. aureus USA300 growing in TSB and human
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serum, two conditions known to result in widespread changes in
gene expression (18). The location, relative expression, and fold
change for each of the 303 sRNA genes in strain USA300 are
shown in Fig. 4 and Table S3 in the supplemental material. To
identify sRNA genes with meaningful differences in expression,
we applied cutoffs to eliminate genes expressed at low levels and
those displaying fold changes that are less than 3-fold (see
Text S1 in the supplemental material for details). This resulted in
a total of 83 sRNAs displaying alterations in gene expression under
the two conditions tested. Forty-two were upregulated in human
serum (Table 2), while 41 were downregulated (Table 3). Of the
newly identified tsr genes, 19 displayed differential regulation,
with 16 downregulated in serum, while 3 (tsr18, tsr25, and tsr30)
were upregulated. Interestingly, the newly identified tsr25 sRNA
demonstrated the largest upregulation in serum of any sRNA
(583-fold). To validate these findings, we performed Northern
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TABLE 3 41 sRNAs that are downregulated in human serum versus TSB
sRNA designation

sRNA gene name
or feature

TSB expression
value (RPKM)a

Serum expression
value (RPKM)

Fold change

SAUSA300s277
SAUSA300s113
SAUSA300s266
SAUSA300s296
SAUSA300s171
SAUSA300s049
SAUSA300s004
SAUSA300s303
SAUSA300s162
SAUSA300s125
SAUSA300s052
SAUSA300s275
SAUSA300s301
SAUSA300s292
SAUSA300s297
SAUSA300s062
SAUSA300s022
SAUSA300s283
SAUSA300s118
SAUSA300s302
SAUSA300s280
SAUSA300s095
SAUSA300s211
SAUSA300s287
SAUSA300s054
SAUSA300s087
SAUSA300s078
SAUSA300s127
SAUSA300s051
SAUSA300s074
SAUSA300s237
SAUSA300s298
SAUSA300s267
SAUSA300s114
SAUSA300s073
SAUSA300s276
SAUSA300s291
SAUSA300s204
SAUSA300s086
SAUSA300s141
SAUSA300s010

tsr13
sbrC
tsr2
tsr32
Sau-6569
RsaC
Purine riboswitch
tsr39
Teg25as
ssr47
RsaF
tsr11
tsr37
tsr28
tsr33
Sau-31
RNAIII
tsr19
ssr16
tsr38
tsr16
Teg116
JKD6008sRNA073
tsr23
RsaH
Teg41
rsaOT
ssr54
RsaE
rsaOI
JKD6008sRNA258
tsr34
tsr3
sbrE
Sau-6072
tsr12
tsr27
RsaX04
Teg39
ssr153
T-box riboswitch

509.65
1,834.12
122.44
92.33
41,077.46
8,079.72
2,277.90
3,132.51
6,668.30
6,272.84
35,374.06
398.93
390.39
513.06
8,987.32
141.32
66,968.70
162.04
478.47
251.17
254.42
1,149.05
59.06
970.48
4,110.36
481.01
17,890.11
3,245.19
2,929.20
721.93
100.89
200.17
85.01
424.58
265.82
295.29
135.22
265.58
50.39
74.69
487.82

0.43
6.3
0.42
0.44
250.83
77.42
45.36
64.48
191.51
256.03
1,713.79
20.01
23.36
31.91
592.2
9.7
5,178.15
13.93
49.19
27.55
30.88
155.21
8
133.71
629.99
74.55
2,790.22
584.15
534.76
135.52
20.87
41.54
19.21
102.21
64.27
73.2
34.48
70.09
13.67
21.06
149.37

⫺1,187.67
⫺291.07
⫺290.6
⫺210.63
⫺163.77
⫺104.37
⫺50.22
⫺48.58
⫺34.82
⫺24.5
⫺20.64
⫺19.94
⫺16.72
⫺16.08
⫺15.18
⫺14.57
⫺12.93
⫺11.63
⫺9.73
⫺9.12
⫺8.24
⫺7.4
⫺7.38
⫺7.26
⫺6.52
⫺6.45
⫺6.41
⫺5.56
⫺5.48
⫺5.33
⫺4.83
⫺4.82
⫺4.43
⫺4.15
⫺4.14
⫺4.03
⫺3.92
⫺3.79
⫺3.69
⫺3.54
⫺3.27

a

RPKM, reads per kilobase of transcript per million mapped reads.

blot analysis of tsr25 and rsaOG (a previously identified sRNA
which showed the second highest degree of upregulation in serum,
376-fold), confirming the predicted size and upregulation of both
sRNAs in human serum (Fig. 5A). RNAIII was downregulated
13-fold in the RNA-seq data analysis, and we also confirmed this
by Northern blotting (Fig. 5B). These results corroborate previously published data (18) and provide validation for the experimental techniques described herein.
The data presented above represent the first global transcriptomic analysis of sRNA gene expression in the CA-MRSA strain
USA300 and demonstrate the utility of the sRNA annotation files
constructed in this study. The biological functions of most sRNAs
are unknown, making it difficult to ascertain the impact on the
bacterial cell of their differential regulation. Studying the variation
in sRNA expression in response to changing environmental conditions may provide insight into which sRNAs play a role in the
adaptive nature of S. aureus. tsr25 and rsaOG, for example, are
upregulated ⬎300-fold in human serum, suggesting a role for
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these molecules under these conditions. In addition, a number of
conserved, well-studied sRNAs were among those differentially
regulated in human serum. 4.5S RNA (SAUSA300s005) and ssrS
(SAUSA300s026) demonstrated increased expression in human
serum (12-fold increase for both). The increased expression of
these RNA species may reflect physiological changes to the bacterial cell in this environmental niche (see Discussion).
DISCUSSION

In 1995, the release of the first fully sequenced bacterial genome
heralded a new era of bacterial genomic research (21). Over the
past 20 years, the number of sequenced bacterial genomes has
risen exponentially, and new research strategies, techniques, and
applications have emerged to exploit the opportunities that these
resources provide. While raw genomic sequence data are valuable,
the availability of fully annotated genome sequences, outlining the
positions of known genes and genomic features, dramatically increases their utility. Global expression analysis techniques such as
®
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FIG 5 Northern blot analysis of serum-regulated sRNAs in strain USA300.
(A) Analysis of sRNAs demonstrating upregulation in human serum. RNA-seq
read alignment data and Northern blot analysis are shown for SAUSA300s289
(tsr25) and SAUSA300s046 (rsaOG) during growth in TSB (T) or human serum (S). (B) Analysis of RNAIII expression in human serum and TSB. RNAseq read alignment data are shown for the entire agr locus. Northern blot
analysis was performed using an oligonucleotide probe specific for the RNAIII
transcript. Annotations for CDS genes are shown by black arrows, annotations
for sRNAs are shown by red arrows, and depth of read coverage on the genome
is shown by the blue histograms.

microarrays and RNA-seq depend heavily on annotated genome
sequences as a reference source for genes in the bacterial cell.
These techniques have proved extremely useful; however, recently, certain limitations to their application are becoming apparent. A major concern in this regard is that they do not provide
expression data for genes that are not included in genome annotation files. Bacterial sRNAs represent a class of genes that are
frequently absent from genome annotation files; consequently,
their expression is rarely studied on a global level. In this work, we
added annotations for 303 sRNA genes to the S. aureus USA300
genome, increasing the number of annotated genes from 2,850 to
3,153 (a 10% increase). Including sRNA gene annotations in S. aureus GenBank files facilitates global expression analysis of these
understudied molecules. The 303 newly added annotations undoubtedly do not represent an exhaustive list of the complete
S. aureus sRNA repertoire, as it is likely that subsequent studies,
using different techniques and environmental conditions, will
continue to add to this number. It is also likely that among the 303
annotations, there may be false positives as only 92 of the 303
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sRNAs reported and annotated here (30%) have been confirmed
by independent experimental methods other than highthroughput sequencing and microarray hybridization. Therefore,
while the sRNA annotated GenBank files generated herein may
not be definitive, they nonetheless represent a significant step forward and pave the way for future studies that can validate the
existence, elucidate the role, and demonstrate the biological impact of these molecules on S. aureus physiology and virulence.
The 303 sRNA genes annotated in this study (representing 10%
of all known genes on the S. aureus genome) were identified in
S. aureus growing under a limited number of environmental conditions. How many sRNAs remain unidentified is unknown; however, on the basis of the data presented in this study and by others
(14), it seems likely that sRNA genes may account for ⬎15 to 20%
of all transcripts in the S. aureus cell. Importantly, a benefit of the
nomenclature system used in this study to annotate sRNAs (in
addition to keeping original names intact) is that it can be expanded upon to accommodate new sRNAs as they are identified.
An unexpected observation arising from this study is the lack of
consistency in genome annotation across multiple strains of S. aureus. The examples highlighted in this study (specifically tsr12 and
Teg23) demonstrate that this phenomenon occurs even at
genomic loci with a high degree of homology (100% identical in
the case of tsr12 in strains USA300 and NCTC 8325). Genome
annotation is typically performed bioinformatically and is rarely
validated and curated (22); therefore, this variation in annotation
likely arises because different annotation pipelines have been used
to annotate different genomes. This raises the important question
of whether certain genomes have been under- and/or overannotated. It is likely that examples of both situations occur; however,
on the basis of our data, it appears that the overannotation of
genomes (i.e., the inclusion of CDS annotations that are not legitimate mRNA transcripts) is common and could have deleterious
consequences for sRNA identification and study. sRNA transcripts that map to genomic regions containing CDS annotations
will mistakenly be assumed to encode proteins. Highlighting this
point is the data presented in Fig. 3, which strongly suggest that
Teg23 is an sRNA and not a protein. Nonetheless, we acknowledge
that this type of data, by its very nature, cannot exclude the possibility that such a gene/protein exists, and hence, once a CDS has
been annotated, it is difficult or impossible to conclusively prove
that it does not exist. Careful attention must be paid to the location of transcript start/stop sites, the existence of ribosome binding sites and the predicted function of annotated genes. We observed many instances of inconsistent genome annotation where a
given gene encoded a protein of unknown function with no homologues and no functional domains. This lack of homology may
indicate that while sequence analysis alone may suggest that a gene
is possible at this locus, it is not certain to exist. The results presented herein are a timely reminder that, although genome annotation files are valuable resources that are increasingly relied upon
by next-generation DNA sequencing technology, these annotations should be treated with a reasonable degree of caution and
not seen as an infallible reference. Confirmation of the existence of
a gene/transcript/protein by traditional biochemical methods
(such as 5= and 3= rapid amplification of cDNA ends [RACE],
primer extension, and in vivo translation) remains essential.
Including sRNA annotations in GenBank files allowed us to
perform global sRNA expression analysis by RNA-seq for the first
time in the CA-MRSA isolate USA300. The data generated dem-
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onstrated that 83 sRNAs are differentially expressed in TSB versus
human serum (Tables 2 and 3). This represents 27% of the known
sRNAs in strain USA300. It is not easy to interpret how their
differential regulation affects the bacterial cell (because the biological functions of most of them are unknown); however, certain
inferences can be made. The newly identified tsr25 sRNA demonstrated a 582-fold increase in expression in human serum. It is
tempting to speculate that increased expression of tsr25 in serum
suggests that it plays an important role during S. aureus bloodstream infections. A small number of conserved, well-studied
sRNAs were also among the differentially regulated sRNAs in serum. 4.5S RNA, a component of the signal recognition particle,
was upregulated 12-fold in human serum, perhaps reflecting altered protein secretion and/or protein composition in the cell
membrane in this environment. Another important cellular RNA
that has been well explored is 6S RNA (ssrS), which we demonstrate also has a 12-fold increase in expression during growth in
serum. In Escherichia coli, 6S RNA binds to the housekeeping
sigma factor 70 and inhibits transcription from 70-dependent
promoters. It is thought that this diverts RNA polymerase to alternative sigma factors (such as the stress response sigma factor),
resulting in increased expression of adaptive and stresscircumventing genes (23). The upregulation of ssrS in human serum suggests that a similar situation occurs in S. aureus, whereby
A-dependent genes are downregulated and B-dependent genes
are upregulated by the action of 6S RNA.
Examining the global transcriptome can provide valuable insights into bacterial physiology and adaptation to environmental
conditions. In the past, global transcriptomic analysis has focused
on protein-coding genes, but here, we conduct global transcriptomic analysis and include newly annotated sRNA genes. Like
protein-coding genes, sRNA genes display differential regulation
that allow bacteria to adapt to environmental changes. The annotation files presented herein, which facilitate this kind of global
analysis will prove to be a valuable resource for the future study of
sRNAs in S. aureus and will more generally broaden our understanding of regulatory circuits.
MATERIALS AND METHODS
Strains, plasmids, and primers. Bacterial strains, plasmids, and primers
used in this study are listed in Table 4. S. aureus and E. coli were grown
routinely at 37°C with shaking in tryptic soy broth (TSB) and lysogeny
broth (LB), respectively. Pooled human serum from anonymous donors,
purchased from MP Biomedicals, was used for growth of S. aureus strain
USA300. When necessary, antibiotics were added at the following concentrations: ampicillin, 100 g ml⫺1; chloramphenicol, 5 g ml⫺1.
RNA-seq. Samples for transcriptome sequencing (RNA-seq) were
prepared as follows for S. aureus USA300 and SH1000. Overnight cultures
were diluted 1:100 in 100 ml of fresh TSB and grown at 37°C with shaking
for 3 h. Exponentially growing cultures were then diluted and synchronized by inoculating fresh 100-ml flasks of TSB at an optical density at 600
nm (OD600) of 0.05, or in the case of strain USA300 growing in serum,
10 ml of human serum in a 50-ml tube. Synchronized cultures were grown
for 3 h at 37°C with shaking, at which time bacteria were pelleted by
centrifugation and stored at ⫺80°C prior to RNA isolation. S. aureus
UAMS-1 (a USA200 strain and close relative of MRSA252) overnight
cultures were diluted to an optical density of 0.05 in 40 ml of TSB containing no dextrose (1:12.5 volume-to-flask volume ratio). Cultures were
grown at 37°C with shaking for 4 h, before cells were harvested and stored
as described above. For each RNA-seq sample, three replicate cultures
were grown, and three biological replicate RNA isolations were performed
(using the procedure outlined in reference 24). For each sample, equimo-
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lar amounts of the three biological replicate RNA preparations were
mixed prior to rRNA reduction. The subsequent RNA-seq analysis therefore represents the average of three biological replicates. RNA-seq and
data analysis were carried out using the protocol previously published by
our research group (24).
Bioinformatics, sRNA identification, and genome annotation. The
CLC Genomics Workbench software platform (Qiagen) was used for all
RNA-seq data analysis and for construction of new GenBank files. Annotated genome files for S. aureus N315, USA300, MRSA252, and NCTC
8325 (GenBank accession numbers NC_002745, CP000255, NC_002952,
and NC_007795, respectively) were downloaded from NCBI. The location, sequence, and orientation of previously described sRNAs on the
N315 genome were calculated based on the information provided in published manuscripts and supplemental information files of the relevant
studies (1–12). Using the CLC Genomics Workbench built-in BLAST
feature, the corresponding positions for sRNAs were identified in the
genomes of strains USA300, MRSA252, and NCTC 8325. The location
and orientation of each sRNA was then annotated.
Northern blots. Northern blots to identify the size and abundance of
sRNAs were performed by the method of Caswell et al. (25). Briefly, 10 g
of total RNA isolated from a 3 h USA300 culture in TSB were loaded on a
10% polyacrylamide gel (7 M urea, 1⫻ Tris-borate-EDTA [TBE]) and
separated by gel electrophoresis. The samples were then transferred via
electroblotting to an Amersham Hybond N⫹ membrane (GE Healthcare). The membrane was exposed to UV light to cross-link samples to the
membrane. Subsequently, membranes were prehybridized (1 h, 45°C) in
ULTRAhyb-Oligo buffer (Ambion) and then incubated (16 h, 45°C) with
sRNA-specific oligonucleotide probes end labeled with [␥-32P]ATP and
T4 polynucleotide kinase (Thermo Scientific). After incubation, membranes were washed with 2⫻, 1⫻, and 0.5⫻ SSC buffer (1⫻ SSC is 300
mM sodium chloride and 30 mM sodium citrate) at 45°C for 30 min each
to remove unspecific bound probes. Finally, X-ray film was exposed to
membranes for sRNA detection.
Cloning of histidine-tagged Teg23P. The genomic region containing
Teg23P (including its native promoter) was amplified using USA300
genomic DNA and primers OL3222 and OL3223. The reverse primer
OL3223, in addition to the gene-specific region, carries a sequence that
encodes a hexahistidine (His6) tag, which allows the detection of a possible encoded protein via Western blotting. The amplified 761-bp product
was cloned into shuttle vector pMK4, and the plasmid was transformed
into chemically competent E. coli DH5␣. The resulting colonies were
screened for correct constructs employing a colony PCR approach using
identical primers to those used for the amplification of the initial fragment. After identification of positive clones, the plasmid was verified via
Sanger sequencing with the plasmid-specific standard primers M13Fw
(Fw stands for forward) and M13Rv (Rv stands for reverse) (Eurofins
MWG Operon). This construct was then transformed into S. aureus
RN4220 and confirmed via PCR. Finally, the plasmid was transduced into
S. aureus USA300 using a 11 phage lysate, and after final confirmation of
the construct using PCR, the strain was utilized for subsequent analysis.
qRT-PCR. Quantitative reverse transcriptase PCR (qRT-PCR) was
conducted as described by our research group previously (26), employing
the teg23-specific primers OL3281, OL3282, OL3232, and OL3282 and
RNA isolated from S. aureus USA300 cultures grown in TSB as described
above for RNA-seq experiments. As a reference, 16S rRNA was amplified
using primers OL1184 and OL1185 (27). All experiments were performed
in triplicate.
Western blots. The evaluation of Teg23 protein abundance was performed by Western immunoblotting as described previously (28).
USA300 cells harboring the His6-tagged version of Teg23P were grown for
3 h in TSB, before they were pelleted and their cytoplasmic proteins were
isolated. Following SDS-polyacrylamide gel electrophoresis and transfer
of the separated proteins to a polyvinylidene difluoride (PVDF) membrane, detection was performed using anti-His monoclonal mouse antibody (Covance) and horseradish peroxidase (HRP)-conjugated anti-
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TABLE 4 Bacterial strains, plasmids, and primers used in this study
Bacterial strain, plasmid,
or primer

Characteristic(s) or sequence

Reference
or source

S. aureus strains
USA300 Houston
SH1000
UAMS-1
RN4220
AW2192
E. coli strain
DH5␣

Community-associated MRSA clinical isolate
Laboratory strain; rsbU functional
Osteomyelitis clinical isolate
Restriction-deficient transformation recipient
USA300 pMK4::teg23p-his6

26
29
30
31
This study

Routine cloning strain

Invitrogen

Plasmids
pMK4
pAW105

Shuttle vector; Cmr
pMK4::teg23P-his6

32
This study

Primers
OL1184
OL1185
OL2701
OL3201
OL3208
OU0121
OL3216
OL3217
OL3222
OL3223
OL3232
OL3281
OL3282
OL3880
OL3882
OL3885
OL3886
OL3916
OL3917
OL3935
OL3937
OL3946
OL3948
OL3956
OL3957

5= TCTGGACCGTGTCTCAGTTCC 3=
5= AGCCGACCTGAGAGGGTGA 3=
5= CCAAATTTAGGCATGTCAAATCGGC 3=
5= GGATTCCCAATTTCTACAGACAATGCA 3=
5= ACGGGCATATAAAAGGGGAATATTTGAAAA 3=
5= GTGTTAAAAAAATAACTGGGATGTG 3=
5= CTCACAAATTCTGTAAGGGGAGCGTAT 3=
5= TTATGTCCCAATGCTGAATAAATAACTTC 3=
5= ACGCGTCGACGCGCTTGTATTCGCTGCAGG 3=
5= CGGGATCCTTAGTGGTGGTGGTGGTGGTGCGCCAACAAGGTTTCAAGAGC 3=
5= CGCCAACAAGGTTTCAAGAGC 3=
5= TAAACAACATACAGCCATTG 3=
5= GAGAATTTGAAGGCAAGTAT 3=
5= GCCAGGATAATGTAGTCTTAA 3=
5= CCATTAATTTACTCAAACCG 3=
5= GCTTCTGTTCGATCTC 3=
5= CACGTCTTCTGATTAAAC 3=
5= CATACCTCTTTAACAACAG 3=
5= GGAGGAATTAATCATGTC 3=
5= GAAGGGATCCAACACA 3=
5= GTCTCGCCATTAATACTAC 3=
5= GTCTTTTCACAACCAAAG 3=
5= GGTTTTATCTTTGGAAAAAG 3=
5= GATGCGGAAAATTTGG 3=
5= GTGCGCAATGAATATTATG 3=

27
27

a

Commenta

teg23 probe
tsr8 probe
tsr25 probe
tsr26 probe
tsr31 probe
tsr33 probe
teg23P F
teg23P-his6 R
teg23 OL1
teg23 OL2
teg23 OL3
tsr1 F
tsr1 R
tsr2 F
tsr2 R
tsr18 F
tsr18 R
tsr24 F
tsr24 R
tsr29 F
tsr29 R
tsr32 F
tsr32 R

F, forward; R, reverse.

mouse secondary antibody. Subsequently, HRP activity was detected and
visualized on X-ray film. Histidine-tagged RpoE, a protein previously described by our group, was included as a control for successful protein
transfer and immunodetection (16).
Accession numbers. The GenBank files generated have been deposited in figshare (https://dx.doi.org/10.6084/m9.figshare.2061132.v1). The
files are provided in .gkb format and can be viewed using a variety of
genome browser software (examples of freely available genome browsers
include Artemis, Genome Compiler, and CLC Sequence Viewer). The
RNA-seq data files have been deposited in GEO under accession number
GSE74936. Newly identified sRNAs (i.e., the tsr sRNAs) have been deposited in GenBank under accession numbers KU639719-KU639757 for
SAUSA300s265-SAUSA300s303, KU639758-KU639789 for SAOUHSCs255SAOUHSCs286, and KU639790-KU639818 for SARs249-SARs277.

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.01990-15/-/DCSupplemental.
Text S1, DOCX file, 0.2 MB.
Figure S1, TIF file, 2 MB.
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Figure S1.

Figure S1. Schematic outlining the procedure used to locate and annotate sRNAs
in S. aureus. A. Using information provided in previous studies the approximate
location of reported sRNAs was identified. B. RNAseq was performed and reads were
aligned to the relevant S. aureus genome. C. Location of aligned reads was used to
precisely locate and annotate sRNAs (blue arrow).

Figure S2.

Figure S2. Distribution of tsr genes in USA300, NCTC 8325 and MRSA252. Five tsr
genes are unique to USA300. An additional five are found in USA300 and NCTC 8325
(but not MRSA252), while two are found in USA300 and MRSA252 (but not NCTC
8325). Twenty-seven tsr genes are found in all three species.

Figure S3.

Figure S3. RNAseq read alignment data for sarR and tsr33 during growth in
human serum. Annotations for CDS genes are shown by black arrows, annotations for
sRNA is shown by red arrow. Depth of read coverage on the genome is shown by blue
histogram. Greater depth of read coverage for tsr33 suggests that a sarR-independent
tsr33 exists under these conditions.

Figure S4.

Figure S4. Reverse transcriptase-PCR based detection of newly identified sRNAs
in S. aureus. PCR reactions were performed with primers specific to newly identified
sRNA genes. DNA-depleted RNA, DNA and H20 were employed as templates to verify
the complete removal of DNA from RNA samples, the correct size of the respective
amplicons and the absence of DNA contaminations. Successful, sizespecific amplification of a target from cDNA suggests the presence of transcript at the
position where a novel sRNA annotation was added to the genome file.

Table S1. List of 25 miscellaneous RNAs from MRSA252 genome
MRSA252

Gene

designation

name

Strand

Position

Description

NCTC 8325

USA300

designation

designation

SARs001

>

12491..12722

T-box riboswitch

SAOUHSCs001

SAUSA300s001

SARs002

>

15939..16037

SAM riboswitch

SAOUHSCs002

SAUSA300s002

SARs003

<

403755..404014

T-box riboswitch

SAOUHSCs003

SAUSA300s003

SARs004

>

441050..441153

Purine riboswitch

SAOUHSCs004

SAUSA300s004

SARs005

ffs

>

509502..509604

Signal recognition particle

SAOUHSCs005

SAUSA300s005

SARs006

ssrA

>

883681..884039

tmRNA

SAOUHSCs006

SAUSA300s006

SARs007

>

908405..908508

SAM riboswitch

SAOUHSCs007

SAUSA300s007

SARs008

<

1098190..1098290

TPP riboswitch

SAOUHSCs008

SAUSA300s008

SARs009

>

1156281..1156504

T-box riboswitch

SAOUHSCs009

SAUSA300s009

SARs010

>

1212605..1212799

T-box riboswitch

SAOUHSCs010

SAUSA300s010

SARs011

>

1437490..1437684

T-box riboswitch

SAOUHSCs011

SAUSA300s011

SARs012

>

1437691..1437899

T-box riboswitch

SAOUHSCs012

SAUSA300s012

SARs013

>

1463346..1463521

Lysine riboswitch

SAOUHSCs013

SAUSA300s013

<

1549260..1549607

Ribonuclease P

SAOUHSCs014

SAUSA300s014

SARs015

<

1588874..1589008

FMN riboswitch

SAOUHSCs015

SAUSA300s015

SARs016

<

1759722..1759920

T-box riboswitch

SAOUHSCs016

SAUSA300s016

SARs017

<

1824382..1824557

Lysine riboswitch

SAOUHSCs017

SAUSA300s017

SARs018

<

1826732..1826959

T-box riboswitch

SAOUHSCs018

SAUSA300s018

SARs019

<

1882961..1883179

T-box riboswitch

SAOUHSCs019

SAUSA300s019

SARs020

<

1943687..1943822

FMN riboswitch

SAOUHSCs020

SAUSA300s020

SARs021

<

1958937..1959048

SAM riboswitch

SAOUHSCs021

SAUSA300s021

<

2183350..2183839

RNAIII

SAOUHSCs022

SAUSA300s022

SARs023

<

2253957..2254059

TPP riboswitch

SAOUHSCs023

SAUSA300s023

SARs024

<

2311657..2311873

GlmS ribozyme

SAOUHSCs024

SAUSA300s024

SARs025

<

2480682..2480777

SAM riboswitch

SAOUHSCs025

SAUSA300s025

SARs014

SARs022

rnpB

RNAIII

Supplemental Methods
sRNA genome annotation
The annotated Genbank (.gbk) files in the NCBI database for most strains of S. aureus
do not contain entries for sRNAs, however, the genome file for MRSA252 (USA200)
includes annotations for 25 RNAs designated as “miscellaneous RNAs” (Table S1).
The nomenclature used for these miscellaneous RNA species, SARs001 to SARs025,
distinguishes them from coding DNA sequence genes (which are annotated SAR0001
to SAR2800). We used these 25 RNAs as a starting point to annotate sRNAs in the
genomes of two additional S. aureus strains i.e. NCTC 8325 and USA300. Using the
sequences of SARs001 to SARs025 as a reference, the corresponding position of their
homologues in the NCTC 8325 and USA300 genomes was identified by BLAST search.
Matches were found for each of the 25 sequences. Genbank files for NCTC 8325 and
USA300 were downloaded from NCBI and new gene annotations were added to each
file for the 25 miscellaneous RNA sequences. A nomenclature system similar to that for
MRSA252 was used to annotate these new genes in the NCTC 8325 and USA300
genomes. In NCTC 8325 sRNA annotations were added using the prefix SAOUHSCs
(to distinguish from CDS annotations which begin with the prefix SAOUHSC) and in
USA300 sRNA annotations were added with the prefix SAUSA300s (CDS annotations
begin with the prefix SAUSA300). Using this system the 25 RNAs from MRSA252
(SARs001 to SARs025) were annotated as SAOUHSCs001 to SAOUHSCs025 in
NCTC 8325 and SAUSA300s001 to SAUSA300s025 in USA300 (Table S1).
Having introduced annotations in the NCTC 8325 and USA300 genomes for these 25
“miscellaneous RNAs”, next we sought to add annotations for other previously identified

sRNAs in S. aureus. To do this a literature search was performed to identify studies in
which sRNAs were described in S. aureus. A total of 12 studies were selected that
employed a variety of methods to identify sRNAs, including computational approaches,
microarray studies, cDNA cloning and high throughput sequencing (1-12). The majority
of these studies have been performed in a single S. aureus background (i.e. strain
N315).

Using the information provided in these publications a list of 928 potential

sRNAs was assembled (Table S2) (1-12). To identify the positions of these sRNAs in
the MRSA252, NCTC 8325 and USA300 genomes we adopted a two-pronged
approach.

First, we assembled all information regarding sRNA sequence, genome

position, and orientation in the N315 genome, from each respective publication. This
information was used to identify the approximate position of each sRNA in MRSA252,
NCTC 8325 and USA300. Second, to facilitate an accurate annotation of each sRNA
position, RNAseq experiments were performed using UAMS-1 (a USA200 isolate, and
close relative of MRSA252), SH1000 (a close relative of NCTC 8325) and USA300
growing under standard laboratory conditions. The reads generated were aligned to the
respective genomes and used as a guide to identify the specific location of each sRNA
on each of the three genomes (Fig. S1).

Using this approach we identified and

annotated an additional 223 sRNAs on the MRSA252 genome, 229 sRNAs on the
NCTC 8325 genome and 239 sRNAs on the USA300 genome (Table S1).

When

combined with the list of 25 RNAs from the MRSA252 genome this brings the total
number of sRNAs annotated to 248 in MRSA252, 254 in NCTC 8325 and 264 on the
USA300 genome. Throughout the annotation process it became apparent, that many of
the sRNAs reported had been identified multiple times in different studies, as has been

noted recently (14). Where multiple copies of sRNAs exist, each copy was individually
annotated to distinguish them from each other. In addition, we observed that the αphenol soluble modulins (α-PSM) transcript was mistakenly identified as a sRNA (6).
The most likely reason for this is that the α-PSMs are not annotated in the S. aureus
genome and therefore any transcript mapping to that location was thought to represent
a sRNA. To avoid future confusion we have included annotations for the PSMs in the
updated MRSA252, NCTC 8325 and USA300 Genbank files.

sRNA gene expression analysis by RNAseq
Expression values for each annotated gene were calculated as RPKM (reads per
kilobase material per million reads) values, using the CLC Genomics Workbench
software platform (Qiagen). TSB and serum data sets were normalized by quantile
normalization (16). To identify sRNA genes differentially expressed in serum Vs TSB,
eliminate lowly expressed genes, and reduce the impact of non-unique reads, three cut
off criteria were applied to the data.
1. Percent unique reads. RPKM values are calculated based upon the number of
reads mapping to a gene. These reads can be unique or non-unique. Non-unique
reads map to multiple locations on the genome and consequently their mapping location
cannot be precisely determined. To avoid artificially inflating RPKM values due to the
incorporation of ambiguous non-unique reads we imposed a cut off whereby >80% of
the reads mapping to a gene (in both data sets) must be unique.
2. Expression values. Small differences in expression values can translate into large
fold-differences for lowly expressed genes. To eliminate lowly expressed genes we

imposed a cut-off whereby the RPKM expression value of a gene must be greater than
or equal to 50 in at least one data set.
3. Fold-change. We imposed a cut-off of 3-fold to identify genes showing differentially
expressed in serum Vs TSB.

sRNA identification in USA300
RNAseq reads generated for USA300 growing in TSB and human serum were aligned
to the newly created Genbank file containing annotations for known sRNAs. These
read alignment files were subsequently examined for transcripts that did not map to
annotated genes. Two types of potential sRNA were identified (i) those mapping to
intergenic regions and (ii) those that were antisense to, and located within annotated
genes.

The following criteria were applied during the selection process to avoid

excessive false positive identifications. The minimum number of unique reads mapping
to a potential sRNA, and minimum RPKM expression value generated must exceed 25
and 40 respectively. Using these selection criteria 39 potential sRNAs were identified
which we named tsr1-39.

Reverse transcriptase polymerase chain reaction
Overnight cultures of wild-type S. aureus USA300 were diluted 1:100 into 5 mL of fresh
TSB and incubated for 3 hours at 37°C in a rotating incubator at 250 RPM. The cultures
were diluted to an OD600 of 0.05 in 100 mL of fresh TSB and incubated for 3 hours at
37°C in a rotating incubator at 250 RPM. Duplicate samples were immediately removed
into 3 volumes of ice cold PBS and centrifuged for 10 minutes at 4150 RPM. RNA was

extracted as previously outlined (16) and contaminating DNA removed using TURBO™
DNase (ThermoFisher Scientific) per their protocol. Finally, 1 µg DNA-free RNA was
used to create cDNA using the iScript™ Reverse Transcription Supermix Kit (BioRad)
per their instructions.
To isolate genomic DNA the pelleted cells were re-suspended in 600 µL of TE buffer in
screw cap tubes with glass beads. The cells were then beaten for a total of 3 minutes in
30-second bursts. The cells were then centrifuged at full speed for 2 minutes. Next, 500
µL of supernatant was transferred to a sterile microfuge tube with 100 µL of 1.6% nlauroylsarcosine and 25 µg Proteinase K (US Biologicals) then incubated for 1 hour at
60°C. After incubation 500 µL of phenol:chloroform (1:1), briefly vortexed, and then
centrifuged at full speed for 2 minutes. The aqueous layer was removed and the DNA
was precipitated with 3 M sodium acetate and isopropanol overnight at -80°C. The DNA
was centrifuged at 4°C at full speed for 20 minutes. DNA pellets were rinsed with ice
cold 70% ethanol, dried at 45°C, and re-suspended in 500 µL of nuclease free water.
Green GoTaq (Promega) was used in an amplification reaction containing 1 mM primers
and 100 ng nucleic acid template (DNase-treated RNA, genomic DNA, or cDNA) or
water. All PCR reactions were performed in a DNA Engine Peltier Thermal Cycler
(BioRad) with an annealing temperature of 45°C and an extension time of 1 minute at
72°C for 35 cycles. PCR products were evaluated for size and specificity by separation
on a 2% (w/v) agarose gel with a 100 bp DNA Molecular Marker (Promega).

